메인콘텐츠로 건너뛰기

TCGA

Breast cancer dataset (Nature 2012, 825 patients)

SUBTYPE SUBTYPE2 SUBTYPE3 SAMPLE_ID PATIENT_ID Gender AGE ER Status PR Status HER2 Final Status Tumor Tumor--T1 Coded Node Node-Coded Metastasis Metastasis-Coded AJCC Stage Converted Stage Survival Data Form OS_STATUS OS_MONTHS PAM50 Subtype SigClust Unsupervised mRNA SigClust Intrinsic mRNA miRNA Clusters methylation Clusters RPPA Clusters CN Clusters Integrated Clusters (with PAM50) Integrated Clusters (no exp) Integrated Clusters (unsup exp) CANCER_TYPE CANCER_TYPE_DETAILED
0 TNBC TNBC TNBC TCGA-A2-A0T2-01 TCGA-A2-A0T2-01 FEMALE 66.0 Negative Negative Negative T3 T_Other N3 Positive M1 Positive Stage IV No_Conversion followup DECEASED 7.89 Basal-like 0.0 -13.0 3.0 5.0 Basal 3.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
1 TNBC TNBC TNBC TCGA-A2-A04P-01 TCGA-A2-A04P-01 FEMALE 36.0 Negative Negative Negative T2 T_Other N3 Positive M0 Negative Stage IIIC No_Conversion followup DECEASED 17.97 Basal-like 0.0 -13.0 5.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
2 TNBC TNBC TNBC TCGA-A1-A0SK-01 TCGA-A1-A0SK-01 FEMALE 54.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup DECEASED 31.77 Basal-like -6.0 -13.0 5.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
3 TNBC TNBC TNBC TCGA-A2-A0CM-01 TCGA-A2-A0CM-01 FEMALE 40.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup DECEASED 24.77 Basal-like -12.0 -13.0 4.0 4.0 Basal 4.0 2.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
4 TNBC TNBC TNBC TCGA-AR-A1AR-01 TCGA-AR-A1AR-01 FEMALE 50.0 Negative Negative Negative T1 T1 N2 Positive M0 Negative Stage III Stage IIIA enrollment DECEASED 17.18 Basal-like 0.0 -13.0 5.0 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
5 TNBC TNBC TNBC TCGA-B6-A0WX-01 TCGA-B6-A0WX-01 FEMALE 40.0 Negative Negative Negative T3 T_Other N1 Positive M0 Negative Stage IIIA No_Conversion followup DECEASED 21.45 Basal-like 0.0 -13.0 4.0 5.0 X 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
6 NaN NaN NaN TCGA-BH-A1F0-01 TCGA-BH-A1F0-01 FEMALE 80.0 Negative Indeterminate Negative T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment DECEASED 25.79 Basal-like -12.0 -13.0 6.0 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
7 NaN NaN NaN TCGA-B6-A0I6-01 TCGA-B6-A0I6-01 FEMALE 49.0 Negative Negative Not Available T1 T1 N1 Positive M0 Negative Stage IIA No_Conversion followup DECEASED 32.76 Basal-like 0.0 -13.0 4.0 5.0 Basal NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
8 TNBC TNBC TNBC TCGA-BH-A18V-01 TCGA-BH-A18V-01 FEMALE 48.0 Negative Negative Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion enrollment DECEASED 51.09 Basal-like -12.0 -13.0 5.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
9 TNBC TNBC TNBC TCGA-BH-A18Q-01 TCGA-BH-A18Q-01 FEMALE 56.0 Negative Negative Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion enrollment DECEASED 55.59 Basal-like -12.0 -13.0 5.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
10 ER+ ER+ ER+ TCGA-BH-A18K-01 TCGA-BH-A18K-01 FEMALE 46.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment DECEASED 90.75 Basal-like -12.0 -13.0 5.0 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
11 ER+ ER+ ER+ TCGA-BH-A0HL-01 TCGA-BH-A0HL-01 FEMALE 56.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 2.37 Basal-like 0.0 -13.0 4.0 3.0 LumA/B NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
12 TNBC TNBC TNBC TCGA-BH-A0E0-01 TCGA-BH-A0E0-01 FEMALE 38.0 Negative Negative Negative T3 T_Other N3 Positive M0 Negative Stage IIIC No_Conversion followup LIVING 4.37 Basal-like 0.0 -13.0 5.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
13 TNBC TNBC TNBC TCGA-BH-A0RX-01 TCGA-BH-A0RX-01 FEMALE 59.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 5.59 Basal-like -12.0 -13.0 4.0 5.0 ReacII 4.0 2.0 3.0 2.0 Breast Cancer Invasive Breast Carcinoma
14 NaN NaN NaN TCGA-A7-A13D-01 TCGA-A7-A13D-01 FEMALE 46.0 Negative Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 8.77 Basal-like 0.0 -13.0 5.0 5.0 ReacII 3.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
15 TNBC TNBC TNBC TCGA-BH-A0E6-01 TCGA-BH-A0E6-01 FEMALE 69.0 Negative Negative Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 9.59 Basal-like 0.0 -13.0 4.0 1.0 ReacI 1.0 3.0 1.0 4.0 Breast Cancer Invasive Breast Carcinoma
16 TNBC TNBC TNBC TCGA-AO-A0J4-01 TCGA-AO-A0J4-01 FEMALE 41.0 Negative Negative Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 9.66 Basal-like -12.0 -13.0 4.0 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
17 TNBC TNBC TNBC TCGA-A7-A0CE-01 TCGA-A7-A0CE-01 FEMALE 57.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 10.15 Basal-like 0.0 -13.0 5.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
18 ER+ ER+ ER+ TCGA-A7-A13E-01 TCGA-A7-A13E-01 FEMALE 62.0 Positive Negative Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 10.71 Basal-like -12.0 -13.0 5.0 4.0 Basal 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
19 TNBC TNBC TNBC TCGA-A7-A0DA-01 TCGA-A7-A0DA-01 FEMALE 62.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 12.25 Basal-like 0.0 -13.0 4.0 5.0 X 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
20 TNBC TNBC TNBC TCGA-D8-A142-01 TCGA-D8-A142-01 FEMALE 74.0 Negative Negative Negative T3 T_Other N0 Negative M0 Negative Stage IIB Stage IIB followup LIVING 13.96 Basal-like 0.0 -13.0 3.0 5.0 X 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
21 TNBC TNBC TNBC TCGA-D8-A143-01 TCGA-D8-A143-01 FEMALE 51.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 14.16 Basal-like 0.0 -13.0 NaN 5.0 Basal 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
22 TNBC TNBC TNBC TCGA-AQ-A04J-01 TCGA-AQ-A04J-01 FEMALE 45.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 16.39 Basal-like -12.0 -13.0 4.0 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
23 ER+ ER+ ER+ TCGA-BH-A0HN-01 TCGA-BH-A0HN-01 FEMALE 67.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 16.95 Basal-like 0.0 -13.0 6.0 2.0 ReacI NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
24 TNBC TNBC TNBC TCGA-A2-A0T0-01 TCGA-A2-A0T0-01 FEMALE 59.0 Negative Negative Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 17.51 Basal-like 0.0 -13.0 5.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
25 TNBC TNBC TNBC TCGA-A2-A0YE-01 TCGA-A2-A0YE-01 FEMALE 48.0 Negative Negative Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 18.17 Basal-like -12.0 -13.0 NaN 5.0 X 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
26 ER+ ER+ ER+ TCGA-A2-A0YJ-01 TCGA-A2-A0YJ-01 FEMALE 39.0 Positive Negative Negative T3 T_Other N2 Positive M0 Negative Stage IIIA No_Conversion followup LIVING 18.56 Basal-like -12.0 -13.0 NaN 5.0 Basal 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
27 TNBC TNBC TNBC TCGA-A2-A0D0-01 TCGA-A2-A0D0-01 FEMALE 60.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 21.13 Basal-like -12.0 -13.0 5.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
28 TNBC TNBC TNBC TCGA-A2-A04U-01 TCGA-A2-A04U-01 FEMALE 47.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 22.01 Basal-like 0.0 -13.0 5.0 5.0 Basal NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
29 TNBC TNBC TNBC TCGA-AO-A0J6-01 TCGA-AO-A0J6-01 FEMALE 61.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 25.46 Basal-like -12.0 -13.0 2.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
30 TNBC TNBC TNBC TCGA-A2-A0YM-01 TCGA-A2-A0YM-01 FEMALE 67.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 31.67 Basal-like -12.0 -13.0 5.0 5.0 Basal 3.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
31 TNBC TNBC TNBC TCGA-A2-A0D2-01 TCGA-A2-A0D2-01 FEMALE 45.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIB Stage IIA followup LIVING 33.74 Basal-like -12.0 -13.0 4.0 5.0 Basal 3.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
32 TNBC TNBC TNBC TCGA-BH-A0B3-01 TCGA-BH-A0B3-01 FEMALE 53.0 Negative Negative Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 39.52 Basal-like -12.0 -13.0 4.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
33 TNBC TNBC TNBC TCGA-A2-A04Q-01 TCGA-A2-A04Q-01 FEMALE 48.0 Negative Negative Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 41.89 Basal-like -12.0 -13.0 4.0 1.0 ReacII 3.0 3.0 1.0 2.0 Breast Cancer Invasive Breast Carcinoma
34 TNBC TNBC TNBC TCGA-A2-A0SX-01 TCGA-A2-A0SX-01 FEMALE 48.0 Negative Negative Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 42.32 Basal-like -12.0 -13.0 4.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
35 TNBC TNBC TNBC TCGA-AO-A0JL-01 TCGA-AO-A0JL-01 FEMALE 59.0 Negative Negative Negative T2 T_Other N2 Positive M0 Negative Stage IIIA No_Conversion followup LIVING 43.34 Basal-like 0.0 -13.0 5.0 5.0 Basal 3.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
36 TNBC TNBC TNBC TCGA-AO-A12F-01 TCGA-AO-A12F-01 FEMALE 36.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 48.33 Basal-like 0.0 -13.0 5.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
37 TNBC TNBC TNBC TCGA-BH-A0B9-01 TCGA-BH-A0B9-01 FEMALE 44.0 Negative Negative Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 51.65 Basal-like -12.0 -13.0 5.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
38 TNBC TNBC TNBC TCGA-A2-A04T-01 TCGA-A2-A04T-01 FEMALE 62.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 73.79 Basal-like -12.0 -13.0 5.0 5.0 Basal 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
39 TNBC TNBC TNBC TCGA-B6-A0RT-01 TCGA-B6-A0RT-01 FEMALE 39.0 Negative Negative Negative T3 T_Other N1 Positive M0 Negative Stage IIIA No_Conversion followup LIVING 89.40 Basal-like -12.0 -13.0 3.0 5.0 ReacII 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
40 TNBC TNBC TNBC TCGA-AO-A128-01 TCGA-AO-A128-01 FEMALE 61.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 94.52 Basal-like 0.0 -13.0 6.0 5.0 Basal 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
41 TNBC TNBC TNBC TCGA-AO-A129-01 TCGA-AO-A129-01 FEMALE 29.0 Negative Negative Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 96.04 Basal-like -12.0 -13.0 3.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
42 TNBC TNBC TNBC TCGA-AO-A124-01 TCGA-AO-A124-01 FEMALE 38.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 102.47 Basal-like -12.0 -13.0 3.0 5.0 Basal 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
43 TNBC TNBC TNBC TCGA-B6-A0RU-01 TCGA-B6-A0RU-01 FEMALE 49.0 Negative Negative Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 131.12 Basal-like -11.0 -13.0 6.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
44 TNBC TNBC TNBC TCGA-B6-A0IQ-01 TCGA-B6-A0IQ-01 FEMALE 40.0 Negative Negative Negative T3 T_Other N1 Positive M0 Negative Stage IIIA No_Conversion followup LIVING 140.75 Basal-like -12.0 -13.0 5.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
45 NaN NaN NaN TCGA-B6-A0I2-01 TCGA-B6-A0I2-01 FEMALE 45.0 Performed but Not Available Performed but Not Available Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 143.25 Basal-like -12.0 -13.0 3.0 5.0 ReacII 3.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
46 ER+ ER+ ER+ TCGA-B6-A0IJ-01 TCGA-B6-A0IJ-01 FEMALE 42.0 Positive Positive Negative T3 T_Other N0 Negative M0 Negative Stage IIB Stage IIB followup LIVING 176.86 Basal-like -12.0 -13.0 5.0 5.0 Basal 3.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
47 NaN NaN NaN TCGA-B6-A0X1-01 TCGA-B6-A0X1-01 FEMALE 48.0 Negative Negative Not Available T2 T_Other N2 Positive M1 Positive Stage IV No_Conversion followup LIVING 186.32 Basal-like -12.0 -13.0 NaN 5.0 Basal 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
48 TNBC TNBC TNBC TCGA-B6-A0RE-01 TCGA-B6-A0RE-01 FEMALE 61.0 Negative Negative Negative TX NaN N0 Negative M0 Negative NaN No_Conversion followup LIVING 211.39 Basal-like -12.0 -13.0 4.0 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
49 TNBC TNBC TNBC TCGA-A2-A0ST-01 TCGA-A2-A0ST-01 FEMALE 62.0 Negative Negative Negative T1 T1 N1 Positive M0 Negative Stage IIA No_Conversion enrollment LIVING 53.98 Basal-like -12.0 -13.0 3.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
50 ER+ ER+ ER+ TCGA-AR-A0TP-01 TCGA-AR-A0TP-01 FEMALE 43.0 Positive Negative Negative T2 T_Other N0 Negative M0 Negative Stage II No_Conversion enrollment LIVING 78.59 Basal-like -11.0 -13.0 3.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
51 TNBC TNBC TNBC TCGA-A1-A0SO-01 TCGA-A1-A0SO-01 FEMALE 67.0 Negative Negative Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 27.99 Basal-like 0.0 -13.0 5.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
52 TNBC TNBC TNBC TCGA-A8-A07C-01 TCGA-A8-A07C-01 FEMALE 57.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 19.06 Basal-like -12.0 -13.0 5.0 5.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
53 TNBC TNBC TNBC TCGA-A8-A07O-01 TCGA-A8-A07O-01 FEMALE 51.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 9.99 Basal-like -12.0 -13.0 4.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
54 NaN NaN NaN TCGA-A8-A07R-01 TCGA-A8-A07R-01 FEMALE 80.0 Negative Negative Equivocal T2 T_Other N3 Positive M0 Negative Stage IIIC Stage IIIC enrollment LIVING 8.97 Basal-like -12.0 -13.0 4.0 5.0 Basal 3.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
55 NaN NaN NaN TCGA-A8-A07U-01 TCGA-A8-A07U-01 FEMALE 66.0 Negative Positive Negative T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 9.96 Basal-like -12.0 -13.0 4.0 5.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
56 HER2+ ER+ ER+/HER2+ TCGA-A8-A08H-01 TCGA-A8-A08H-01 FEMALE 66.0 Positive Positive Positive T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.00 Basal-like -8.0 -5.0 4.0 1.0 ReacI 1.0 3.0 1.0 4.0 Breast Cancer Invasive Breast Carcinoma
57 TNBC TNBC TNBC TCGA-A8-A08R-01 TCGA-A8-A08R-01 FEMALE 52.0 Negative Negative Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 0.99 Basal-like -12.0 -13.0 4.0 5.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
58 TNBC TNBC TNBC TCGA-AN-A04D-01 TCGA-AN-A04D-01 FEMALE 58.0 Negative Negative Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion enrollment LIVING 1.71 Basal-like 0.0 -13.0 5.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
59 TNBC TNBC TNBC TCGA-AN-A0AL-01 TCGA-AN-A0AL-01 FEMALE 41.0 Negative Negative Negative T4 T_Other N0 Negative M0 Negative Stage IIIB No_Conversion enrollment LIVING 6.47 Basal-like 0.0 -13.0 3.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
60 TNBC TNBC TNBC TCGA-AN-A0AR-01 TCGA-AN-A0AR-01 FEMALE 55.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA No_Conversion enrollment LIVING 0.30 Basal-like 0.0 -13.0 5.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
61 TNBC TNBC TNBC TCGA-AN-A0AT-01 TCGA-AN-A0AT-01 FEMALE 62.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA No_Conversion enrollment LIVING 0.33 Basal-like -12.0 -13.0 NaN 5.0 Basal 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
62 ER+ ER+ ER+ TCGA-AN-A0FJ-01 TCGA-AN-A0FJ-01 FEMALE 59.0 Positive Negative Negative T2 T_Other N2 Positive M0 Negative Stage IV No_Conversion enrollment LIVING 7.92 Basal-like 0.0 -13.0 5.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
63 TNBC TNBC TNBC TCGA-AN-A0FL-01 TCGA-AN-A0FL-01 FEMALE 62.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA No_Conversion enrollment LIVING 7.56 Basal-like 0.0 -13.0 5.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
64 TNBC TNBC TNBC TCGA-AN-A0FX-01 TCGA-AN-A0FX-01 FEMALE 52.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA No_Conversion enrollment LIVING 0.33 Basal-like -11.0 -13.0 4.0 4.0 ReacII 1.0 2.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
65 TNBC TNBC TNBC TCGA-AN-A0G0-01 TCGA-AN-A0G0-01 FEMALE 56.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA No_Conversion enrollment LIVING 0.53 Basal-like 0.0 -13.0 3.0 5.0 Basal NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
66 TNBC TNBC TNBC TCGA-AN-A0XU-01 TCGA-AN-A0XU-01 FEMALE 54.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.33 Basal-like -12.0 -13.0 4.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
67 TNBC TNBC TNBC TCGA-AR-A0TS-01 TCGA-AR-A0TS-01 FEMALE 46.0 Negative Negative Negative T2 T_Other N1 Positive M0 Negative Stage II No_Conversion enrollment LIVING 37.39 Basal-like -12.0 -13.0 5.0 5.0 Basal 4.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
68 TNBC TNBC TNBC TCGA-AR-A0TU-01 TCGA-AR-A0TU-01 FEMALE 35.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage II No_Conversion enrollment LIVING 11.83 Basal-like -12.0 -13.0 NaN 5.0 Basal 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
69 TNBC TNBC TNBC TCGA-AR-A0U0-01 TCGA-AR-A0U0-01 FEMALE 73.0 Negative Negative Negative T2 T_Other N1 Positive M0 Negative Stage II No_Conversion enrollment LIVING 0.26 Basal-like -12.0 -13.0 NaN 1.0 Basal 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
70 TNBC TNBC TNBC TCGA-AR-A0U1-01 TCGA-AR-A0U1-01 FEMALE 36.0 Negative Negative Negative T2 T_Other N1 Positive M0 Negative Stage II No_Conversion enrollment LIVING 6.08 Basal-like 0.0 -13.0 6.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
71 TNBC TNBC TNBC TCGA-AR-A0U4-01 TCGA-AR-A0U4-01 FEMALE 54.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage II No_Conversion enrollment LIVING 53.46 Basal-like -12.0 -13.0 5.0 5.0 ReacII 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
72 ER+ ER+ ER+ TCGA-AR-A1AH-01 TCGA-AR-A1AH-01 FEMALE 51.0 Positive Negative Negative T2 T_Other N1 Positive M0 Negative Stage II Stage IIB enrollment LIVING 75.50 Basal-like 0.0 -13.0 5.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
73 TNBC TNBC TNBC TCGA-AR-A1AI-01 TCGA-AR-A1AI-01 FEMALE 47.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage II Stage IIA enrollment LIVING 61.80 Basal-like -12.0 -13.0 3.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
74 ER+ ER+ ER+ TCGA-AR-A1AJ-01 TCGA-AR-A1AJ-01 FEMALE 83.0 Positive Negative Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 52.70 Basal-like -12.0 -13.0 4.0 5.0 ReacI 3.0 2.0 1.0 2.0 Breast Cancer Invasive Breast Carcinoma
75 TNBC TNBC TNBC TCGA-AR-A1AQ-01 TCGA-AR-A1AQ-01 FEMALE 49.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage II Stage IIA enrollment LIVING 43.01 Basal-like -12.0 -13.0 3.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
76 TNBC TNBC TNBC TCGA-AR-A1AY-01 TCGA-AR-A1AY-01 FEMALE 65.0 Negative Negative Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 20.17 Basal-like -12.0 -13.0 5.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
77 TNBC TNBC TNBC TCGA-BH-A0AV-01 TCGA-BH-A0AV-01 FEMALE 52.0 Negative Negative Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 38.77 Basal-like 0.0 -13.0 4.0 5.0 ReacII 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
78 TNBC TNBC TNBC TCGA-BH-A0BG-01 TCGA-BH-A0BG-01 FEMALE 73.0 Negative Negative Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 24.84 Basal-like -12.0 -13.0 4.0 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
79 TNBC TNBC TNBC TCGA-BH-A0BL-01 TCGA-BH-A0BL-01 FEMALE 35.0 Negative Negative Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 43.99 Basal-like -12.0 -13.0 4.0 5.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
80 TNBC TNBC TNBC TCGA-BH-A0BW-01 TCGA-BH-A0BW-01 FEMALE 71.0 Negative Negative Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 11.66 Basal-like -12.0 -13.0 3.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
81 ER+ ER+ ER+ TCGA-BH-A0DL-01 TCGA-BH-A0DL-01 FEMALE 64.0 Positive Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 48.20 Basal-like 0.0 -13.0 4.0 5.0 Basal 3.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
82 TNBC TNBC TNBC TCGA-BH-A0WA-01 TCGA-BH-A0WA-01 FEMALE 82.0 Negative Negative Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I enrollment LIVING 12.22 Basal-like -12.0 -13.0 5.0 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
83 TNBC TNBC TNBC TCGA-BH-A18G-01 TCGA-BH-A18G-01 FEMALE 81.0 Negative Negative Negative T1 T1 N0 Negative M0 Negative Stage X No_Conversion enrollment LIVING 2.00 Basal-like 0.0 -13.0 4.0 4.0 Basal 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
84 NaN NaN NaN TCGA-C8-A12K-01 TCGA-C8-A12K-01 FEMALE 80.0 Not Performed Not Performed Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion enrollment LIVING 0.00 Basal-like -12.0 -13.0 3.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
85 TNBC TNBC TNBC TCGA-C8-A12V-01 TCGA-C8-A12V-01 FEMALE 55.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.00 Basal-like -12.0 -13.0 3.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
86 TNBC TNBC TNBC TCGA-C8-A131-01 TCGA-C8-A131-01 FEMALE 82.0 Negative Negative Negative T2 T_Other N2 Positive M0 Negative Stage III Stage IIIA enrollment LIVING 0.00 Basal-like 0.0 -13.0 5.0 1.0 ReacII 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
87 TNBC TNBC TNBC TCGA-C8-A134-01 TCGA-C8-A134-01 FEMALE 52.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA No_Conversion enrollment LIVING 0.00 Basal-like -12.0 -13.0 6.0 4.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
88 TNBC TNBC TNBC TCGA-D8-A147-01 TCGA-D8-A147-01 FEMALE 45.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage X Stage IIA enrollment LIVING 0.07 Basal-like -12.0 -13.0 5.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
89 TNBC TNBC TNBC TCGA-E2-A14N-01 TCGA-E2-A14N-01 FEMALE 37.0 Negative Negative Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 44.35 Basal-like -12.0 -13.0 6.0 5.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
90 TNBC TNBC TNBC TCGA-E2-A14R-01 TCGA-E2-A14R-01 FEMALE 62.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 27.76 Basal-like -12.0 -13.0 5.0 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
91 TNBC TNBC TNBC TCGA-E2-A14X-01 TCGA-E2-A14X-01 FEMALE 55.0 Negative Negative Negative T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 22.74 Basal-like -12.0 -13.0 3.0 5.0 ReacII 4.0 2.0 3.0 2.0 Breast Cancer Invasive Breast Carcinoma
92 HER2+ ER+ ER+/HER2+ TCGA-E2-A14Y-01 TCGA-E2-A14Y-01 FEMALE 35.0 Positive Positive Positive T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 22.60 Basal-like 0.0 -13.0 5.0 2.0 ReacII 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
93 TNBC TNBC TNBC TCGA-E2-A150-01 TCGA-E2-A150-01 FEMALE 48.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 19.42 Basal-like -12.0 -13.0 3.0 5.0 X 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
94 TNBC TNBC TNBC TCGA-E2-A158-01 TCGA-E2-A158-01 FEMALE 43.0 Negative Negative Negative T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment LIVING 14.78 Basal-like 0.0 -13.0 5.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
95 TNBC TNBC TNBC TCGA-E2-A159-01 TCGA-E2-A159-01 FEMALE 50.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 16.92 Basal-like -10.0 -13.0 3.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
96 TNBC TNBC TNBC TCGA-E2-A1AZ-01 TCGA-E2-A1AZ-01 FEMALE 63.0 Negative Negative Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 64.53 Basal-like -12.0 -13.0 NaN 5.0 Basal 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
97 ER+ ER+ ER+ TCGA-E2-A1B5-01 TCGA-E2-A1B5-01 FEMALE 46.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 25.43 Basal-like -12.0 -13.0 6.0 1.0 ReacI 3.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
98 ER+ ER+ ER+ TCGA-A8-A08L-01 TCGA-A8-A08L-01 FEMALE 89.0 Positive Negative Negative T3 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment DECEASED 9.99 HER2-enriched -6.0 -2.0 1.0 4.0 X 1.0 1.0 5.0 2.0 Breast Cancer Invasive Breast Carcinoma
99 ER+ ER+ ER+ TCGA-BH-A1EV-01 TCGA-BH-A1EV-01 FEMALE 45.0 Positive Positive NaN NaN NaN NaN NaN NaN NaN NaN NaN enrollment DECEASED 11.99 HER2-enriched -5.0 -1.0 7.0 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
100 HER2+ HER2+ None TCGA-B6-A0I9-01 TCGA-B6-A0I9-01 FEMALE 62.0 Indeterminate Positive Positive T3 T_Other N0 Negative M1 Positive Stage IV No_Conversion followup DECEASED 12.12 HER2-enriched -5.0 -2.0 4.0 4.0 Her2 5.0 1.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
101 TNBC TNBC TNBC TCGA-A8-A09X-01 TCGA-A8-A09X-01 FEMALE 62.0 Negative Negative Negative T2 T_Other N3 Positive M0 Negative Stage IIIC Stage IIIC enrollment DECEASED 14.00 HER2-enriched -5.0 -11.0 3.0 4.0 Her2 3.0 1.0 2.0 1.0 Breast Cancer Invasive Breast Carcinoma
102 TNBC TNBC TNBC TCGA-B6-A0IK-01 TCGA-B6-A0IK-01 FEMALE 63.0 Negative Negative Negative T4 T_Other N1 Positive M0 Negative Stage IIIB No_Conversion followup DECEASED 18.76 HER2-enriched -5.0 -11.0 4.0 4.0 ReacII 5.0 1.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
103 ER+ ER+ ER+ TCGA-BH-A18P-01 TCGA-BH-A18P-01 FEMALE 60.0 Positive Negative Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment DECEASED 30.26 HER2-enriched -1.0 -1.0 5.0 4.0 X 2.0 1.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
104 ER+ ER+ ER+ TCGA-A8-A08J-01 TCGA-A8-A08J-01 FEMALE 52.0 Positive Negative Negative T4 T_Other N3 Positive M1 Positive Stage IV Stage IV enrollment DECEASED 37.03 HER2-enriched -5.0 -2.0 4.0 4.0 Her2 5.0 1.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
105 HER2+ HER2+ None TCGA-BH-A18R-01 TCGA-BH-A18R-01 FEMALE 50.0 Indeterminate Negative Positive T2 T_Other N1 Positive M0 Negative Stage IB No_Conversion enrollment DECEASED 37.49 HER2-enriched 0.0 -2.0 4.0 4.0 Her2 3.0 1.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
106 HER2+ ER+ ER+/HER2+ TCGA-AR-A1AT-01 TCGA-AR-A1AT-01 FEMALE 62.0 Positive Positive Positive T2 T_Other N0 Negative M0 Negative Stage II Stage IIA enrollment DECEASED 41.79 HER2-enriched -5.0 -11.0 4.0 1.0 Her2 NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
107 TNBC TNBC TNBC TCGA-B6-A0RS-01 TCGA-B6-A0RS-01 FEMALE 38.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup DECEASED 100.60 HER2-enriched 0.0 0.0 4.0 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
108 HER2+ ER+ ER+/HER2+ TCGA-BH-A0DZ-01 TCGA-BH-A0DZ-01 FEMALE 43.0 Positive Positive Positive T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 16.26 HER2-enriched -3.0 -2.0 4.0 4.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
109 HER2+ HER2+ ER-/HER2+ TCGA-A2-A0T1-01 TCGA-A2-A0T1-01 FEMALE 55.0 Negative Negative Positive T3 T_Other N3 Positive M0 Negative Stage IIIC No_Conversion followup LIVING 17.08 HER2-enriched -5.0 -11.0 4.0 5.0 Her2 4.0 1.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
110 TNBC TNBC TNBC TCGA-AO-A0J2-01 TCGA-AO-A0J2-01 FEMALE 41.0 Negative Negative Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 19.22 HER2-enriched -9.0 -11.0 4.0 5.0 Basal 3.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
111 HER2+ ER+ ER+/HER2+ TCGA-BH-A0AW-01 TCGA-BH-A0AW-01 FEMALE 56.0 Positive Negative Positive T1 T1 N1 Positive M0 Negative Stage IIA No_Conversion followup LIVING 20.44 HER2-enriched -5.0 -11.0 5.0 1.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
112 HER2+ HER2+ ER-/HER2+ TCGA-BH-A0EE-01 TCGA-BH-A0EE-01 FEMALE 68.0 Negative Negative Positive T3 T_Other N0 Negative M0 Negative Stage IIB Stage IIB followup LIVING 30.98 HER2-enriched -9.0 -11.0 7.0 1.0 Basal 5.0 1.0 2.0 3.0 Breast Cancer Invasive Breast Carcinoma
113 HER2+ HER2+ ER-/HER2+ TCGA-A2-A0D1-01 TCGA-A2-A0D1-01 FEMALE 76.0 Negative Negative Positive T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 34.53 HER2-enriched -6.0 -2.0 1.0 3.0 Basal 1.0 1.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
114 ER+ ER+ ER+ TCGA-AO-A03N-01 TCGA-AO-A03N-01 FEMALE 59.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 54.05 HER2-enriched -3.0 -2.0 6.0 2.0 Her2 3.0 4.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
115 ER+ ER+ ER+ TCGA-A2-A0CY-01 TCGA-A2-A0CY-01 FEMALE 63.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 54.97 HER2-enriched -3.0 0.0 7.0 5.0 LumA/B 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
116 HER2+ ER+ ER+/HER2+ TCGA-A2-A04X-01 TCGA-A2-A04X-01 FEMALE 34.0 Positive Positive Positive T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 55.39 HER2-enriched -5.0 -2.0 4.0 1.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
117 HER2+ ER+ ER+/HER2+ TCGA-A2-A0CX-01 TCGA-A2-A0CX-01 FEMALE 52.0 Positive Negative Positive T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 56.77 HER2-enriched -5.0 -11.0 NaN 4.0 Her2 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
118 HER2+ HER2+ ER-/HER2+ TCGA-A2-A04W-01 TCGA-A2-A04W-01 FEMALE 50.0 Negative Negative Positive T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 64.00 HER2-enriched -5.0 -11.0 4.0 1.0 Her2 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
119 HER2+ HER2+ ER-/HER2+ TCGA-AO-A12D-01 TCGA-AO-A12D-01 FEMALE 43.0 Negative Negative Positive T1 T1 N1 Positive M0 Negative Stage IIA No_Conversion followup LIVING 64.00 HER2-enriched -10.0 -11.0 3.0 5.0 Her2 3.0 1.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
120 ER+ ER+ ER+ TCGA-A2-A0CL-01 TCGA-A2-A0CL-01 FEMALE 37.0 Positive Positive Negative T3 T_Other N2 Positive M0 Negative Stage IIIA No_Conversion followup LIVING 64.49 HER2-enriched -5.0 -2.0 4.0 1.0 Basal 3.0 1.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
121 HER2+ HER2+ ER-/HER2+ TCGA-AO-A0JE-01 TCGA-AO-A0JE-01 FEMALE 53.0 Negative Negative Positive T2 T_Other N2 Positive M0 Negative Stage IIIA No_Conversion followup LIVING 64.56 HER2-enriched -5.0 -11.0 4.0 4.0 Her2 5.0 1.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
122 HER2+ HER2+ ER-/HER2+ TCGA-A2-A0EQ-01 TCGA-A2-A0EQ-01 FEMALE 64.0 Negative Negative Positive T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 79.71 HER2-enriched -5.0 -2.0 5.0 4.0 Basal 4.0 4.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
123 ER+ ER+ ER+ TCGA-AO-A03L-01 TCGA-AO-A03L-01 FEMALE 34.0 Positive Positive Negative T3 T_Other N2 Positive M0 Negative Stage IIIA No_Conversion followup LIVING 80.23 HER2-enriched -4.0 -2.0 1.0 4.0 Basal 5.0 1.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
124 HER2+ ER+ ER+/HER2+ TCGA-B6-A0RH-01 TCGA-B6-A0RH-01 FEMALE 51.0 Positive Positive Positive T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 188.85 HER2-enriched -5.0 -1.0 6.0 2.0 ReacII 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
125 ER+ ER+ ER+ TCGA-A8-A075-01 TCGA-A8-A075-01 FEMALE 42.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 16.99 HER2-enriched -5.0 -2.0 1.0 5.0 X 2.0 1.0 5.0 2.0 Breast Cancer Invasive Breast Carcinoma
126 HER2+ ER+ ER+/HER2+ TCGA-A8-A076-01 TCGA-A8-A076-01 FEMALE 66.0 Positive Positive Positive T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 53.91 HER2-enriched -5.0 -2.0 4.0 3.0 Her2 4.0 1.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
127 HER2+ ER+ ER+/HER2+ TCGA-A8-A07B-01 TCGA-A8-A07B-01 FEMALE 69.0 Positive Positive Positive T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 32.99 HER2-enriched -3.0 -1.0 2.0 3.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
128 HER2+ ER+ ER+/HER2+ TCGA-A8-A07I-01 TCGA-A8-A07I-01 FEMALE 69.0 Positive Negative Positive T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 14.00 HER2-enriched -5.0 -2.0 4.0 3.0 Her2 3.0 1.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
129 ER+ ER+ ER+ TCGA-A8-A081-01 TCGA-A8-A081-01 FEMALE 80.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.00 HER2-enriched -5.0 -2.0 3.0 4.0 Her2 5.0 1.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
130 HER2+ ER+ ER+/HER2+ TCGA-A8-A08B-01 TCGA-A8-A08B-01 FEMALE 52.0 Positive Negative Positive T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 23.06 HER2-enriched -5.0 -1.0 7.0 1.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
131 HER2+ HER2+ ER-/HER2+ TCGA-A8-A08X-01 TCGA-A8-A08X-01 FEMALE 43.0 Negative Negative Positive T4 T_Other N3 Positive M0 Negative Stage IIIC Stage IIIC enrollment LIVING 33.97 HER2-enriched -10.0 -13.0 3.0 1.0 Her2 3.0 1.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
132 ER+ ER+ ER+ TCGA-A8-A092-01 TCGA-A8-A092-01 FEMALE 48.0 Positive Positive Negative T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 17.02 HER2-enriched -3.0 -2.0 4.0 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
133 ER+ ER+ ER+ TCGA-A8-A094-01 TCGA-A8-A094-01 FEMALE 75.0 Positive Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.00 HER2-enriched -5.0 -11.0 3.0 1.0 Basal 1.0 1.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
134 HER2+ ER+ ER+/HER2+ TCGA-A8-A09G-01 TCGA-A8-A09G-01 FEMALE 79.0 Positive Negative Positive T3 T_Other N3 Positive M0 Negative Stage IIIC Stage IIIC enrollment LIVING 0.00 HER2-enriched -5.0 -11.0 3.0 1.0 Her2 2.0 1.0 3.0 2.0 Breast Cancer Invasive Breast Carcinoma
135 HER2+ HER2+ ER-/HER2+ TCGA-A8-A0A7-01 TCGA-A8-A0A7-01 FEMALE 57.0 Negative Negative Positive T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 0.99 HER2-enriched -5.0 -2.0 4.0 1.0 Her2 3.0 1.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
136 HER2+ HER2+ ER-/HER2+ TCGA-AN-A04C-01 TCGA-AN-A04C-01 FEMALE 51.0 Negative Negative Positive T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion enrollment LIVING 1.77 HER2-enriched -9.0 -11.0 5.0 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
137 HER2+ HER2+ ER-/HER2+ TCGA-AN-A0FV-01 TCGA-AN-A0FV-01 FEMALE 58.0 Negative Negative Positive T2 T_Other N0 Negative M0 Negative Stage IIA No_Conversion enrollment LIVING 0.33 HER2-enriched -5.0 -11.0 4.0 2.0 Her2 1.0 1.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
138 HER2+ ER+ ER+/HER2+ TCGA-AR-A0TX-01 TCGA-AR-A0TX-01 FEMALE 64.0 Positive Positive Positive T1 T1 N1 Positive M0 Negative Stage II No_Conversion enrollment LIVING 0.49 HER2-enriched -5.0 -11.0 1.0 1.0 ReacII 1.0 1.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
139 HER2+ ER+ ER+/HER2+ TCGA-BH-A0B7-01 TCGA-BH-A0B7-01 FEMALE 42.0 Positive Positive Positive T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 56.94 HER2-enriched -8.0 -11.0 3.0 5.0 Her2 3.0 1.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
140 ER+ ER+ ER+ TCGA-BH-A0HY-01 TCGA-BH-A0HY-01 FEMALE 60.0 Positive Negative Not Available T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 28.49 HER2-enriched -5.0 -1.0 4.0 3.0 ReacII NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
141 HER2+ HER2+ ER-/HER2+ TCGA-C8-A12L-01 TCGA-C8-A12L-01 FEMALE 67.0 Negative Negative Positive T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.00 HER2-enriched -9.0 -11.0 4.0 4.0 Her2 1.0 1.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
142 HER2+ HER2+ ER-/HER2+ TCGA-C8-A12P-01 TCGA-C8-A12P-01 FEMALE 55.0 Negative Negative Positive T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion enrollment LIVING 0.00 HER2-enriched -10.0 -11.0 4.0 1.0 Her2 3.0 1.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
143 HER2+ HER2+ ER-/HER2+ TCGA-C8-A12Q-01 TCGA-C8-A12Q-01 FEMALE 78.0 Negative Negative Positive T1 T1 N2 Positive M0 Negative Stage IIIA No_Conversion enrollment LIVING 0.00 HER2-enriched -5.0 -11.0 4.0 2.0 Her2 5.0 1.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
144 HER2+ ER+ ER+/HER2+ TCGA-C8-A12T-01 TCGA-C8-A12T-01 FEMALE 43.0 Positive Positive Positive T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.00 HER2-enriched -1.0 -2.0 4.0 4.0 ReacII 4.0 1.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
145 HER2+ HER2+ ER-/HER2+ TCGA-C8-A12Z-01 TCGA-C8-A12Z-01 FEMALE 45.0 Negative Negative Positive T2 T_Other N1 Positive M0 Negative Stage II Stage IIB enrollment LIVING 0.00 HER2-enriched -5.0 -11.0 4.0 4.0 Her2 2.0 1.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
146 ER+ ER+ ER+ TCGA-C8-A130-01 TCGA-C8-A130-01 FEMALE 52.0 Positive Positive Equivocal T3 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 0.00 HER2-enriched 0.0 -2.0 4.0 2.0 Her2 1.0 1.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
147 HER2+ HER2+ ER-/HER2+ TCGA-C8-A135-01 TCGA-C8-A135-01 FEMALE 64.0 Negative Negative Positive T2 T_Other N1 Positive M0 Negative Stage II Stage IIB enrollment LIVING 0.00 HER2-enriched -5.0 -11.0 7.0 1.0 Her2 1.0 1.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
148 HER2+ HER2+ ER-/HER2+ TCGA-C8-A137-01 TCGA-C8-A137-01 FEMALE 34.0 Negative Negative Positive T2 T_Other N1 Positive M0 Negative Stage II Stage IIB enrollment LIVING 0.10 HER2-enriched -5.0 -11.0 NaN 4.0 Her2 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
149 HER2+ ER+ ER+/HER2+ TCGA-C8-A138-01 TCGA-C8-A138-01 FEMALE 54.0 Positive Negative Positive T2 T_Other N2 Positive M0 Negative Stage III Stage IIIA enrollment LIVING 0.23 HER2-enriched -5.0 -2.0 1.0 2.0 Basal 2.0 1.0 3.0 2.0 Breast Cancer Invasive Breast Carcinoma
150 HER2+ HER2+ ER-/HER2+ TCGA-C8-A1HF-01 TCGA-C8-A1HF-01 FEMALE 48.0 Negative Positive Positive T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.00 HER2-enriched -5.0 -11.0 6.0 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
151 TNBC TNBC TNBC TCGA-D8-A13Z-01 TCGA-D8-A13Z-01 FEMALE 51.0 Negative Negative Negative T2 T_Other N2 Positive M0 Negative Stage X Stage IIIA enrollment LIVING 6.90 HER2-enriched -10.0 -13.0 4.0 1.0 Basal 1.0 1.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
152 HER2+ HER2+ ER-/HER2+ TCGA-E2-A14P-01 TCGA-E2-A14P-01 FEMALE 79.0 Negative Negative Positive T2 T_Other N3 Positive M0 Negative Stage IIIC Stage IIIC enrollment LIVING 16.00 HER2-enriched -5.0 -11.0 4.0 1.0 Her2 3.0 1.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
153 HER2+ ER+ ER+/HER2+ TCGA-E2-A14V-01 TCGA-E2-A14V-01 FEMALE 53.0 Positive Positive Positive T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 24.58 HER2-enriched -5.0 -1.0 4.0 4.0 Her2 5.0 1.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
154 HER2+ ER+ ER+/HER2+ TCGA-E2-A152-01 TCGA-E2-A152-01 FEMALE 56.0 Positive Negative Positive T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 19.32 HER2-enriched -5.0 -1.0 5.0 1.0 Her2 1.0 1.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
155 HER2+ HER2+ ER-/HER2+ TCGA-E2-A1B0-01 TCGA-E2-A1B0-01 FEMALE 50.0 Negative Negative Positive T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 41.76 HER2-enriched -10.0 -13.0 4.0 5.0 ReacI 3.0 2.0 1.0 2.0 Breast Cancer Invasive Breast Carcinoma
156 ER+ ER+ ER+ TCGA-A2-A0CU-01 TCGA-A2-A0CU-01 FEMALE 73.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup DECEASED 5.16 Luminal A -3.0 0.0 2.0 2.0 LumA/B 5.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
157 ER+ ER+ ER+ TCGA-AR-A0TR-01 TCGA-AR-A0TR-01 FEMALE 68.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage II No_Conversion enrollment DECEASED 5.26 Luminal A -3.0 -12.0 7.0 2.0 LumA/B 1.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
158 TNBC TNBC TNBC TCGA-BH-A18T-01 TCGA-BH-A18T-01 FEMALE 70.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment DECEASED 7.36 Luminal A -3.0 0.0 2.0 5.0 ReacII 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
159 NaN NaN NaN TCGA-B6-A0I8-01 TCGA-B6-A0I8-01 FEMALE 46.0 Not Performed Not Performed Not Available T1 T1 N0 Negative M0 Negative NaN No_Conversion followup DECEASED 24.61 Luminal A -3.0 0.0 4.0 2.0 Her2 NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
160 ER+ ER+ ER+ TCGA-B6-A0X4-01 TCGA-B6-A0X4-01 FEMALE 62.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup DECEASED 28.22 Luminal A -3.0 -12.0 1.0 2.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
161 ER+ ER+ ER+ TCGA-A8-A06U-01 TCGA-A8-A06U-01 FEMALE 80.0 Positive Positive Equivocal T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment DECEASED 28.98 Luminal A -5.0 -2.0 4.0 4.0 LumA/B NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
162 ER+ ER+ ER+ TCGA-BH-A0EA-01 TCGA-BH-A0EA-01 FEMALE 72.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment DECEASED 32.62 Luminal A -7.0 -5.0 6.0 1.0 ReacI 2.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
163 ER+ ER+ ER+ TCGA-BH-A18N-01 TCGA-BH-A18N-01 FEMALE 88.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIA No_Conversion enrollment DECEASED 37.72 Luminal A -3.0 -12.0 6.0 2.0 LumA 3.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
164 ER+ ER+ ER+ TCGA-BH-A1EU-01 TCGA-BH-A1EU-01 FEMALE 83.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment DECEASED 42.25 Luminal A -7.0 -5.0 6.0 1.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
165 ER+ ER+ ER+ TCGA-B6-A0X7-01 TCGA-B6-A0X7-01 FEMALE 62.0 Positive Positive Negative T1 T1 N0 Negative NaN NaN NaN No_Conversion enrollment DECEASED 58.84 Luminal A -3.0 -5.0 3.0 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
166 ER+ ER+ ER+ TCGA-A2-A04V-01 TCGA-A2-A04V-01 FEMALE 39.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment DECEASED 63.08 Luminal A -3.0 0.0 2.0 2.0 LumA/B 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
167 ER+ ER+ ER+ TCGA-BH-A18S-01 TCGA-BH-A18S-01 FEMALE 79.0 Positive Positive Not Available T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment DECEASED 66.01 Luminal A -3.0 -12.0 7.0 2.0 LumA/B 5.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
168 HER2+ ER+ ER+/HER2+ TCGA-BH-A18M-01 TCGA-BH-A18M-01 FEMALE 39.0 Positive Positive Positive T3 T_Other N1 Positive M0 Negative Stage IIB Stage IIIA enrollment DECEASED 72.51 Luminal A -7.0 -5.0 6.0 1.0 ReacI 2.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
169 ER+ ER+ ER+ TCGA-B6-A0RM-01 TCGA-B6-A0RM-01 FEMALE 57.0 Positive Positive Negative TX NaN N0 Negative NaN NaN NaN No_Conversion followup DECEASED 77.96 Luminal A -3.0 -10.0 2.0 2.0 LumA 4.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
170 ER+ ER+ ER+ TCGA-BH-A1ET-01 TCGA-BH-A1ET-01 FEMALE 55.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IIA Stage I enrollment DECEASED 82.79 Luminal A -7.0 -12.0 6.0 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
171 ER+ ER+ ER+ TCGA-B6-A0IN-01 TCGA-B6-A0IN-01 FEMALE 45.0 Positive Negative Not Available T1 T1 N0 Negative NaN NaN NaN No_Conversion followup DECEASED 84.54 Luminal A -3.0 -2.0 1.0 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
172 ER+ ER+ ER+ TCGA-BH-A1EO-01 TCGA-BH-A1EO-01 FEMALE 68.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment DECEASED 91.93 Luminal A -3.0 -5.0 6.0 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
173 ER+ ER+ ER+ TCGA-B6-A0WS-01 TCGA-B6-A0WS-01 FEMALE 58.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative NaN Stage I followup DECEASED 97.41 Luminal A -4.0 0.0 7.0 1.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
174 ER+ ER+ ER+ TCGA-B6-A0RP-01 TCGA-B6-A0RP-01 FEMALE 73.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIIB No_Conversion followup DECEASED 102.70 Luminal A -4.0 -12.0 4.0 2.0 LumA 4.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
175 ER+ ER+ ER+ TCGA-B6-A0IH-01 TCGA-B6-A0IH-01 FEMALE 81.0 Positive Positive Negative T3 T_Other N1 Positive M0 Negative Stage IIIA Stage IIIA followup DECEASED 112.30 Luminal A -7.0 -5.0 6.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
176 ER+ ER+ ER+ TCGA-B6-A0WY-01 TCGA-B6-A0WY-01 FEMALE 40.0 Positive Negative Negative T3 T_Other N1 Positive M0 Negative Stage IIIA No_Conversion followup DECEASED 113.68 Luminal A -3.0 -5.0 4.0 1.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
177 ER+ ER+ ER+ TCGA-BH-A1ES-01 TCGA-BH-A1ES-01 FEMALE 35.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment DECEASED 113.74 Luminal A -3.0 -9.0 5.0 4.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
178 ER+ ER+ ER+ TCGA-B6-A0X0-01 TCGA-B6-A0X0-01 FEMALE 54.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup DECEASED 129.61 Luminal A -3.0 -5.0 7.0 2.0 LumA 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
179 ER+ ER+ ER+ TCGA-B6-A0RQ-01 TCGA-B6-A0RQ-01 FEMALE 68.0 Positive Positive Negative T3 T_Other N0 Negative M0 Negative Stage IIB Stage IIB followup DECEASED 140.39 Luminal A -7.0 -5.0 6.0 1.0 ReacI 1.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
180 ER+ ER+ ER+ TCGA-B6-A0IG-01 TCGA-B6-A0IG-01 FEMALE 50.0 Positive Positive Not Available T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup DECEASED 146.40 Luminal A 0.0 -2.0 7.0 4.0 Her2 NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
181 ER+ ER+ ER+ TCGA-BH-A0HO-01 TCGA-BH-A0HO-01 FEMALE 48.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIA No_Conversion followup LIVING 2.50 Luminal A -3.0 -12.0 2.0 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
182 ER+ ER+ ER+ TCGA-BH-A0DS-01 TCGA-BH-A0DS-01 FEMALE 71.0 Positive Positive Negative T2 T_Other N2 Positive M0 Negative Stage IIIA No_Conversion followup LIVING 2.53 Luminal A -7.0 -5.0 6.0 3.0 LumA 3.0 3.0 4.0 5.0 Breast Cancer Invasive Breast Carcinoma
183 ER+ ER+ ER+ TCGA-BH-A0DQ-01 TCGA-BH-A0DQ-01 FEMALE 42.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 3.22 Luminal A 0.0 -5.0 6.0 2.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
184 ER+ ER+ ER+ TCGA-BH-A0HK-01 TCGA-BH-A0HK-01 FEMALE 81.0 Positive Negative Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 5.85 Luminal A 0.0 0.0 7.0 3.0 LumA/B 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
185 ER+ ER+ ER+ TCGA-A7-A0CG-01 TCGA-A7-A0CG-01 FEMALE 78.0 Positive Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 7.56 Luminal A -7.0 -5.0 7.0 1.0 ReacI 2.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
186 NaN NaN NaN TCGA-A7-A0CH-01 TCGA-A7-A0CH-01 FEMALE 79.0 Performed but Not Available Performed but Not Available Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 7.62 Luminal A -3.0 -12.0 2.0 2.0 LumA 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
187 ER+ ER+ ER+ TCGA-A7-A0DB-01 TCGA-A7-A0DB-01 FEMALE 56.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 8.74 Luminal A -7.0 -5.0 4.0 1.0 LumA 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
188 ER+ ER+ ER+ TCGA-A7-A0D9-01 TCGA-A7-A0D9-01 FEMALE 37.0 Positive Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 8.94 Luminal A -3.0 -3.0 5.0 2.0 ReacII 4.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
189 ER+ ER+ ER+ TCGA-AO-A0J8-01 TCGA-AO-A0J8-01 FEMALE 61.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 9.10 Luminal A -3.0 -12.0 2.0 1.0 ReacI 2.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
190 ER+ ER+ ER+ TCGA-BH-A0GZ-01 TCGA-BH-A0GZ-01 FEMALE 62.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIA No_Conversion followup LIVING 10.78 Luminal A -3.0 0.0 2.0 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
191 ER+ ER+ ER+ TCGA-AO-A0JA-01 TCGA-AO-A0JA-01 FEMALE 36.0 Positive Positive Negative T2 T_Other N3 Positive M0 Negative Stage IIIC No_Conversion followup LIVING 11.37 Luminal A -4.0 -4.0 1.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
192 ER+ ER+ ER+ TCGA-AO-A0JF-01 TCGA-AO-A0JF-01 FEMALE 68.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIA No_Conversion followup LIVING 11.63 Luminal A -7.0 -5.0 7.0 2.0 ReacI 2.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
193 ER+ ER+ ER+ TCGA-A7-A0CD-01 TCGA-A7-A0CD-01 FEMALE 66.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 12.22 Luminal A -3.0 -10.0 2.0 3.0 LumA 3.0 3.0 4.0 3.0 Breast Cancer Invasive Breast Carcinoma
194 ER+ ER+ ER+ TCGA-D8-A145-01 TCGA-D8-A145-01 FEMALE 80.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA followup LIVING 13.47 Luminal A -7.0 -5.0 6.0 2.0 ReacI 1.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
195 ER+ ER+ ER+ TCGA-BH-A0HP-01 TCGA-BH-A0HP-01 FEMALE 65.0 Positive Negative Negative T3 T_Other N2 Positive M0 Negative Stage IIIA No_Conversion followup LIVING 13.60 Luminal A -7.0 -5.0 6.0 1.0 ReacI 2.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
196 ER+ ER+ ER+ TCGA-BH-A0DK-01 TCGA-BH-A0DK-01 FEMALE 49.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 13.90 Luminal A -4.0 -4.0 2.0 3.0 LumA/B 2.0 3.0 4.0 3.0 Breast Cancer Invasive Breast Carcinoma
197 ER+ ER+ ER+ TCGA-BH-A0E2-01 TCGA-BH-A0E2-01 FEMALE 49.0 Positive Positive Negative T2 T_Other N2 Positive M0 Negative Stage IIIA No_Conversion followup LIVING 14.29 Luminal A -3.0 -8.0 NaN 4.0 LumA/B 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
198 ER+ ER+ ER+ TCGA-A2-A0YI-01 TCGA-A2-A0YI-01 FEMALE 62.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 14.49 Luminal A -4.0 -12.0 4.0 1.0 ReacI 3.0 3.0 1.0 4.0 Breast Cancer Invasive Breast Carcinoma
199 ER+ ER+ ER+ TCGA-A2-A0YL-01 TCGA-A2-A0YL-01 FEMALE 48.0 Positive Positive Negative T3 T_Other N2 Positive M0 Negative Stage IIIA No_Conversion followup LIVING 14.62 Luminal A -7.0 -5.0 6.0 1.0 ReacI 2.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
200 ER+ ER+ ER+ TCGA-AO-A0JG-01 TCGA-AO-A0JG-01 FEMALE 49.0 Positive Positive Negative T2 T_Other N2 Positive M0 Negative Stage IIIA No_Conversion followup LIVING 14.75 Luminal A -7.0 -5.0 1.0 4.0 LumA/B 5.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
201 ER+ ER+ ER+ TCGA-A2-A0YF-01 TCGA-A2-A0YF-01 FEMALE 67.0 Positive Negative Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 15.41 Luminal A -3.0 -12.0 1.0 2.0 ReacII 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
202 ER+ ER+ ER+ TCGA-BH-A0DP-01 TCGA-BH-A0DP-01 FEMALE 60.0 Positive Positive Negative T3 T_Other N0 Negative M0 Negative Stage IIB Stage IIB followup LIVING 15.64 Luminal A -7.0 -5.0 2.0 4.0 ReacI 2.0 3.0 1.0 4.0 Breast Cancer Invasive Breast Carcinoma
203 ER+ ER+ ER+ TCGA-BH-A0E1-01 TCGA-BH-A0E1-01 FEMALE 52.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 15.67 Luminal A -3.0 -12.0 6.0 2.0 ReacII 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
204 ER+ ER+ ER+ TCGA-A2-A0T5-01 TCGA-A2-A0T5-01 FEMALE 39.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIB Stage IIA followup LIVING 17.45 Luminal A -3.0 -5.0 6.0 2.0 LumA 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
205 ER+ ER+ ER+ TCGA-A2-A0T6-01 TCGA-A2-A0T6-01 FEMALE 50.0 Positive Positive Negative T3 T_Other N0 Negative M0 Negative Stage IIB Stage IIB followup LIVING 18.89 Luminal A -7.0 -5.0 2.0 4.0 ReacI 2.0 3.0 1.0 4.0 Breast Cancer Invasive Breast Carcinoma
206 ER+ ER+ ER+ TCGA-BH-A0HI-01 TCGA-BH-A0HI-01 FEMALE 78.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 20.34 Luminal A -3.0 -12.0 7.0 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
207 ER+ ER+ ER+ TCGA-A2-A0T7-01 TCGA-A2-A0T7-01 FEMALE 51.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 20.73 Luminal A 0.0 -3.0 4.0 1.0 ReacI 2.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
208 ER+ ER+ ER+ TCGA-BH-A0BJ-01 TCGA-BH-A0BJ-01 FEMALE 41.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 21.68 Luminal A -7.0 -5.0 7.0 2.0 ReacI 3.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
209 ER+ ER+ ER+ TCGA-BH-A0H7-01 TCGA-BH-A0H7-01 FEMALE 65.0 Positive Positive Negative T1 T1 N2 Positive M0 Negative Stage IIIA No_Conversion followup LIVING 23.03 Luminal A -3.0 -3.0 4.0 4.0 ReacII 3.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
210 ER+ ER+ ER+ TCGA-BH-A0HF-01 TCGA-BH-A0HF-01 FEMALE 77.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 23.89 Luminal A -7.0 -5.0 4.0 2.0 NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
211 ER+ ER+ ER+ TCGA-BH-A0EB-01 TCGA-BH-A0EB-01 FEMALE 69.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 24.48 Luminal A -4.0 -12.0 NaN 1.0 LumA 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
212 ER+ ER+ ER+ TCGA-BH-A0H6-01 TCGA-BH-A0H6-01 FEMALE 82.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA No_Conversion followup LIVING 24.54 Luminal A -3.0 -5.0 2.0 2.0 ReacI 4.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
213 ER+ ER+ ER+ TCGA-A2-A0YD-01 TCGA-A2-A0YD-01 FEMALE 63.0 Positive Positive Negative T3 T_Other N0 Negative M0 Negative Stage IIB Stage IIB followup LIVING 25.27 Luminal A -7.0 -5.0 4.0 1.0 LumA 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
214 ER+ ER+ ER+ TCGA-BH-A0HB-01 TCGA-BH-A0HB-01 FEMALE 55.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 26.48 Luminal A -3.0 -8.0 4.0 1.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
215 ER+ ER+ ER+ TCGA-BH-A0HX-01 TCGA-BH-A0HX-01 FEMALE 54.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 27.24 Luminal A -3.0 -10.0 4.0 4.0 LumA/B 4.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
216 ER+ ER+ ER+ TCGA-AO-A12H-01 TCGA-AO-A12H-01 FEMALE 69.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 28.32 Luminal A -3.0 -12.0 2.0 2.0 LumA/B 1.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
217 ER+ ER+ ER+ TCGA-E2-A10E-01 TCGA-E2-A10E-01 FEMALE 64.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIA No_Conversion followup LIVING 28.42 Luminal A -3.0 -12.0 4.0 4.0 LumA/B 2.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
218 ER+ ER+ ER+ TCGA-A2-A0D3-01 TCGA-A2-A0D3-01 FEMALE 42.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 28.75 Luminal A -3.0 -5.0 6.0 4.0 LumA 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
219 ER+ ER+ ER+ TCGA-E2-A10F-01 TCGA-E2-A10F-01 FEMALE 47.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 28.85 Luminal A -4.0 -5.0 4.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
220 ER+ ER+ ER+ TCGA-AO-A03V-01 TCGA-AO-A03V-01 FEMALE 41.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 29.11 Luminal A -3.0 0.0 7.0 2.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
221 ER+ ER+ ER+ TCGA-A2-A0EW-01 TCGA-A2-A0EW-01 FEMALE 53.0 Positive Positive Negative T1 T1 N3 Positive M0 Negative Stage IIIC No_Conversion followup LIVING 29.70 Luminal A -7.0 -5.0 6.0 2.0 ReacI 2.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
222 ER+ ER+ ER+ TCGA-BH-A0GY-01 TCGA-BH-A0GY-01 FEMALE 67.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIA No_Conversion followup LIVING 30.33 Luminal A -3.0 -3.0 5.0 2.0 ReacI 3.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
223 ER+ ER+ ER+ TCGA-A2-A0EV-01 TCGA-A2-A0EV-01 FEMALE 80.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 31.80 Luminal A -4.0 0.0 4.0 2.0 ReacI 3.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
224 ER+ ER+ ER+ TCGA-BH-A0BC-01 TCGA-BH-A0BC-01 FEMALE 60.0 Positive Positive Negative T2 T_Other N3 Positive M0 Negative Stage IIIC No_Conversion followup LIVING 32.00 Luminal A -4.0 -4.0 4.0 2.0 ReacI 2.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
225 ER+ ER+ ER+ TCGA-A2-A0YC-01 TCGA-A2-A0YC-01 FEMALE 59.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 32.49 Luminal A -3.0 -12.0 4.0 4.0 ReacII 2.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
226 ER+ ER+ ER+ TCGA-A2-A0EU-01 TCGA-A2-A0EU-01 FEMALE 79.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 34.27 Luminal A -3.0 -10.0 2.0 2.0 ReacI 4.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
227 ER+ ER+ ER+ TCGA-A2-A0ET-01 TCGA-A2-A0ET-01 FEMALE 58.0 Positive Positive Negative T2 T_Other N2 Positive M0 Negative Stage IIIA No_Conversion followup LIVING 35.02 Luminal A -3.0 -10.0 1.0 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
228 ER+ ER+ ER+ TCGA-A2-A04Y-01 TCGA-A2-A04Y-01 FEMALE 53.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 36.11 Luminal A -3.0 -2.0 5.0 1.0 LumA 5.0 3.0 2.0 3.0 Breast Cancer Invasive Breast Carcinoma
229 ER+ ER+ ER+ TCGA-BH-A0HQ-01 TCGA-BH-A0HQ-01 FEMALE 56.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 36.83 Luminal A -3.0 -5.0 2.0 4.0 NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
230 ER+ ER+ ER+ TCGA-A2-A0ES-01 TCGA-A2-A0ES-01 FEMALE 52.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 37.03 Luminal A -7.0 -5.0 6.0 1.0 ReacII 4.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
231 ER+ ER+ ER+ TCGA-BH-A0BA-01 TCGA-BH-A0BA-01 FEMALE 51.0 Positive Positive Negative T3 T_Other N3 Positive M0 Negative Stage IIIC No_Conversion followup LIVING 37.19 Luminal A 0.0 -5.0 6.0 4.0 ReacI 3.0 3.0 1.0 4.0 Breast Cancer Invasive Breast Carcinoma
232 ER+ ER+ ER+ TCGA-E2-A10B-01 TCGA-E2-A10B-01 FEMALE 67.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 37.49 Luminal A -3.0 -12.0 4.0 4.0 LumA 3.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
233 ER+ ER+ ER+ TCGA-BH-A0B1-01 TCGA-BH-A0B1-01 FEMALE 66.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 37.72 Luminal A -3.0 -3.0 6.0 NaN LumA/B NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
234 ER+ ER+ ER+ TCGA-BH-A0DH-01 TCGA-BH-A0DH-01 FEMALE 63.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 37.98 Luminal A -3.0 0.0 1.0 3.0 X 2.0 3.0 5.0 3.0 Breast Cancer Invasive Breast Carcinoma
235 HER2+ ER+ ER+/HER2+ TCGA-BH-A0B4-01 TCGA-BH-A0B4-01 MALE 65.0 Positive Positive Positive T2 T_Other N2 Positive M0 Negative Stage IIIA No_Conversion followup LIVING 39.13 Luminal A -3.0 -3.0 6.0 4.0 ReacII 5.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
236 ER+ ER+ ER+ TCGA-BH-A0H9-01 TCGA-BH-A0H9-01 FEMALE 69.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 40.97 Luminal A -3.0 -3.0 6.0 5.0 LumA/B 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
237 ER+ ER+ ER+ TCGA-AO-A0J9-01 TCGA-AO-A0J9-01 FEMALE 61.0 Positive Positive Negative T2 T_Other N3 Positive M0 Negative Stage IIIC No_Conversion followup LIVING 41.23 Luminal A -3.0 -2.0 2.0 4.0 ReacI 2.0 3.0 1.0 4.0 Breast Cancer Invasive Breast Carcinoma
238 ER+ ER+ ER+ TCGA-AO-A12G-01 TCGA-AO-A12G-01 FEMALE 75.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 41.56 Luminal A 0.0 -1.0 2.0 4.0 LumA/B 2.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
239 HER2+ ER+ ER+/HER2+ TCGA-A2-A0SY-01 TCGA-A2-A0SY-01 FEMALE 62.0 Positive Positive Positive T3 T_Other N1 Positive M0 Negative Stage IIIA No_Conversion followup LIVING 44.26 Luminal A -7.0 -5.0 6.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
240 ER+ ER+ ER+ TCGA-BH-A0E7-01 TCGA-BH-A0E7-01 FEMALE 79.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 44.75 Luminal A -3.0 -12.0 2.0 2.0 LumA 4.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
241 ER+ ER+ ER+ TCGA-AO-A03M-01 TCGA-AO-A03M-01 FEMALE 29.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 47.80 Luminal A -5.0 -2.0 7.0 1.0 ReacII 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
242 ER+ ER+ ER+ TCGA-BH-A0BV-01 TCGA-BH-A0BV-01 FEMALE 78.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 49.91 Luminal A -4.0 0.0 7.0 4.0 LumA/B 5.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
243 ER+ ER+ ER+ TCGA-BH-A0B8-01 TCGA-BH-A0B8-01 FEMALE 64.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IB Stage I followup LIVING 51.55 Luminal A -3.0 -10.0 7.0 3.0 NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
244 ER+ ER+ ER+ TCGA-A2-A0CZ-01 TCGA-A2-A0CZ-01 FEMALE 46.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 53.06 Luminal A -7.0 -5.0 2.0 1.0 ReacII 4.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
245 ER+ ER+ ER+ TCGA-A2-A0SU-01 TCGA-A2-A0SU-01 FEMALE 66.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 54.57 Luminal A 0.0 0.0 2.0 2.0 LumA/B 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
246 ER+ ER+ ER+ TCGA-AO-A12E-01 TCGA-AO-A12E-01 FEMALE 51.0 Positive Positive Negative T3 T_Other N0 Negative M0 Negative Stage IIB Stage IIB followup LIVING 57.23 Luminal A -7.0 -5.0 1.0 3.0 LumA/B 3.0 3.0 4.0 3.0 Breast Cancer Invasive Breast Carcinoma
247 ER+ ER+ ER+ TCGA-E2-A106-01 TCGA-E2-A106-01 FEMALE 34.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IB No_Conversion followup LIVING 59.37 Luminal A -3.0 0.0 4.0 4.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
248 ER+ ER+ ER+ TCGA-A2-A0CV-01 TCGA-A2-A0CV-01 FEMALE 41.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 63.38 Luminal A -7.0 -5.0 6.0 2.0 LumA/B 2.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
249 HER2+ ER+ ER+/HER2+ TCGA-AO-A12C-01 TCGA-AO-A12C-01 FEMALE 42.0 Positive Positive Positive T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 65.48 Luminal A -7.0 -5.0 6.0 4.0 ReacI 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
250 TNBC TNBC TNBC TCGA-B6-A0RG-01 TCGA-B6-A0RG-01 FEMALE 26.0 Negative Negative Negative T3 T_Other N0 Negative M0 Negative Stage IIB Stage IIB followup LIVING 68.40 Luminal A -3.0 0.0 4.0 2.0 ReacII 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
251 ER+ ER+ ER+ TCGA-A2-A0CS-01 TCGA-A2-A0CS-01 FEMALE 73.0 Positive Positive Negative T4 T_Other N3 Positive M1 Positive Stage IV No_Conversion followup LIVING 75.50 Luminal A -3.0 -12.0 4.0 2.0 LumA 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
252 ER+ ER+ ER+ TCGA-A2-A0EO-01 TCGA-A2-A0EO-01 FEMALE 54.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 80.20 Luminal A -7.0 -5.0 2.0 4.0 LumA 2.0 3.0 1.0 4.0 Breast Cancer Invasive Breast Carcinoma
253 ER+ ER+ ER+ TCGA-A2-A0CQ-01 TCGA-A2-A0CQ-01 FEMALE 62.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 88.51 Luminal A -3.0 -12.0 2.0 4.0 LumA/B 2.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
254 ER+ ER+ ER+ TCGA-A2-A0EN-01 TCGA-A2-A0EN-01 FEMALE 70.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 89.27 Luminal A -7.0 -5.0 2.0 1.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
255 ER+ ER+ ER+ TCGA-AO-A12A-01 TCGA-AO-A12A-01 FEMALE 47.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 90.48 Luminal A -7.0 -5.0 6.0 2.0 LumA 2.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
256 ER+ ER+ ER+ TCGA-A2-A0CP-01 TCGA-A2-A0CP-01 FEMALE 60.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 92.42 Luminal A -7.0 -5.0 4.0 1.0 X 4.0 3.0 1.0 4.0 Breast Cancer Invasive Breast Carcinoma
257 ER+ ER+ ER+ TCGA-AO-A126-01 TCGA-AO-A126-01 FEMALE 39.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 93.64 Luminal A -3.0 0.0 6.0 4.0 Her2 5.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
258 ER+ ER+ ER+ TCGA-AO-A125-01 TCGA-AO-A125-01 FEMALE 72.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 99.16 Luminal A -3.0 -12.0 3.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
259 ER+ ER+ ER+ TCGA-A2-A0EM-01 TCGA-A2-A0EM-01 FEMALE 73.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 101.62 Luminal A -3.0 -12.0 2.0 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
260 ER+ ER+ ER+ TCGA-A2-A04N-01 TCGA-A2-A04N-01 FEMALE 66.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 104.74 Luminal A -3.0 -5.0 6.0 2.0 LumA 4.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
261 HER2+ ER+ ER+/HER2+ TCGA-AQ-A04L-01 TCGA-AQ-A04L-01 FEMALE 48.0 Positive Negative Positive T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 109.87 Luminal A -5.0 -1.0 3.0 3.0 ReacI 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
262 ER+ ER+ ER+ TCGA-B6-A0IO-01 TCGA-B6-A0IO-01 FEMALE 66.0 Positive Indeterminate Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 110.06 Luminal A -3.0 0.0 1.0 2.0 X 3.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
263 ER+ ER+ ER+ TCGA-B6-A0IP-01 TCGA-B6-A0IP-01 FEMALE 74.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 110.85 Luminal A 0.0 -5.0 2.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
264 ER+ ER+ ER+ TCGA-B6-A0WZ-01 TCGA-B6-A0WZ-01 FEMALE 50.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 129.48 Luminal A -3.0 -12.0 4.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
265 ER+ ER+ ER+ TCGA-B6-A0I5-01 TCGA-B6-A0I5-01 FEMALE 49.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 149.46 Luminal A -3.0 -5.0 6.0 1.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
266 ER+ ER+ ER+ TCGA-B6-A0RV-01 TCGA-B6-A0RV-01 FEMALE 42.0 Positive Positive Negative T3 T_Other N2 Positive M0 Negative Stage IIIA No_Conversion followup LIVING 157.31 Luminal A 0.0 -5.0 6.0 1.0 ReacII 4.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
267 ER+ ER+ ER+ TCGA-B6-A0RO-01 TCGA-B6-A0RO-01 FEMALE 71.0 Positive Positive Negative T4 T_Other N1 Positive M0 Negative Stage IIIB No_Conversion followup LIVING 161.91 Luminal A -3.0 0.0 1.0 2.0 ReacI 3.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
268 TNBC TNBC TNBC TCGA-B6-A0RN-01 TCGA-B6-A0RN-01 FEMALE 60.0 Negative Negative Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 172.85 Luminal A -3.0 -5.0 2.0 4.0 ReacI 2.0 3.0 1.0 4.0 Breast Cancer Invasive Breast Carcinoma
269 ER+ ER+ ER+ TCGA-B6-A0WT-01 TCGA-B6-A0WT-01 FEMALE 61.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 188.55 Luminal A -4.0 -2.0 4.0 2.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
270 ER+ ER+ ER+ TCGA-B6-A0IA-01 TCGA-B6-A0IA-01 FEMALE 51.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 220.72 Luminal A -3.0 -12.0 4.0 2.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
271 ER+ ER+ ER+ TCGA-B6-A0RI-01 TCGA-B6-A0RI-01 FEMALE 44.0 Positive Positive Negative T4 T_Other N1 Positive M0 Negative Stage IIIB No_Conversion followup LIVING 234.09 Luminal A -3.0 -7.0 4.0 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
272 ER+ ER+ ER+ TCGA-A1-A0SE-01 TCGA-A1-A0SE-01 FEMALE 56.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 43.37 Luminal A -7.0 -5.0 6.0 1.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
273 ER+ ER+ ER+ TCGA-A2-A0EX-01 TCGA-A2-A0EX-01 FEMALE 46.0 Positive Positive Negative T3 T_Other N0 Negative M0 Negative Stage IIB Stage IIB enrollment LIVING 18.04 Luminal A -7.0 -5.0 4.0 4.0 ReacI 4.0 3.0 1.0 4.0 Breast Cancer Invasive Breast Carcinoma
274 ER+ ER+ ER+ TCGA-AO-A0JJ-01 TCGA-AO-A0JJ-01 FEMALE 54.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion enrollment LIVING 49.68 Luminal A -7.0 -5.0 7.0 1.0 LumA/B 2.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
275 ER+ ER+ ER+ TCGA-E2-A105-01 TCGA-E2-A105-01 FEMALE 79.0 Positive Positive Equivocal T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 38.21 Luminal A -3.0 -10.0 1.0 3.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
276 ER+ ER+ ER+ TCGA-A1-A0SD-01 TCGA-A1-A0SD-01 FEMALE 59.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 14.36 Luminal A -3.0 -9.0 6.0 1.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
277 NaN NaN NaN TCGA-A1-A0SH-01 TCGA-A1-A0SH-01 FEMALE 39.0 Negative Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 47.21 Luminal A -7.0 -5.0 4.0 2.0 Her2 5.0 1.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
278 ER+ ER+ ER+ TCGA-A1-A0SJ-01 TCGA-A1-A0SJ-01 FEMALE 39.0 Positive Positive Negative T3 T_Other N1 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 14.00 Luminal A -3.0 -3.0 4.0 4.0 ReacI 3.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
279 ER+ ER+ ER+ TCGA-A8-A06P-01 TCGA-A8-A06P-01 FEMALE 63.0 Positive Positive Negative T1 T1 N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 13.01 Luminal A -3.0 -5.0 4.0 2.0 ReacI 4.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
280 ER+ ER+ ER+ TCGA-A8-A06T-01 TCGA-A8-A06T-01 FEMALE 75.0 Positive Positive Negative T3 T_Other N1 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 41.04 Luminal A -3.0 -10.0 2.0 4.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
281 ER+ ER+ ER+ TCGA-A8-A06Y-01 TCGA-A8-A06Y-01 FEMALE 66.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 25.99 Luminal A -3.0 0.0 2.0 4.0 LumA 4.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
282 ER+ ER+ ER+ TCGA-A8-A07E-01 TCGA-A8-A07E-01 FEMALE 81.0 Positive Positive Negative T4 T_Other N3 Positive M0 Negative Stage X Stage IIIC enrollment LIVING 19.98 Luminal A -3.0 -4.0 1.0 4.0 ReacII 2.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
283 ER+ ER+ ER+ TCGA-A8-A07F-01 TCGA-A8-A07F-01 FEMALE 65.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 18.92 Luminal A -1.0 -1.0 4.0 4.0 ReacI 2.0 3.0 1.0 4.0 Breast Cancer Invasive Breast Carcinoma
284 ER+ ER+ ER+ TCGA-A8-A07G-01 TCGA-A8-A07G-01 FEMALE 65.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment LIVING 18.92 Luminal A -7.0 -5.0 4.0 1.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
285 ER+ ER+ ER+ TCGA-A8-A07J-01 TCGA-A8-A07J-01 FEMALE 35.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 11.99 Luminal A -7.0 -5.0 4.0 1.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
286 HER2+ ER+ ER+/HER2+ TCGA-A8-A07P-01 TCGA-A8-A07P-01 FEMALE 68.0 Positive Positive Positive T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 10.97 Luminal A -3.0 -10.0 2.0 3.0 LumA/B 4.0 3.0 4.0 3.0 Breast Cancer Invasive Breast Carcinoma
287 ER+ ER+ ER+ TCGA-A8-A083-01 TCGA-A8-A083-01 FEMALE 67.0 Positive Positive Negative T3 T_Other N0 Negative M0 Negative Stage IIB Stage IIB enrollment LIVING 0.00 Luminal A -3.0 -12.0 2.0 2.0 LumA 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
288 ER+ ER+ ER+ TCGA-A8-A086-01 TCGA-A8-A086-01 FEMALE 59.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment LIVING 13.01 Luminal A -3.0 -9.0 5.0 2.0 LumA 5.0 3.0 2.0 3.0 Breast Cancer Invasive Breast Carcinoma
289 ER+ ER+ ER+ TCGA-A8-A08A-01 TCGA-A8-A08A-01 FEMALE 89.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 0.99 Luminal A -3.0 -12.0 2.0 2.0 LumA 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
290 ER+ ER+ ER+ TCGA-A8-A08C-01 TCGA-A8-A08C-01 FEMALE 65.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 19.94 Luminal A -3.0 -12.0 NaN 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
291 ER+ ER+ ER+ TCGA-A8-A08O-01 TCGA-A8-A08O-01 FEMALE 45.0 Positive Positive Negative T2 T_Other N3 Positive M1 Positive Stage IV Stage IV enrollment LIVING 30.95 Luminal A -7.0 -5.0 6.0 2.0 ReacI 2.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
292 ER+ ER+ ER+ TCGA-A8-A08T-01 TCGA-A8-A08T-01 FEMALE 64.0 Positive Positive Negative T2 T_Other N1 Positive M1 Positive Stage IV Stage IV enrollment LIVING 92.98 Luminal A -3.0 -5.0 2.0 4.0 LumA 4.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
293 ER+ ER+ ER+ TCGA-A8-A08Z-01 TCGA-A8-A08Z-01 FEMALE 76.0 Positive Positive Negative T4 T_Other N3 Positive M0 Negative Stage IIIB Stage IIIC enrollment LIVING 39.98 Luminal A -3.0 -5.0 4.0 2.0 LumA 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
294 ER+ ER+ ER+ TCGA-A8-A090-01 TCGA-A8-A090-01 FEMALE 74.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.00 Luminal A -3.0 0.0 2.0 4.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
295 ER+ ER+ ER+ TCGA-A8-A091-01 TCGA-A8-A091-01 FEMALE 61.0 Positive Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 19.06 Luminal A -3.0 -10.0 2.0 4.0 LumA/B 4.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
296 ER+ ER+ ER+ TCGA-A8-A093-01 TCGA-A8-A093-01 FEMALE 61.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 17.91 Luminal A -3.0 -12.0 2.0 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
297 HER2+ ER+ ER+/HER2+ TCGA-A8-A099-01 TCGA-A8-A099-01 FEMALE 76.0 Positive Positive Positive T4 T_Other N3 Positive M0 Negative Stage X Stage IIIC enrollment LIVING 9.99 Luminal A -3.0 -12.0 1.0 3.0 LumA/B 2.0 3.0 4.0 3.0 Breast Cancer Invasive Breast Carcinoma
298 ER+ ER+ ER+ TCGA-A8-A09A-01 TCGA-A8-A09A-01 FEMALE 40.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage X Stage IIA enrollment LIVING 9.99 Luminal A -3.0 -3.0 4.0 4.0 LumA 4.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
299 ER+ ER+ ER+ TCGA-A8-A09B-01 TCGA-A8-A09B-01 FEMALE 58.0 Positive Positive Negative T4 T_Other N1 Positive M0 Negative Stage IIIB Stage IIIB enrollment LIVING 11.99 Luminal A -3.0 0.0 4.0 4.0 LumA 4.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
300 ER+ ER+ ER+ TCGA-A8-A09T-01 TCGA-A8-A09T-01 FEMALE 68.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage X Stage I enrollment LIVING 18.99 Luminal A -3.0 -12.0 2.0 2.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
301 ER+ ER+ ER+ TCGA-A8-A09V-01 TCGA-A8-A09V-01 FEMALE 51.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 15.01 Luminal A -3.0 -12.0 NaN 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
302 ER+ ER+ ER+ TCGA-A8-A0A1-01 TCGA-A8-A0A1-01 FEMALE 84.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 11.99 Luminal A -7.0 -5.0 4.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
303 ER+ ER+ ER+ TCGA-A8-A0A2-01 TCGA-A8-A0A2-01 FEMALE 66.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 18.99 Luminal A -3.0 0.0 2.0 3.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
304 ER+ ER+ ER+ TCGA-A8-A0A4-01 TCGA-A8-A0A4-01 FEMALE 73.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 13.01 Luminal A -7.0 -5.0 3.0 4.0 ReacII 2.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
305 ER+ ER+ ER+ TCGA-A8-A0A6-01 TCGA-A8-A0A6-01 FEMALE 64.0 Positive Positive Negative T2 T_Other N3 Positive M0 Negative Stage IIIC Stage IIIC enrollment LIVING 21.03 Luminal A -4.0 -5.0 1.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
306 ER+ ER+ ER+ TCGA-A8-A0AD-01 TCGA-A8-A0AD-01 FEMALE 83.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 38.01 Luminal A -3.0 -12.0 2.0 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
307 ER+ ER+ ER+ TCGA-AN-A03X-01 TCGA-AN-A03X-01 FEMALE 74.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA No_Conversion enrollment LIVING 0.33 Luminal A -3.0 0.0 4.0 3.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
308 ER+ ER+ ER+ TCGA-AN-A046-01 TCGA-AN-A046-01 FEMALE 68.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA No_Conversion enrollment LIVING 0.33 Luminal A -3.0 0.0 4.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
309 ER+ ER+ ER+ TCGA-AN-A04A-01 TCGA-AN-A04A-01 FEMALE 36.0 Positive Positive Negative T2 T_Other N2 Positive M0 Negative Stage IIIA No_Conversion enrollment LIVING 2.92 Luminal A -3.0 -5.0 4.0 2.0 LumA/B 5.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
310 HER2+ ER+ ER+/HER2+ TCGA-AN-A0FD-01 TCGA-AN-A0FD-01 FEMALE 71.0 Positive Positive Positive T2 T_Other N0 Negative M0 Negative Stage IIA No_Conversion enrollment LIVING 6.41 Luminal A -3.0 -8.0 4.0 2.0 LumA/B 1.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
311 ER+ ER+ ER+ TCGA-AN-A0FN-01 TCGA-AN-A0FN-01 FEMALE 61.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IB No_Conversion enrollment LIVING 7.16 Luminal A -7.0 -5.0 4.0 1.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
312 ER+ ER+ ER+ TCGA-AN-A0FS-01 TCGA-AN-A0FS-01 FEMALE 55.0 Positive Negative Negative T1 T1 N0 Negative M0 Negative Stage IB No_Conversion enrollment LIVING 6.28 Luminal A -7.0 -5.0 2.0 2.0 ReacII 2.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
313 HER2+ ER+ ER+/HER2+ TCGA-AN-A0FT-01 TCGA-AN-A0FT-01 FEMALE 63.0 Positive Positive Positive T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion enrollment LIVING 6.01 Luminal A -3.0 -2.0 5.0 3.0 Her2 3.0 3.0 4.0 5.0 Breast Cancer Invasive Breast Carcinoma
314 ER+ ER+ ER+ TCGA-AN-A0FW-01 TCGA-AN-A0FW-01 FEMALE 67.0 Positive Indeterminate Negative T2 T_Other N2 Positive M0 Negative Stage IIIA No_Conversion enrollment LIVING 0.36 Luminal A -3.0 -4.0 1.0 3.0 LumA/B 3.0 3.0 4.0 3.0 Breast Cancer Invasive Breast Carcinoma
315 ER+ ER+ ER+ TCGA-AN-A0FZ-01 TCGA-AN-A0FZ-01 FEMALE 45.0 Positive Negative Equivocal T2 T_Other N2 Positive M0 Negative Stage IIIA No_Conversion enrollment LIVING 0.33 Luminal A -3.0 -3.0 4.0 2.0 LumA/B 3.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
316 ER+ ER+ ER+ TCGA-AN-A0XL-01 TCGA-AN-A0XL-01 FEMALE 61.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.33 Luminal A -7.0 -5.0 6.0 2.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
317 NaN NaN NaN TCGA-AN-A0XN-01 TCGA-AN-A0XN-01 FEMALE 68.0 Negative Positive Negative T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 0.33 Luminal A -3.0 -5.0 4.0 3.0 ReacI 4.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
318 ER+ ER+ ER+ TCGA-AN-A0XO-01 TCGA-AN-A0XO-01 FEMALE 59.0 Positive Negative Negative T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 12.32 Luminal A -3.0 -7.0 4.0 4.0 LumA/B 2.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
319 ER+ ER+ ER+ TCGA-AN-A0XP-01 TCGA-AN-A0XP-01 FEMALE 69.0 Positive Positive Negative T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 0.30 Luminal A -3.0 -12.0 4.0 2.0 LumA 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
320 NaN NaN NaN TCGA-AN-A0XS-01 TCGA-AN-A0XS-01 FEMALE 63.0 Negative Positive Negative T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 0.33 Luminal A -4.0 -5.0 4.0 2.0 LumA 4.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
321 ER+ ER+ ER+ TCGA-AN-A0XT-01 TCGA-AN-A0XT-01 FEMALE 54.0 Positive Negative Negative T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 0.33 Luminal A -3.0 0.0 7.0 5.0 LumA/B 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
322 ER+ ER+ ER+ TCGA-AN-A0XV-01 TCGA-AN-A0XV-01 FEMALE 67.0 Positive Positive Negative T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 5.32 Luminal A 0.0 0.0 2.0 4.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
323 ER+ ER+ ER+ TCGA-AR-A0TW-01 TCGA-AR-A0TW-01 FEMALE 50.0 Positive Positive Negative T3 T_Other N1 Positive M0 Negative Stage III No_Conversion enrollment LIVING 24.28 Luminal A -5.0 -2.0 NaN 4.0 Basal 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
324 ER+ ER+ ER+ TCGA-AR-A1AK-01 TCGA-AR-A1AK-01 FEMALE 70.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 51.19 Luminal A 0.0 -5.0 4.0 1.0 ReacI 3.0 3.0 1.0 4.0 Breast Cancer Invasive Breast Carcinoma
325 ER+ ER+ ER+ TCGA-AR-A1AL-01 TCGA-AR-A1AL-01 FEMALE 60.0 Positive Positive Negative T3 T_Other N1 Positive M0 Negative Stage III Stage IIIA enrollment LIVING 48.79 Luminal A 0.0 -4.0 6.0 2.0 ReacI 2.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
326 ER+ ER+ ER+ TCGA-AR-A1AN-01 TCGA-AR-A1AN-01 FEMALE 46.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage II Stage IIA enrollment LIVING 43.66 Luminal A -7.0 -5.0 6.0 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
327 ER+ ER+ ER+ TCGA-AR-A1AP-01 TCGA-AR-A1AP-01 FEMALE 80.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 39.92 Luminal A 0.0 0.0 4.0 4.0 LumA/B 2.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
328 ER+ ER+ ER+ TCGA-AR-A1AS-01 TCGA-AR-A1AS-01 FEMALE 54.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage II Stage IIB enrollment LIVING 40.81 Luminal A -3.0 -7.0 4.0 2.0 LumA 3.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
329 ER+ ER+ ER+ TCGA-AR-A1AU-01 TCGA-AR-A1AU-01 FEMALE 39.0 Positive Positive Negative T2 T_Other N2 Positive M0 Negative Stage III Stage IIIA enrollment LIVING 46.29 Luminal A -7.0 -3.0 6.0 2.0 ReacI 4.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
330 ER+ ER+ ER+ TCGA-AR-A1AW-01 TCGA-AR-A1AW-01 FEMALE 65.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage II Stage IIA enrollment LIVING 35.22 Luminal A -3.0 -12.0 3.0 1.0 ReacII 3.0 3.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
331 HER2+ ER+ ER+/HER2+ TCGA-AR-A1AX-01 TCGA-AR-A1AX-01 FEMALE 64.0 Positive Positive Positive T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 36.24 Luminal A -5.0 0.0 6.0 5.0 ReacII 4.0 3.0 3.0 1.0 Breast Cancer Invasive Breast Carcinoma
332 ER+ ER+ ER+ TCGA-BH-A0AZ-01 TCGA-BH-A0AZ-01 FEMALE 47.0 Positive Positive Negative T3 T_Other N1 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 28.49 Luminal A -7.0 -5.0 4.0 2.0 ReacI 2.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
333 ER+ ER+ ER+ TCGA-BH-A0B0-01 TCGA-BH-A0B0-01 FEMALE 56.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 46.88 Luminal A -7.0 -5.0 6.0 1.0 ReacI 2.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
334 ER+ ER+ ER+ TCGA-BH-A0BM-01 TCGA-BH-A0BM-01 FEMALE 54.0 Positive Negative Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion enrollment LIVING 36.70 Luminal A -7.0 -5.0 6.0 2.0 ReacI 2.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
335 ER+ ER+ ER+ TCGA-BH-A0BO-01 TCGA-BH-A0BO-01 FEMALE 54.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 35.65 Luminal A -7.0 -5.0 6.0 1.0 ReacI 1.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
336 ER+ ER+ ER+ TCGA-BH-A0BP-01 TCGA-BH-A0BP-01 FEMALE 76.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 48.66 Luminal A -7.0 -5.0 4.0 4.0 ReacI 2.0 3.0 1.0 4.0 Breast Cancer Invasive Breast Carcinoma
337 ER+ ER+ ER+ TCGA-BH-A0BQ-01 TCGA-BH-A0BQ-01 FEMALE 39.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 27.14 Luminal A -7.0 -5.0 6.0 1.0 Her2 2.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
338 ER+ ER+ ER+ TCGA-BH-A0BR-01 TCGA-BH-A0BR-01 FEMALE 59.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 53.62 Luminal A -3.0 -4.0 4.0 4.0 ReacI 1.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
339 ER+ ER+ ER+ TCGA-BH-A0BS-01 TCGA-BH-A0BS-01 FEMALE 55.0 Positive Positive Negative T3 T_Other N1 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 53.88 Luminal A -2.0 0.0 7.0 2.0 LumA/B 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
340 ER+ ER+ ER+ TCGA-BH-A0BT-01 TCGA-BH-A0BT-01 FEMALE 56.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment LIVING 45.54 Luminal A -3.0 -12.0 6.0 2.0 ReacII 4.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
341 ER+ ER+ ER+ TCGA-BH-A0C1-01 TCGA-BH-A0C1-01 FEMALE 61.0 Positive Positive Negative T3 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 43.96 Luminal A -1.0 -1.0 5.0 4.0 ReacII 2.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
342 ER+ ER+ ER+ TCGA-BH-A0DE-01 TCGA-BH-A0DE-01 FEMALE 62.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 31.15 Luminal A -7.0 -5.0 6.0 4.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
343 ER+ ER+ ER+ TCGA-BH-A0DG-01 TCGA-BH-A0DG-01 FEMALE 30.0 Positive Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 23.43 Luminal A -4.0 -4.0 4.0 1.0 ReacI 3.0 3.0 1.0 4.0 Breast Cancer Invasive Breast Carcinoma
344 ER+ ER+ ER+ TCGA-BH-A0DI-01 TCGA-BH-A0DI-01 FEMALE 63.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 22.11 Luminal A -7.0 -5.0 4.0 1.0 ReacI 5.0 3.0 1.0 4.0 Breast Cancer Invasive Breast Carcinoma
345 ER+ ER+ ER+ TCGA-BH-A0DO-01 TCGA-BH-A0DO-01 FEMALE 78.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 17.25 Luminal A -7.0 -5.0 6.0 1.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
346 ER+ ER+ ER+ TCGA-BH-A0DT-01 TCGA-BH-A0DT-01 FEMALE 41.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment LIVING 38.44 Luminal A -7.0 -5.0 6.0 1.0 LumA 2.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
347 ER+ ER+ ER+ TCGA-BH-A0DX-01 TCGA-BH-A0DX-01 FEMALE 62.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 47.38 Luminal A -7.0 -4.0 6.0 1.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
348 ER+ ER+ ER+ TCGA-BH-A0E9-01 TCGA-BH-A0E9-01 FEMALE 53.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 46.16 Luminal A -7.0 -5.0 6.0 1.0 ReacI 3.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
349 ER+ ER+ ER+ TCGA-BH-A0EI-01 TCGA-BH-A0EI-01 FEMALE 51.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment LIVING 24.41 Luminal A -7.0 -5.0 4.0 4.0 LumA 5.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
350 ER+ ER+ ER+ TCGA-BH-A0H3-01 TCGA-BH-A0H3-01 FEMALE 46.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 37.75 Luminal A -4.0 -2.0 6.0 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
351 ER+ ER+ ER+ TCGA-BH-A0H5-01 TCGA-BH-A0H5-01 FEMALE 45.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 35.48 Luminal A -5.0 -2.0 3.0 1.0 Basal 1.0 1.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
352 ER+ ER+ ER+ TCGA-BH-A0HA-01 TCGA-BH-A0HA-01 FEMALE 31.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 28.12 Luminal A -7.0 -5.0 6.0 2.0 ReacI 1.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
353 ER+ ER+ ER+ TCGA-BH-A0W4-01 TCGA-BH-A0W4-01 FEMALE 46.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 5.75 Luminal A -7.0 -5.0 4.0 2.0 LumA 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
354 ER+ ER+ ER+ TCGA-BH-A0W5-01 TCGA-BH-A0W5-01 FEMALE 77.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIA No_Conversion enrollment LIVING 17.84 Luminal A -4.0 -5.0 4.0 1.0 LumA 4.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
355 ER+ ER+ ER+ TCGA-BH-A0W7-01 TCGA-BH-A0W7-01 FEMALE 49.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I enrollment LIVING 18.33 Luminal A -4.0 -4.0 4.0 1.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
356 ER+ ER+ ER+ TCGA-BH-A18H-01 TCGA-BH-A18H-01 FEMALE 63.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IB Stage I enrollment LIVING 0.00 Luminal A -5.0 -2.0 6.0 1.0 LumA/B 3.0 3.0 3.0 1.0 Breast Cancer Invasive Breast Carcinoma
357 ER+ ER+ ER+ TCGA-BH-A18I-01 TCGA-BH-A18I-01 FEMALE 53.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment LIVING 7.23 Luminal A -4.0 -5.0 4.0 2.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
358 ER+ ER+ ER+ TCGA-C8-A12N-01 TCGA-C8-A12N-01 FEMALE 58.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.00 Luminal A -3.0 -12.0 6.0 2.0 ReacI 4.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
359 ER+ ER+ ER+ TCGA-C8-A12O-01 TCGA-C8-A12O-01 FEMALE 50.0 Positive Positive Not Available T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.00 Luminal A 0.0 -2.0 4.0 1.0 Her2 NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
360 NaN NaN NaN TCGA-C8-A12Y-01 TCGA-C8-A12Y-01 FEMALE 44.0 Not Performed Not Performed Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 0.00 Luminal A -3.0 0.0 6.0 2.0 LumA 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
361 HER2+ ER+ ER+/HER2+ TCGA-C8-A132-01 TCGA-C8-A132-01 FEMALE 56.0 Positive Positive Positive T2 T_Other N1 Positive M0 Negative Stage II Stage IIB enrollment LIVING 0.00 Luminal A -4.0 -2.0 5.0 1.0 Her2 5.0 3.0 2.0 3.0 Breast Cancer Invasive Breast Carcinoma
362 ER+ ER+ ER+ TCGA-C8-A133-01 TCGA-C8-A133-01 FEMALE 65.0 Positive Positive Negative T3 T_Other N1 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 0.00 Luminal A -3.0 -12.0 1.0 2.0 LumA/B 1.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
363 ER+ ER+ ER+ TCGA-C8-A1HI-01 TCGA-C8-A1HI-01 FEMALE 40.0 Positive Positive Negative T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 0.07 Luminal A 0.0 -5.0 6.0 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
364 ER+ ER+ ER+ TCGA-D8-A141-01 TCGA-D8-A141-01 FEMALE 40.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage X Stage IIA enrollment LIVING 3.71 Luminal A -4.0 -5.0 4.0 1.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
365 ER+ ER+ ER+ TCGA-E2-A14Q-01 TCGA-E2-A14Q-01 FEMALE 50.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIA Stage IIB enrollment LIVING 32.00 Luminal A -7.0 0.0 2.0 2.0 LumA 2.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
366 ER+ ER+ ER+ TCGA-E2-A14T-01 TCGA-E2-A14T-01 FEMALE 52.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 29.24 Luminal A -3.0 0.0 1.0 2.0 LumA/B NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
367 ER+ ER+ ER+ TCGA-E2-A14Z-01 TCGA-E2-A14Z-01 FEMALE 64.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 17.02 Luminal A -2.0 0.0 6.0 1.0 LumA 1.0 3.0 3.0 2.0 Breast Cancer Invasive Breast Carcinoma
368 ER+ ER+ ER+ TCGA-E2-A153-01 TCGA-E2-A153-01 FEMALE 51.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIB Stage IIA enrollment LIVING 19.25 Luminal A -3.0 -12.0 4.0 1.0 LumA 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
369 ER+ ER+ ER+ TCGA-E2-A154-01 TCGA-E2-A154-01 FEMALE 68.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 10.68 Luminal A -3.0 -12.0 6.0 4.0 LumA 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
370 ER+ ER+ ER+ TCGA-E2-A156-01 TCGA-E2-A156-01 FEMALE 61.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 15.80 Luminal A -3.0 -12.0 2.0 2.0 LumA 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
371 ER+ ER+ ER+ TCGA-E2-A15C-01 TCGA-E2-A15C-01 FEMALE 61.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 16.30 Luminal A -4.0 -5.0 2.0 2.0 ReacI 4.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
372 ER+ ER+ ER+ TCGA-E2-A15D-01 TCGA-E2-A15D-01 FEMALE 47.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 10.35 Luminal A -3.0 -5.0 4.0 1.0 LumA NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
373 HER2+ ER+ ER+/HER2+ TCGA-E2-A15E-01 TCGA-E2-A15E-01 FEMALE 40.0 Positive Positive Positive T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment LIVING 16.99 Luminal A -7.0 -5.0 6.0 2.0 Her2 4.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
374 ER+ ER+ ER+ TCGA-E2-A15F-01 TCGA-E2-A15F-01 FEMALE 64.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage I Stage IIA enrollment LIVING 15.38 Luminal A -3.0 -3.0 4.0 2.0 ReacI NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
375 ER+ ER+ ER+ TCGA-E2-A15G-01 TCGA-E2-A15G-01 FEMALE 76.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 10.35 Luminal A -3.0 -12.0 1.0 1.0 LumA 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
376 HER2+ ER+ ER+/HER2+ TCGA-E2-A15H-01 TCGA-E2-A15H-01 FEMALE 38.0 Positive Positive Positive T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment LIVING 1.38 Luminal A 0.0 0.0 4.0 2.0 Her2 2.0 3.0 3.0 1.0 Breast Cancer Invasive Breast Carcinoma
377 ER+ ER+ ER+ TCGA-E2-A15I-01 TCGA-E2-A15I-01 FEMALE 44.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 13.50 Luminal A -7.0 -5.0 7.0 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
378 ER+ ER+ ER+ TCGA-E2-A15J-01 TCGA-E2-A15J-01 FEMALE 51.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 15.21 Luminal A -3.0 -12.0 4.0 4.0 LumA/B 2.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
379 ER+ ER+ ER+ TCGA-E2-A15O-01 TCGA-E2-A15O-01 FEMALE 89.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage I Stage IIA enrollment LIVING 12.98 Luminal A -3.0 0.0 2.0 4.0 LumA 4.0 3.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
380 ER+ ER+ ER+ TCGA-E2-A15P-01 TCGA-E2-A15P-01 FEMALE 61.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I enrollment LIVING 10.35 Luminal A -7.0 -5.0 2.0 2.0 ReacI 2.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
381 ER+ ER+ ER+ TCGA-E2-A15R-01 TCGA-E2-A15R-01 FEMALE 64.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIIA Stage IIA enrollment LIVING 10.84 Luminal A -3.0 -10.0 5.0 3.0 LumA/B 4.0 3.0 4.0 3.0 Breast Cancer Invasive Breast Carcinoma
382 HER2+ ER+ ER+/HER2+ TCGA-E2-A1B1-01 TCGA-E2-A1B1-01 FEMALE 45.0 Positive Positive Positive T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 44.72 Luminal A -7.0 -5.0 4.0 5.0 ReacI 3.0 3.0 1.0 2.0 Breast Cancer Invasive Breast Carcinoma
383 ER+ ER+ ER+ TCGA-E2-A1B4-01 TCGA-E2-A1B4-01 FEMALE 74.0 Positive Positive Negative T1 T1 N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 29.93 Luminal A -3.0 -12.0 6.0 2.0 LumA/B 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
384 TNBC TNBC TNBC TCGA-E2-A1B6-01 TCGA-E2-A1B6-01 FEMALE 44.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 11.10 Luminal A -7.0 -5.0 6.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
385 ER+ ER+ ER+ TCGA-E2-A1BC-01 TCGA-E2-A1BC-01 FEMALE 63.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I enrollment LIVING 9.76 Luminal A -7.0 -5.0 6.0 2.0 ReacI 2.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
386 ER+ ER+ ER+ TCGA-E2-A1BD-01 TCGA-E2-A1BD-01 FEMALE 53.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 10.42 Luminal A -3.0 -7.0 6.0 4.0 LumA 2.0 3.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
387 ER+ ER+ ER+ TCGA-A2-A0SV-01 TCGA-A2-A0SV-01 FEMALE 63.0 Positive Positive Negative T2 T_Other N2 Positive M1 Positive Stage IV No_Conversion followup DECEASED 27.11 Luminal B -3.0 -2.0 6.0 2.0 Basal 5.0 4.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
388 ER+ ER+ ER+ TCGA-AO-A03O-01 TCGA-AO-A03O-01 FEMALE 69.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup DECEASED 81.58 Luminal B -5.0 -2.0 1.0 4.0 LumA/B 3.0 4.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
389 ER+ ER+ ER+ TCGA-A2-A0SW-01 TCGA-A2-A0SW-01 FEMALE 82.0 Positive Negative Negative T2 T_Other N2 Positive M1 Positive Stage IV No_Conversion followup DECEASED 44.81 Luminal B -5.0 -2.0 3.0 4.0 Basal 4.0 4.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
390 ER+ ER+ ER+ TCGA-B6-A0WW-01 TCGA-B6-A0WW-01 FEMALE 58.0 Positive Positive Negative T2 T_Other N1 Positive NaN NaN NaN No_Conversion followup DECEASED 18.30 Luminal B -3.0 0.0 2.0 4.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
391 ER+ ER+ ER+ TCGA-BH-A18J-01 TCGA-BH-A18J-01 FEMALE 56.0 Positive Positive Negative T4 T_Other N2 Positive M1 Positive Stage IV No_Conversion enrollment DECEASED 20.07 Luminal B -3.0 -1.0 4.0 1.0 ReacII 2.0 4.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
392 ER+ ER+ ER+ TCGA-BH-A18L-01 TCGA-BH-A18L-01 FEMALE 50.0 Positive Positive Not Available T3 T_Other N1 Positive M0 Negative Stage IIB Stage IIIA enrollment DECEASED 26.65 Luminal B -5.0 -10.0 1.0 4.0 ReacII 5.0 4.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
393 HER2+ ER+ ER+/HER2+ TCGA-A8-A06X-01 TCGA-A8-A06X-01 FEMALE 77.0 Positive Negative Positive T3 T_Other N0 Negative M0 Negative Stage IIB Stage IIB enrollment DECEASED 30.98 Luminal B -5.0 -2.0 NaN 3.0 LumA/B 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
394 ER+ ER+ ER+ TCGA-B6-A0IC-01 TCGA-B6-A0IC-01 FEMALE 90.0 Positive Positive Negative T2 T_Other N0 Negative NaN NaN NaN No_Conversion followup DECEASED 50.66 Luminal B -3.0 -12.0 2.0 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
395 HER2+ ER+ ER+/HER2+ TCGA-BH-A18U-01 TCGA-BH-A18U-01 FEMALE 72.0 Positive Positive Positive T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment DECEASED 51.35 Luminal B -5.0 -2.0 5.0 3.0 ReacI 3.0 4.0 4.0 5.0 Breast Cancer Invasive Breast Carcinoma
396 TNBC TNBC TNBC TCGA-BH-A1EW-01 TCGA-BH-A1EW-01 FEMALE 38.0 Negative Negative Negative T2 T_Other N1 Positive M0 Negative Stage IIA No_Conversion enrollment DECEASED 55.66 Luminal B -3.0 -3.0 6.0 1.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
397 ER+ ER+ ER+ TCGA-AR-A0TY-01 TCGA-AR-A0TY-01 FEMALE 54.0 Positive Negative Negative T2 T_Other N0 Negative M0 Negative Stage II No_Conversion enrollment DECEASED 55.82 Luminal B -5.0 -2.0 4.0 4.0 LumA/B 1.0 4.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
398 ER+ ER+ ER+ TCGA-B6-A0X5-01 TCGA-B6-A0X5-01 FEMALE 61.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup DECEASED 68.90 Luminal B -3.0 0.0 1.0 4.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
399 ER+ ER+ ER+ TCGA-B6-A0WV-01 TCGA-B6-A0WV-01 FEMALE 67.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup DECEASED 79.57 Luminal B -3.0 0.0 4.0 4.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
400 ER+ ER+ ER+ TCGA-B6-A0RL-01 TCGA-B6-A0RL-01 FEMALE 60.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup DECEASED 81.12 Luminal B -3.0 -10.0 5.0 3.0 LumA/B 2.0 4.0 4.0 3.0 Breast Cancer Invasive Breast Carcinoma
401 ER+ ER+ ER+ TCGA-AR-A0U2-01 TCGA-AR-A0U2-01 FEMALE 47.0 Positive Positive Negative T2 T_Other N2 Positive M0 Negative Stage III No_Conversion enrollment DECEASED 83.81 Luminal B -5.0 -10.0 5.0 2.0 ReacII 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
402 ER+ ER+ ER+ TCGA-B6-A0IB-01 TCGA-B6-A0IB-01 FEMALE 64.0 Positive Positive Negative T3 T_Other N3 Positive M1 Positive Stage IV No_Conversion followup DECEASED 129.48 Luminal B -3.0 0.0 1.0 4.0 LumA/B 4.0 4.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
403 ER+ ER+ ER+ TCGA-AO-A0J7-01 TCGA-AO-A0J7-01 FEMALE 71.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 8.54 Luminal B -3.0 0.0 2.0 4.0 LumA/B 2.0 4.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
404 ER+ ER+ ER+ TCGA-AO-A0J3-01 TCGA-AO-A0J3-01 FEMALE 67.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 9.92 Luminal B -3.0 -10.0 1.0 3.0 LumA/B 5.0 4.0 4.0 3.0 Breast Cancer Invasive Breast Carcinoma
405 ER+ ER+ ER+ TCGA-D8-A13Y-01 TCGA-D8-A13Y-01 FEMALE 52.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA No_Conversion followup LIVING 11.89 Luminal B -6.0 -2.0 1.0 2.0 Basal 5.0 4.0 3.0 2.0 Breast Cancer Invasive Breast Carcinoma
406 ER+ ER+ ER+ TCGA-A7-A13F-01 TCGA-A7-A13F-01 FEMALE 44.0 Positive Positive Negative T3 T_Other N1 Positive M0 Negative Stage IIIA No_Conversion followup LIVING 12.71 Luminal B -3.0 0.0 4.0 4.0 LumA/B 3.0 4.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
407 ER+ ER+ ER+ TCGA-BH-A0HU-01 TCGA-BH-A0HU-01 FEMALE 52.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 12.88 Luminal B -3.0 -2.0 4.0 2.0 Her2 2.0 4.0 3.0 1.0 Breast Cancer Invasive Breast Carcinoma
408 HER2+ ER+ ER+/HER2+ TCGA-D8-A140-01 TCGA-D8-A140-01 FEMALE 62.0 Positive Positive Positive T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB followup LIVING 13.24 Luminal B -5.0 -10.0 6.0 3.0 LumA/B NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
409 ER+ ER+ ER+ TCGA-A7-A0CJ-01 TCGA-A7-A0CJ-01 FEMALE 57.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 13.44 Luminal B -3.0 -6.0 2.0 3.0 LumA/B 1.0 4.0 4.0 3.0 Breast Cancer Invasive Breast Carcinoma
410 HER2+ ER+ ER+/HER2+ TCGA-AQ-A04H-01 TCGA-AQ-A04H-01 FEMALE 61.0 Positive Positive Positive T2 T_Other N2 Positive NaN NaN Stage IIIA No_Conversion followup LIVING 14.42 Luminal B -3.0 -10.0 7.0 3.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
411 ER+ ER+ ER+ TCGA-BH-A0H0-01 TCGA-BH-A0H0-01 FEMALE 69.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 15.15 Luminal B -3.0 -10.0 2.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
412 ER+ ER+ ER+ TCGA-BH-A0BD-01 TCGA-BH-A0BD-01 FEMALE 47.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIA No_Conversion followup LIVING 18.20 Luminal B 0.0 0.0 4.0 4.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
413 ER+ ER+ ER+ TCGA-A2-A0T3-01 TCGA-A2-A0T3-01 FEMALE 37.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IA Stage IIA followup LIVING 18.69 Luminal B -3.0 0.0 7.0 3.0 ReacII 3.0 4.0 4.0 5.0 Breast Cancer Invasive Breast Carcinoma
414 ER+ ER+ ER+ TCGA-A2-A0T4-01 TCGA-A2-A0T4-01 FEMALE 62.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 20.50 Luminal B -7.0 -5.0 4.0 4.0 ReacI 2.0 3.0 1.0 4.0 Breast Cancer Invasive Breast Carcinoma
415 ER+ ER+ ER+ TCGA-A2-A0YH-01 TCGA-A2-A0YH-01 FEMALE 53.0 Positive Positive Negative T2 T_Other N2 Positive M0 Negative Stage IIIA No_Conversion followup LIVING 21.62 Luminal B -5.0 -2.0 4.0 2.0 LumA/B 4.0 4.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
416 HER2+ ER+ ER+/HER2+ TCGA-A2-A0YG-01 TCGA-A2-A0YG-01 FEMALE 63.0 Positive Positive Positive T2 T_Other N3 Positive M0 Negative Stage IIIC No_Conversion followup LIVING 21.85 Luminal B -5.0 -2.0 4.0 4.0 Her2 5.0 4.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
417 HER2+ ER+ ER+/HER2+ TCGA-A2-A0EY-01 TCGA-A2-A0EY-01 FEMALE 62.0 Positive Negative Positive T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 24.15 Luminal B -5.0 -2.0 1.0 4.0 Her2 3.0 4.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
418 ER+ ER+ ER+ TCGA-A2-A0D4-01 TCGA-A2-A0D4-01 FEMALE 37.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 25.20 Luminal B -3.0 -10.0 5.0 3.0 LumA/B 5.0 4.0 4.0 3.0 Breast Cancer Invasive Breast Carcinoma
419 ER+ ER+ ER+ TCGA-BH-A0AY-01 TCGA-BH-A0AY-01 FEMALE 62.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 25.53 Luminal B -3.0 -1.0 4.0 1.0 ReacI 3.0 3.0 1.0 4.0 Breast Cancer Invasive Breast Carcinoma
420 ER+ ER+ ER+ TCGA-E2-A107-01 TCGA-E2-A107-01 FEMALE 54.0 Positive Negative Negative T3 T_Other N2 Positive M0 Negative Stage IIIA No_Conversion followup LIVING 34.37 Luminal B -3.0 0.0 4.0 4.0 LumA/B 2.0 4.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
421 ER+ ER+ ER+ TCGA-AO-A0JI-01 TCGA-AO-A0JI-01 FEMALE 56.0 Positive Negative Negative T1 T1 N1 Positive M0 Negative Stage IIA No_Conversion followup LIVING 38.51 Luminal B -3.0 -10.0 2.0 3.0 LumA/B 4.0 4.0 4.0 3.0 Breast Cancer Invasive Breast Carcinoma
422 ER+ ER+ ER+ TCGA-E2-A10C-01 TCGA-E2-A10C-01 FEMALE 54.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 40.05 Luminal B -5.0 -2.0 7.0 4.0 ReacI 3.0 4.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
423 ER+ ER+ ER+ TCGA-E2-A10A-01 TCGA-E2-A10A-01 FEMALE 41.0 Positive Positive Negative T3 T_Other N0 Negative M0 Negative Stage IIB Stage IIB followup LIVING 40.38 Luminal B -3.0 0.0 1.0 2.0 LumA/B 2.0 4.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
424 HER2+ ER+ ER+/HER2+ TCGA-BH-A0C0-01 TCGA-BH-A0C0-01 FEMALE 62.0 Positive Positive Positive T1 T1 N1 Positive M0 Negative Stage IIA No_Conversion followup LIVING 41.73 Luminal B -5.0 -2.0 4.0 4.0 Basal 3.0 4.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
425 ER+ ER+ ER+ TCGA-E2-A109-01 TCGA-E2-A109-01 FEMALE 64.0 Positive Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 46.56 Luminal B -5.0 -10.0 6.0 3.0 LumA/B 5.0 4.0 4.0 1.0 Breast Cancer Invasive Breast Carcinoma
426 ER+ ER+ ER+ TCGA-AO-A0JC-01 TCGA-AO-A0JC-01 FEMALE 64.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 50.83 Luminal B -5.0 -2.0 2.0 5.0 LumA 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
427 ER+ ER+ ER+ TCGA-BH-A0HW-01 TCGA-BH-A0HW-01 FEMALE 62.0 Positive Negative Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 51.25 Luminal B -3.0 -10.0 2.0 2.0 LumA/B 4.0 4.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
428 ER+ ER+ ER+ TCGA-AO-A0JD-01 TCGA-AO-A0JD-01 FEMALE 59.0 Positive Positive Negative T3 T_Other N1 Positive M0 Negative Stage IIIA No_Conversion followup LIVING 59.57 Luminal B -2.0 -2.0 5.0 2.0 Basal 2.0 4.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
429 HER2+ ER+ ER+/HER2+ TCGA-AO-A0JM-01 TCGA-AO-A0JM-01 FEMALE 40.0 Positive Positive Positive T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 59.99 Luminal B -5.0 -2.0 5.0 3.0 ReacII 3.0 4.0 4.0 5.0 Breast Cancer Invasive Breast Carcinoma
430 ER+ ER+ ER+ TCGA-A2-A0CW-01 TCGA-A2-A0CW-01 FEMALE 67.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 63.97 Luminal B -5.0 -2.0 NaN 1.0 LumA/B 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
431 ER+ ER+ ER+ TCGA-A2-A0ER-01 TCGA-A2-A0ER-01 FEMALE 63.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IB No_Conversion followup LIVING 74.32 Luminal B -3.0 -10.0 2.0 2.0 ReacII 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
432 ER+ ER+ ER+ TCGA-A2-A0CT-01 TCGA-A2-A0CT-01 FEMALE 71.0 Positive Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 75.17 Luminal B -3.0 -10.0 2.0 3.0 LumA/B 5.0 4.0 4.0 3.0 Breast Cancer Invasive Breast Carcinoma
433 ER+ ER+ ER+ TCGA-AO-A12B-01 TCGA-AO-A12B-01 FEMALE 63.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 77.50 Luminal B -3.0 -12.0 3.0 2.0 LumA/B 3.0 4.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
434 ER+ ER+ ER+ TCGA-A2-A04R-01 TCGA-A2-A04R-01 FEMALE 36.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 82.10 Luminal B -3.0 -10.0 4.0 4.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
435 ER+ ER+ ER+ TCGA-B6-A0IM-01 TCGA-B6-A0IM-01 FEMALE 75.0 Positive Positive Negative T3 T_Other N0 Negative M0 Negative Stage IIB Stage IIB followup LIVING 126.03 Luminal B -3.0 -10.0 4.0 4.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
436 ER+ ER+ ER+ TCGA-AO-A03P-01 TCGA-AO-A03P-01 FEMALE 54.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIA No_Conversion enrollment LIVING 84.63 Luminal B -5.0 -10.0 NaN 2.0 LumA/B 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
437 HER2+ ER+ ER+/HER2+ TCGA-A1-A0SM-01 TCGA-A1-A0SM-01 MALE 77.0 Positive Negative Positive T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 7.95 Luminal B -3.0 -1.0 4.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
438 ER+ ER+ ER+ TCGA-A8-A06N-01 TCGA-A8-A06N-01 FEMALE 66.0 Positive Negative Negative T4 T_Other N0 Negative M0 Negative Stage IIIB Stage IIIB enrollment LIVING 0.00 Luminal B -3.0 -10.0 2.0 4.0 LumA/B 3.0 4.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
439 ER+ ER+ ER+ TCGA-A8-A06O-01 TCGA-A8-A06O-01 FEMALE 60.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 13.01 Luminal B -3.0 -2.0 4.0 4.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
440 ER+ ER+ ER+ TCGA-A8-A06Q-01 TCGA-A8-A06Q-01 FEMALE 63.0 Positive Positive Negative T3 T_Other N2 Positive M0 Negative Stage IIIA No_Conversion enrollment LIVING 1.02 Luminal B -3.0 -2.0 7.0 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
441 ER+ ER+ ER+ TCGA-A8-A06R-01 TCGA-A8-A06R-01 FEMALE 69.0 Positive Negative Equivocal T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion enrollment LIVING 17.94 Luminal B -5.0 -2.0 4.0 4.0 ReacI NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
442 ER+ ER+ ER+ TCGA-A8-A06Z-01 TCGA-A8-A06Z-01 FEMALE 84.0 Positive Positive Negative T3 T_Other N0 Negative M0 Negative Stage IIB Stage IIB enrollment LIVING 1.02 Luminal B -3.0 -10.0 1.0 5.0 Her2 5.0 4.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
443 ER+ ER+ ER+ TCGA-A8-A079-01 TCGA-A8-A079-01 FEMALE 69.0 Positive Positive Negative T4 T_Other N3 Positive M0 Negative Stage IIIB Stage IIIC enrollment LIVING 9.00 Luminal B -3.0 -6.0 5.0 3.0 LumA/B 5.0 4.0 4.0 3.0 Breast Cancer Invasive Breast Carcinoma
444 ER+ ER+ ER+ TCGA-A8-A07L-01 TCGA-A8-A07L-01 FEMALE 58.0 Positive Positive Negative T3 T_Other N1 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 16.99 Luminal B -3.0 -10.0 5.0 4.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
445 ER+ ER+ ER+ TCGA-A8-A07S-01 TCGA-A8-A07S-01 FEMALE 73.0 Positive Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 7.95 Luminal B -3.0 -12.0 7.0 2.0 LumA 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
446 ER+ ER+ ER+ TCGA-A8-A07W-01 TCGA-A8-A07W-01 FEMALE 76.0 Positive Positive Negative T2 T_Other N0 Negative M1 Positive Stage IV Stage IV enrollment LIVING 9.99 Luminal B -5.0 -2.0 4.0 4.0 LumA/B 3.0 4.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
447 ER+ ER+ ER+ TCGA-A8-A07Z-01 TCGA-A8-A07Z-01 FEMALE 85.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 28.03 Luminal B -3.0 -12.0 2.0 2.0 LumA 3.0 4.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
448 ER+ ER+ ER+ TCGA-A8-A082-01 TCGA-A8-A082-01 FEMALE 58.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 18.04 Luminal B -3.0 -9.0 5.0 4.0 LumA 4.0 4.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
449 ER+ ER+ ER+ TCGA-A8-A084-01 TCGA-A8-A084-01 FEMALE 81.0 Positive Negative Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion enrollment LIVING 15.05 Luminal B -5.0 -1.0 3.0 3.0 X 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
450 ER+ ER+ ER+ TCGA-A8-A085-01 TCGA-A8-A085-01 MALE 44.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 36.93 Luminal B -3.0 -10.0 2.0 4.0 LumA/B 5.0 4.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
451 ER+ ER+ ER+ TCGA-A8-A08F-01 TCGA-A8-A08F-01 FEMALE 59.0 Positive Positive Negative T2 T_Other N3 Positive M0 Negative Stage IIIC Stage IIIC enrollment LIVING 18.04 Luminal B -3.0 -2.0 NaN 2.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
452 HER2+ ER+ ER+/HER2+ TCGA-A8-A08G-01 TCGA-A8-A08G-01 FEMALE 41.0 Positive Positive Positive T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 19.91 Luminal B -3.0 -10.0 4.0 2.0 LumA/B 3.0 4.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
453 ER+ ER+ ER+ TCGA-A8-A08I-01 TCGA-A8-A08I-01 FEMALE 53.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 11.99 Luminal B -5.0 -2.0 3.0 2.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
454 HER2+ ER+ ER+/HER2+ TCGA-A8-A08P-01 TCGA-A8-A08P-01 FEMALE 70.0 Positive Positive Positive T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 30.95 Luminal B -5.0 -2.0 NaN 4.0 ReacII 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
455 ER+ ER+ ER+ TCGA-A8-A095-01 TCGA-A8-A095-01 FEMALE 45.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 41.92 Luminal B -3.0 -7.0 4.0 4.0 ReacII 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
456 ER+ ER+ ER+ TCGA-A8-A096-01 TCGA-A8-A096-01 FEMALE 73.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.00 Luminal B -4.0 -12.0 4.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
457 HER2+ ER+ ER+/HER2+ TCGA-A8-A097-01 TCGA-A8-A097-01 FEMALE 65.0 Positive Positive Positive T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 11.99 Luminal B -2.0 0.0 4.0 2.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
458 ER+ ER+ ER+ TCGA-A8-A09C-01 TCGA-A8-A09C-01 FEMALE 69.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage X Stage IIA enrollment LIVING 1.02 Luminal B -3.0 0.0 2.0 2.0 LumA 4.0 4.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
459 ER+ ER+ ER+ TCGA-A8-A09D-01 TCGA-A8-A09D-01 FEMALE 47.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion enrollment LIVING 13.01 Luminal B -3.0 -3.0 1.0 1.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
460 HER2+ ER+ ER+/HER2+ TCGA-A8-A09I-01 TCGA-A8-A09I-01 FEMALE 84.0 Positive Positive Positive T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 33.05 Luminal B -5.0 -2.0 4.0 3.0 Her2 5.0 4.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
461 ER+ ER+ ER+ TCGA-A8-A09M-01 TCGA-A8-A09M-01 FEMALE 75.0 Positive Positive Negative T2 T_Other N3 Positive M0 Negative Stage IIIC Stage IIIC enrollment LIVING 15.01 Luminal B -5.0 -2.0 5.0 4.0 LumA/B 5.0 4.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
462 HER2+ ER+ ER+/HER2+ TCGA-A8-A09N-01 TCGA-A8-A09N-01 FEMALE 57.0 Positive Positive Positive T2 T_Other N3 Positive M0 Negative Stage IIIC Stage IIIC enrollment LIVING 1.02 Luminal B -3.0 0.0 7.0 4.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
463 ER+ ER+ ER+ TCGA-A8-A09Q-01 TCGA-A8-A09Q-01 FEMALE 83.0 Positive Positive Negative T4 T_Other N2 Positive M0 Negative Stage IIIB Stage IIIB enrollment LIVING 25.00 Luminal B -5.0 -2.0 4.0 3.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
464 ER+ ER+ ER+ TCGA-A8-A09R-01 TCGA-A8-A09R-01 FEMALE 82.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 8.97 Luminal B -3.0 0.0 4.0 4.0 Her2 5.0 4.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
465 ER+ ER+ ER+ TCGA-A8-A09W-01 TCGA-A8-A09W-01 FEMALE 70.0 Positive Positive Negative T2 T_Other N3 Positive M0 Negative Stage IIIB Stage IIIC enrollment LIVING 0.99 Luminal B -5.0 -2.0 NaN 4.0 Her2 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
466 ER+ ER+ ER+ TCGA-A8-A09Z-01 TCGA-A8-A09Z-01 FEMALE 83.0 Positive Negative Negative T3 T_Other N0 Negative M0 Negative Stage IIB Stage IIB enrollment LIVING 0.00 Luminal B -5.0 0.0 2.0 4.0 Basal 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
467 ER+ ER+ ER+ TCGA-A8-A0A9-01 TCGA-A8-A0A9-01 FEMALE 80.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 13.01 Luminal B -3.0 0.0 2.0 3.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
468 ER+ ER+ ER+ TCGA-A8-A0AB-01 TCGA-A8-A0AB-01 FEMALE 54.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 16.99 Luminal B -3.0 -1.0 2.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
469 ER+ ER+ ER+ TCGA-AN-A03Y-01 TCGA-AN-A03Y-01 FEMALE 66.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA No_Conversion enrollment LIVING 0.33 Luminal B -3.0 -1.0 5.0 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
470 ER+ ER+ ER+ TCGA-AN-A041-01 TCGA-AN-A041-01 FEMALE 29.0 Positive Negative Equivocal T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 0.23 Luminal B -3.0 -2.0 4.0 4.0 LumA 5.0 4.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
471 ER+ ER+ ER+ TCGA-AN-A049-01 TCGA-AN-A049-01 FEMALE 62.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA No_Conversion enrollment LIVING 0.62 Luminal B -3.0 0.0 3.0 4.0 ReacI 5.0 4.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
472 HER2+ ER+ ER+/HER2+ TCGA-AN-A0AJ-01 TCGA-AN-A0AJ-01 FEMALE 79.0 Positive Positive Positive T3 T_Other N0 Negative M0 Negative Stage IIB No_Conversion enrollment LIVING 7.98 Luminal B -5.0 -2.0 4.0 3.0 LumA 5.0 4.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
473 ER+ ER+ ER+ TCGA-AN-A0AK-01 TCGA-AN-A0AK-01 FEMALE 76.0 Positive Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA No_Conversion enrollment LIVING 7.33 Luminal B -5.0 -10.0 1.0 4.0 Basal 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
474 ER+ ER+ ER+ TCGA-AN-A0AM-01 TCGA-AN-A0AM-01 FEMALE 56.0 Positive Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA No_Conversion enrollment LIVING 0.16 Luminal B -5.0 -2.0 4.0 4.0 LumA/B 3.0 4.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
475 ER+ ER+ ER+ TCGA-AN-A0AS-01 TCGA-AN-A0AS-01 FEMALE 70.0 Positive Negative Negative T2 T_Other N2 Positive M0 Negative Stage IIIA No_Conversion enrollment LIVING 0.30 Luminal B -3.0 -1.0 2.0 2.0 Basal 3.0 4.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
476 ER+ ER+ ER+ TCGA-AN-A0FF-01 TCGA-AN-A0FF-01 FEMALE 32.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA No_Conversion enrollment LIVING 4.60 Luminal B -3.0 0.0 1.0 4.0 LumA 3.0 4.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
477 ER+ ER+ ER+ TCGA-AN-A0FK-01 TCGA-AN-A0FK-01 FEMALE 88.0 Positive Positive Negative T4 T_Other N0 Negative M0 Negative Stage IIIB No_Conversion enrollment LIVING 6.97 Luminal B -3.0 -12.0 4.0 2.0 LumA 2.0 4.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
478 ER+ ER+ ER+ TCGA-AN-A0FY-01 TCGA-AN-A0FY-01 FEMALE 55.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IB No_Conversion enrollment LIVING 0.33 Luminal B -3.0 -2.0 5.0 2.0 LumA 3.0 4.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
479 ER+ ER+ ER+ TCGA-AN-A0XR-01 TCGA-AN-A0XR-01 FEMALE 55.0 Positive Negative Negative T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 0.33 Luminal B -3.0 -12.0 4.0 3.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
480 ER+ ER+ ER+ TCGA-AN-A0XW-01 TCGA-AN-A0XW-01 FEMALE 36.0 Positive Positive Negative T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 5.59 Luminal B -4.0 -2.0 4.0 2.0 Her2 5.0 4.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
481 HER2+ ER+ ER+/HER2+ TCGA-AR-A0TQ-01 TCGA-AR-A0TQ-01 FEMALE 27.0 Positive Negative Positive T3 T_Other N1 Positive M0 Negative Stage III No_Conversion enrollment LIVING 49.28 Luminal B -5.0 -2.0 4.0 4.0 Her2 3.0 4.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
482 ER+ ER+ ER+ TCGA-AR-A0TT-01 TCGA-AR-A0TT-01 FEMALE 53.0 Positive Negative Negative T2 T_Other N2 Positive M0 Negative Stage III No_Conversion enrollment LIVING 55.16 Luminal B -5.0 -2.0 4.0 1.0 LumA/B 3.0 4.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
483 ER+ ER+ ER+ TCGA-AR-A0TV-01 TCGA-AR-A0TV-01 FEMALE 66.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage II No_Conversion enrollment LIVING 29.70 Luminal B -5.0 -10.0 2.0 4.0 LumA/B 1.0 4.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
484 ER+ ER+ ER+ TCGA-AR-A0TZ-01 TCGA-AR-A0TZ-01 FEMALE 43.0 Positive Positive Negative T2 T_Other N2 Positive M0 Negative Stage III No_Conversion enrollment LIVING 43.14 Luminal B -3.0 -10.0 2.0 3.0 ReacII 5.0 4.0 4.0 3.0 Breast Cancer Invasive Breast Carcinoma
485 ER+ ER+ ER+ TCGA-AR-A0U3-01 TCGA-AR-A0U3-01 FEMALE 59.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage II No_Conversion enrollment LIVING 74.35 Luminal B -3.0 0.0 7.0 3.0 LumA/B 4.0 4.0 4.0 3.0 Breast Cancer Invasive Breast Carcinoma
486 ER+ ER+ ER+ TCGA-AR-A1AV-01 TCGA-AR-A1AV-01 MALE 68.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage II Stage IIB enrollment LIVING 42.55 Luminal B -5.0 -2.0 7.0 3.0 LumA/B 3.0 4.0 4.0 5.0 Breast Cancer Invasive Breast Carcinoma
487 ER+ ER+ ER+ TCGA-BH-A0AU-01 TCGA-BH-A0AU-01 FEMALE 45.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 24.51 Luminal B -3.0 -3.0 6.0 2.0 ReacI 1.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
488 ER+ ER+ ER+ TCGA-BH-A0B5-01 TCGA-BH-A0B5-01 FEMALE 40.0 Positive Positive Negative T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 48.33 Luminal B -3.0 -7.0 7.0 4.0 ReacII 2.0 4.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
489 ER+ ER+ ER+ TCGA-BH-A0BF-01 TCGA-BH-A0BF-01 FEMALE 56.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 25.66 Luminal B -5.0 -2.0 4.0 1.0 Basal 2.0 4.0 3.0 1.0 Breast Cancer Invasive Breast Carcinoma
490 ER+ ER+ ER+ TCGA-BH-A0BZ-01 TCGA-BH-A0BZ-01 FEMALE 59.0 Positive Positive Negative T3 T_Other N1 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 49.02 Luminal B -5.0 -2.0 6.0 4.0 X 4.0 4.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
491 ER+ ER+ ER+ TCGA-BH-A0C3-01 TCGA-BH-A0C3-01 FEMALE 47.0 Positive Negative Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 48.10 Luminal B 0.0 -4.0 6.0 2.0 Her2 3.0 4.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
492 HER2+ ER+ ER+/HER2+ TCGA-BH-A0C7-01 TCGA-BH-A0C7-01 FEMALE 48.0 Positive Negative Positive T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 42.88 Luminal B -3.0 0.0 4.0 4.0 LumA/B 5.0 4.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
493 HER2+ ER+ ER+/HER2+ TCGA-BH-A0DD-01 TCGA-BH-A0DD-01 MALE 58.0 Positive Positive Positive T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 45.77 Luminal B -3.0 -6.0 4.0 4.0 LumA/B 3.0 4.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
494 ER+ ER+ ER+ TCGA-BH-A0W3-01 TCGA-BH-A0W3-01 FEMALE 58.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIA No_Conversion enrollment LIVING 5.91 Luminal B -3.0 -12.0 5.0 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
495 ER+ ER+ ER+ TCGA-BH-A18F-01 TCGA-BH-A18F-01 FEMALE 50.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 8.81 Luminal B -7.0 -4.0 6.0 1.0 ReacI 2.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
496 ER+ ER+ ER+ TCGA-C8-A12M-01 TCGA-C8-A12M-01 FEMALE 70.0 Positive Negative Not Available T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.00 Luminal B -5.0 -10.0 4.0 3.0 LumA/B 5.0 4.0 4.0 1.0 Breast Cancer Invasive Breast Carcinoma
497 ER+ ER+ ER+ TCGA-C8-A12U-01 TCGA-C8-A12U-01 FEMALE 46.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IB Stage IIB enrollment LIVING 0.00 Luminal B -5.0 -2.0 5.0 4.0 Basal 5.0 4.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
498 ER+ ER+ ER+ TCGA-C8-A12W-01 TCGA-C8-A12W-01 FEMALE 49.0 Positive Positive Negative T4 T_Other N1 Positive M0 Negative Stage IIIB Stage IIIB enrollment LIVING 0.00 Luminal B -5.0 -2.0 4.0 4.0 ReacII 3.0 4.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
499 ER+ ER+ ER+ TCGA-C8-A12X-01 TCGA-C8-A12X-01 FEMALE 62.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 0.00 Luminal B -3.0 -10.0 1.0 3.0 LumA/B 4.0 4.0 4.0 3.0 Breast Cancer Invasive Breast Carcinoma
500 ER+ ER+ ER+ TCGA-C8-A1HG-01 TCGA-C8-A1HG-01 FEMALE 50.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.00 Luminal B -5.0 -2.0 3.0 5.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
501 HER2+ ER+ ER+/HER2+ TCGA-C8-A1HL-01 TCGA-C8-A1HL-01 FEMALE 38.0 Positive Negative Positive T3 T_Other N1 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 0.07 Luminal B -3.0 -2.0 4.0 2.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
502 ER+ ER+ ER+ TCGA-C8-A1HM-01 TCGA-C8-A1HM-01 FEMALE 74.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage II Stage IIA enrollment LIVING 0.20 Luminal B -5.0 -2.0 4.0 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
503 ER+ ER+ ER+ TCGA-C8-A1HN-01 TCGA-C8-A1HN-01 FEMALE 56.0 Positive Positive Equivocal T2 T_Other N0 Negative M0 Negative Stage II Stage IIA enrollment LIVING 0.07 Luminal B -5.0 -10.0 7.0 2.0 NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
504 ER+ ER+ ER+ TCGA-E2-A14O-01 TCGA-E2-A14O-01 FEMALE 76.0 Positive Positive Negative T3 T_Other N1 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 38.51 Luminal B -3.0 0.0 4.0 4.0 LumA/B 2.0 4.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
505 ER+ ER+ ER+ TCGA-E2-A14S-01 TCGA-E2-A14S-01 FEMALE 65.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 27.40 Luminal B -3.0 -10.0 2.0 4.0 LumA/B 4.0 4.0 1.0 3.0 Breast Cancer Invasive Breast Carcinoma
506 HER2+ ER+ ER+/HER2+ TCGA-E2-A14W-01 TCGA-E2-A14W-01 FEMALE 78.0 Positive Positive Positive T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 27.37 Luminal B -3.0 0.0 7.0 2.0 Her2 5.0 4.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
507 ER+ ER+ ER+ TCGA-E2-A155-01 TCGA-E2-A155-01 FEMALE 58.0 Positive Negative Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 18.17 Luminal B -3.0 -10.0 5.0 3.0 LumA/B 1.0 4.0 4.0 3.0 Breast Cancer Invasive Breast Carcinoma
508 ER+ ER+ ER+ TCGA-E2-A15A-01 TCGA-E2-A15A-01 FEMALE 45.0 Positive Positive Negative T2 T_Other N3 Positive M0 Negative Stage IIIC Stage IIIC enrollment LIVING 16.49 Luminal B -5.0 -2.0 4.0 4.0 Her2 4.0 4.0 1.0 1.0 Breast Cancer Invasive Breast Carcinoma
509 ER+ ER+ ER+ TCGA-E2-A15K-01 TCGA-E2-A15K-01 FEMALE 58.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIA Stage IIB enrollment LIVING 1.12 Luminal B -3.0 -12.0 4.0 2.0 LumA 2.0 4.0 3.0 3.0 Breast Cancer Invasive Breast Carcinoma
510 ER+ ER+ ER+ TCGA-E2-A15L-01 TCGA-E2-A15L-01 FEMALE 65.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 10.87 Luminal B -3.0 -12.0 NaN 2.0 ReacI 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
511 ER+ ER+ ER+ TCGA-E2-A15M-01 TCGA-E2-A15M-01 FEMALE 66.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 7.69 Luminal B -4.0 -4.0 6.0 1.0 ReacI 3.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
512 ER+ ER+ ER+ TCGA-E2-A15S-01 TCGA-E2-A15S-01 FEMALE 34.0 Positive Negative Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 9.00 Luminal B -3.0 -10.0 6.0 4.0 LumA/B NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
513 ER+ ER+ ER+ TCGA-E2-A15T-01 TCGA-E2-A15T-01 FEMALE 65.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 8.77 Luminal B -3.0 -10.0 2.0 4.0 LumA/B NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
514 TNBC TNBC TNBC TCGA-AO-A03U-01 TCGA-AO-A03U-01 FEMALE 31.0 Negative Negative Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup DECEASED 59.01 Normal-like 0.0 -5.0 4.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
515 TNBC TNBC TNBC TCGA-B6-A0IE-01 TCGA-B6-A0IE-01 FEMALE 38.0 Negative Negative Negative TX NaN N1 Positive M0 Negative NaN No_Conversion followup DECEASED 65.64 Normal-like -3.0 -2.0 4.0 1.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
516 ER+ ER+ ER+ TCGA-A2-A0YK-01 TCGA-A2-A0YK-01 FEMALE 61.0 Positive Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 19.29 Normal-like -7.0 -5.0 6.0 1.0 ReacII 5.0 3.0 3.0 4.0 Breast Cancer Invasive Breast Carcinoma
517 ER+ ER+ ER+ TCGA-E2-A108-01 TCGA-E2-A108-01 FEMALE 64.0 Positive Positive Negative T2 T_Other N2 Positive M0 Negative Stage IIIA No_Conversion followup LIVING 27.50 Normal-like -8.0 -5.0 4.0 1.0 ReacI 4.0 3.0 1.0 4.0 Breast Cancer Invasive Breast Carcinoma
518 ER+ ER+ ER+ TCGA-AO-A0JB-01 TCGA-AO-A0JB-01 FEMALE 50.0 Positive Positive Negative T3 T_Other N1 Positive M0 Negative Stage IIIA No_Conversion followup LIVING 37.78 Normal-like -3.0 -2.0 2.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
519 ER+ ER+ ER+ TCGA-AO-A03R-01 TCGA-AO-A03R-01 FEMALE 57.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion followup LIVING 56.08 Normal-like 0.0 0.0 2.0 2.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
520 ER+ ER+ ER+ TCGA-AO-A03T-01 TCGA-AO-A03T-01 FEMALE 42.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB No_Conversion enrollment LIVING 39.00 Normal-like -3.0 -2.0 4.0 2.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
521 ER+ ER+ ER+ TCGA-AR-A1AO-01 TCGA-AR-A1AO-01 FEMALE 47.0 Positive Negative Negative T1 T1 N1 Positive M0 Negative Stage II Stage IIA enrollment LIVING 43.50 Normal-like -8.0 -5.0 4.0 5.0 Basal 1.0 2.0 2.0 2.0 Breast Cancer Invasive Breast Carcinoma
522 ER+ ER+ ER+ TCGA-A2-A0YT-01 TCGA-A2-A0YT-01 FEMALE 56.0 Positive Negative Negative T4 T_Other N2 Positive M0 Negative Stage IIIB No_Conversion followup DECEASED 23.75 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
523 HER2+ ER+ ER+/HER2+ TCGA-AQ-A0Y5-01 TCGA-AQ-A0Y5-01 FEMALE 70.0 Positive Positive Positive T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA followup DECEASED 5.29 NaN NaN NaN 4.0 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
524 TNBC TNBC TNBC TCGA-EW-A1P8-01 TCGA-EW-A1P8-01 FEMALE 58.0 Negative Negative Negative T2 T_Other N3 Positive M0 Negative Stage IIIC Stage IIIC enrollment DECEASED 7.85 NaN NaN NaN 5.0 5.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
525 TNBC TNBC TNBC TCGA-E2-A1LK-01 TCGA-E2-A1LK-01 FEMALE 84.0 Negative Negative Negative T3 T_Other N1 Positive M0 Negative Stage IIIC Stage IIIA enrollment DECEASED 8.74 NaN NaN NaN 5.0 3.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
526 ER+ ER+ ER+ TCGA-BH-A1EY-01 TCGA-BH-A1EY-01 FEMALE 79.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment DECEASED 17.68 NaN NaN NaN 1.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
527 ER+ ER+ ER+ TCGA-BH-A1F8-01 TCGA-BH-A1F8-01 FEMALE 90.0 Positive Positive Negative T4 T_Other N2 Positive M0 Negative Stage IIIB Stage IIIC enrollment DECEASED 24.61 NaN NaN NaN 4.0 4.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
528 HER2+ ER+ ER+/HER2+ TCGA-BH-A1F2-01 TCGA-BH-A1F2-01 FEMALE 53.0 Positive Positive Positive T4 T_Other N1 Positive M0 Negative Stage IIIB Stage enrollment DECEASED 31.51 NaN NaN NaN 6.0 2.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
529 ER+ ER+ ER+ TCGA-BH-A1FD-01 TCGA-BH-A1FD-01 FEMALE 68.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment DECEASED 33.12 NaN NaN NaN NaN 3.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
530 ER+ ER+ ER+ TCGA-BH-A1FH-01 TCGA-BH-A1FH-01 FEMALE 47.0 Positive Negative Negative T2 T_Other N1 Positive M1 Positive Stage IV No_Conversion enrollment DECEASED 36.90 NaN NaN NaN 6.0 1.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
531 NaN NaN NaN TCGA-BH-A203-01 TCGA-BH-A203-01 FEMALE 78.0 Performed but Not Available Performed but Not Available NaN NaN NaN NaN NaN NaN NaN NaN NaN enrollment DECEASED 38.57 NaN NaN NaN NaN 3.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
532 ER+ ER+ ER+ TCGA-BH-A1FM-01 TCGA-BH-A1FM-01 FEMALE 44.0 Positive Negative Negative T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment DECEASED 45.60 NaN NaN NaN 4.0 3.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
533 ER+ ER+ ER+ TCGA-BH-A1EX-01 TCGA-BH-A1EX-01 FEMALE 67.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment DECEASED 49.55 NaN NaN NaN 5.0 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
534 ER+ ER+ ER+ TCGA-BH-A1FL-01 TCGA-BH-A1FL-01 FEMALE 69.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIIA enrollment DECEASED 54.97 NaN NaN NaN 6.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
535 NaN NaN NaN TCGA-BH-A208-01 TCGA-BH-A208-01 FEMALE 48.0 Performed but Not Available Performed but Not Available NaN NaN NaN NaN NaN NaN NaN NaN NaN enrollment DECEASED 57.79 NaN NaN NaN NaN 5.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
536 ER+ ER+ ER+ TCGA-GM-A2D9-01 TCGA-GM-A2D9-01 FEMALE 69.0 Positive Positive NaN NaN NaN NaN NaN NaN NaN NaN NaN enrollment DECEASED 59.53 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
537 NaN NaN NaN TCGA-BH-A1FJ-01 TCGA-BH-A1FJ-01 FEMALE 66.0 Negative Positive Negative T3 T_Other N1 Positive M0 Negative Stage IIIA Stage IIIA enrollment DECEASED 63.31 NaN NaN NaN 2.0 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
538 HER2+ HER2+ ER-/HER2+ TCGA-BH-A1EN-01 TCGA-BH-A1EN-01 FEMALE 78.0 Negative Negative Positive T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment DECEASED 67.42 NaN NaN NaN 3.0 3.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
539 ER+ ER+ ER+ TCGA-BH-A1FN-01 TCGA-BH-A1FN-01 FEMALE 34.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment DECEASED 72.02 NaN NaN NaN 4.0 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
540 HER2+ HER2+ ER-/HER2+ TCGA-BH-A1FU-01 TCGA-BH-A1FU-01 FEMALE 44.0 Negative Negative Positive T1 T1 N0 Negative M0 Negative Stage IA Stage I enrollment DECEASED 72.02 NaN NaN NaN 6.0 1.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
541 ER+ ER+ ER+ TCGA-BH-A1FE-01 TCGA-BH-A1FE-01 FEMALE 31.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment DECEASED 74.68 NaN NaN NaN 6.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
542 NaN NaN NaN TCGA-BH-A204-01 TCGA-BH-A204-01 FEMALE 80.0 Performed but Not Available Performed but Not Available NaN NaN NaN NaN NaN NaN NaN NaN NaN enrollment DECEASED 83.25 NaN NaN NaN NaN 3.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
543 ER+ ER+ ER+ TCGA-BH-A1F5-01 TCGA-BH-A1F5-01 FEMALE 62.0 Positive Positive NaN NaN NaN NaN NaN NaN NaN NaN NaN enrollment DECEASED 89.10 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
544 TNBC TNBC TNBC TCGA-AR-A256-01 TCGA-AR-A256-01 FEMALE 45.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage II Stage IIA enrollment DECEASED 93.77 NaN NaN NaN NaN 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
545 NaN NaN NaN TCGA-BH-A1F6-01 TCGA-BH-A1F6-01 FEMALE 51.0 Negative Negative NaN NaN NaN NaN NaN NaN NaN NaN NaN enrollment DECEASED 97.41 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
546 TNBC TNBC TNBC TCGA-BH-A1FC-01 TCGA-BH-A1FC-01 FEMALE 78.0 Negative Negative Negative T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment DECEASED 114.04 NaN NaN NaN 3.0 4.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
547 ER+ ER+ ER+ TCGA-BH-A1FB-01 TCGA-BH-A1FB-01 FEMALE 60.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment DECEASED 120.54 NaN NaN NaN 6.0 1.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
548 ER+ ER+ ER+ TCGA-BH-A1FG-01 TCGA-BH-A1FG-01 FEMALE 88.0 Positive Positive Not Available T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment DECEASED 122.81 NaN NaN NaN 2.0 2.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
549 ER+ ER+ ER+ TCGA-BH-A209-01 TCGA-BH-A209-01 FEMALE 77.0 Positive Positive NaN NaN NaN NaN NaN NaN NaN NaN NaN enrollment DECEASED 130.07 NaN NaN NaN NaN 3.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
550 ER+ ER+ ER+ TCGA-BH-A1FR-01 TCGA-BH-A1FR-01 FEMALE 73.0 Positive Positive Negative T4 T_Other N1 Positive M0 Negative Stage IIIB No_Conversion enrollment DECEASED 144.50 NaN NaN NaN 1.0 2.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
551 ER+ ER+ ER+ TCGA-AO-A1KS-01 TCGA-AO-A1KS-01 FEMALE 69.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 0.53 NaN NaN NaN 5.0 4.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
552 ER+ ER+ ER+ TCGA-A7-A13G-01 TCGA-A7-A13G-01 FEMALE 79.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 11.43 NaN NaN NaN 3.0 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
553 ER+ ER+ ER+ TCGA-D8-A1JS-01 TCGA-D8-A1JS-01 FEMALE 77.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 12.19 NaN NaN NaN 3.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
554 ER+ ER+ ER+ TCGA-A7-A0DC-01 TCGA-A7-A0DC-01 FEMALE 63.0 Positive Negative Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 12.68 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
555 ER+ ER+ ER+ TCGA-D8-A1JT-01 TCGA-D8-A1JT-01 FEMALE 70.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA followup LIVING 13.31 NaN NaN NaN 4.0 4.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
556 ER+ ER+ ER+ TCGA-A7-A26E-01 TCGA-A7-A26E-01 FEMALE 71.0 Positive Positive Negative T3 T_Other N1 Positive M0 Negative Stage IIIA Stage IIIA followup LIVING 13.83 NaN NaN NaN 7.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
557 ER+ ER+ ER+ TCGA-D8-A1JH-01 TCGA-D8-A1JH-01 FEMALE 56.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 14.00 NaN NaN NaN 6.0 4.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
558 ER+ ER+ ER+ TCGA-D8-A1JU-01 TCGA-D8-A1JU-01 FEMALE 51.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I followup LIVING 14.69 NaN NaN NaN 6.0 5.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
559 ER+ ER+ ER+ TCGA-AO-A1KO-01 TCGA-AO-A1KO-01 FEMALE 46.0 Positive Positive Negative T3 T_Other N0 Negative M0 Negative Stage IIB Stage IIB followup LIVING 14.72 NaN NaN NaN 6.0 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
560 ER+ ER+ ER+ TCGA-AO-A1KT-01 TCGA-AO-A1KT-01 FEMALE 78.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA followup LIVING 17.77 NaN NaN NaN 4.0 3.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
561 ER+ ER+ ER+ TCGA-AO-A0J5-01 TCGA-AO-A0J5-01 FEMALE 48.0 Positive Negative Negative T4 T_Other N1 Positive M1 Positive Stage IV No_Conversion followup LIVING 23.13 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
562 ER+ ER+ ER+ TCGA-B6-A1KC-01 TCGA-B6-A1KC-01 FEMALE 67.0 Positive Negative Not Available T2 T_Other N1 Positive M0 Negative Stage IIA Stage IIB followup LIVING 43.57 NaN NaN NaN 5.0 3.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
563 ER+ ER+ ER+ TCGA-AO-A1KQ-01 TCGA-AO-A1KQ-01 MALE 84.0 Positive Positive Negative T4 T_Other N1 Positive M0 Negative Stage IIIB Stage IIIB followup LIVING 49.91 NaN NaN NaN 4.0 2.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
564 ER+ ER+ ER+ TCGA-B6-A1KI-01 TCGA-B6-A1KI-01 FEMALE 63.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I followup LIVING 73.46 NaN NaN NaN 2.0 1.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
565 ER+ ER+ ER+ TCGA-AO-A1KP-01 TCGA-AO-A1KP-01 FEMALE 77.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA followup LIVING 82.56 NaN NaN NaN 6.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
566 HER2+ HER2+ ER-/HER2+ TCGA-B6-A1KF-01 TCGA-B6-A1KF-01 FEMALE 68.0 Negative Negative Positive T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB followup LIVING 101.46 NaN NaN NaN 5.0 4.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
567 HER2+ HER2+ ER-/HER2+ TCGA-B6-A1KN-01 TCGA-B6-A1KN-01 FEMALE 57.0 Negative Negative Positive T4 T_Other N1 Positive M0 Negative Stage IIIB Stage IIIC followup LIVING 139.08 NaN NaN NaN 6.0 3.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
568 ER+ ER+ ER+ TCGA-D8-A1XO-01 TCGA-D8-A1XO-01 FEMALE 56.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 7.95 NaN NaN NaN 7.0 1.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
569 HER2+ HER2+ ER-/HER2+ TCGA-D8-A1XT-01 TCGA-D8-A1XT-01 FEMALE 61.0 Negative Negative Positive T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment LIVING 6.34 NaN NaN NaN 4.0 4.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
570 TNBC TNBC TNBC TCGA-A1-A0SP-01 TCGA-A1-A0SP-01 FEMALE 40.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 19.15 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
571 ER+ ER+ ER+ TCGA-D8-A1J8-01 TCGA-D8-A1J8-01 FEMALE 77.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 8.41 NaN NaN NaN 4.0 3.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
572 TNBC TNBC TNBC TCGA-D8-A1JF-01 TCGA-D8-A1JF-01 FEMALE 79.0 Negative Negative Negative T1 T1 N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 3.15 NaN NaN NaN 3.0 1.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
573 TNBC TNBC TNBC TCGA-D8-A1JG-01 TCGA-D8-A1JG-01 FEMALE 62.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 6.14 NaN NaN NaN 3.0 4.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
574 HER2+ ER+ ER+/HER2+ TCGA-D8-A1XS-01 TCGA-D8-A1XS-01 MALE 48.0 Positive Positive Positive T2 T_Other N3 Positive M0 Negative Stage IIIC Stage IIIC enrollment LIVING 0.59 NaN NaN NaN 4.0 2.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
575 ER+ ER+ ER+ TCGA-A1-A0SB-01 TCGA-A1-A0SB-01 FEMALE 70.0 Positive Negative Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 8.51 NaN NaN NaN 3.0 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
576 ER+ ER+ ER+ TCGA-A1-A0SF-01 TCGA-A1-A0SF-01 FEMALE 54.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 48.07 NaN NaN NaN 6.0 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
577 ER+ ER+ ER+ TCGA-A1-A0SG-01 TCGA-A1-A0SG-01 FEMALE 61.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 14.23 NaN NaN NaN 5.0 2.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
578 ER+ ER+ ER+ TCGA-A1-A0SI-01 TCGA-A1-A0SI-01 FEMALE 52.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 20.83 NaN NaN NaN 7.0 5.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
579 HER2+ ER+ ER+/HER2+ TCGA-A1-A0SN-01 TCGA-A1-A0SN-01 FEMALE 50.0 Positive Positive Positive T1 T1 N1 Positive M0 Negative Stage IIIA Stage IIA enrollment LIVING 39.29 NaN NaN NaN 4.0 3.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
580 ER+ ER+ ER+ TCGA-A1-A0SQ-01 TCGA-A1-A0SQ-01 FEMALE 45.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 18.17 NaN NaN NaN 2.0 2.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
581 ER+ ER+ ER+ TCGA-A2-A1FV-01 TCGA-A2-A1FV-01 FEMALE 74.0 Positive Positive Negative T3 T_Other N0 Negative M0 Negative Stage IIB Stage IIB enrollment LIVING 15.11 NaN NaN NaN 6.0 3.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
582 ER+ ER+ ER+ TCGA-A2-A1FW-01 TCGA-A2-A1FW-01 FEMALE 62.0 Positive Negative Negative T3 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 7.26 NaN NaN NaN 6.0 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
583 ER+ ER+ ER+ TCGA-A2-A1FX-01 TCGA-A2-A1FX-01 FEMALE 61.0 Positive Positive Negative T3 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 30.72 NaN NaN NaN 4.0 4.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
584 ER+ ER+ ER+ TCGA-A2-A1FZ-01 TCGA-A2-A1FZ-01 FEMALE 63.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 13.44 NaN NaN NaN 6.0 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
585 ER+ ER+ ER+ TCGA-A2-A1G0-01 TCGA-A2-A1G0-01 FEMALE 49.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 12.48 NaN NaN NaN 6.0 2.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
586 HER2+ HER2+ ER-/HER2+ TCGA-A2-A1G1-01 TCGA-A2-A1G1-01 FEMALE 85.0 Negative Negative Positive T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 12.19 NaN NaN NaN 6.0 5.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
587 ER+ ER+ ER+ TCGA-A2-A1G4-01 TCGA-A2-A1G4-01 FEMALE 71.0 Positive Positive Negative T3 T_Other N1 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 12.22 NaN NaN NaN 5.0 4.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
588 TNBC TNBC TNBC TCGA-A2-A1G6-01 TCGA-A2-A1G6-01 FEMALE 50.0 Negative Negative Negative T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 4.34 NaN NaN NaN 6.0 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
589 ER+ ER+ ER+ TCGA-A2-A259-01 TCGA-A2-A259-01 FEMALE 70.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I enrollment LIVING 42.22 NaN NaN NaN NaN 1.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
590 ER+ ER+ ER+ TCGA-A2-A25A-01 TCGA-A2-A25A-01 FEMALE 44.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 97.51 NaN NaN NaN NaN 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
591 ER+ ER+ ER+ TCGA-A2-A25B-01 TCGA-A2-A25B-01 FEMALE 39.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 8.48 NaN NaN NaN 5.0 4.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
592 ER+ ER+ ER+ TCGA-A2-A25C-01 TCGA-A2-A25C-01 FEMALE 50.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 9.36 NaN NaN NaN 5.0 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
593 ER+ ER+ ER+ TCGA-A2-A25D-01 TCGA-A2-A25D-01 FEMALE 90.0 Positive Negative Negative T2 T_Other N3 Positive M0 Negative Stage IIIC Stage IIIC enrollment LIVING 7.98 NaN NaN NaN NaN 4.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
594 ER+ ER+ ER+ TCGA-A2-A25E-01 TCGA-A2-A25E-01 FEMALE 34.0 Positive Positive Equivocal T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 82.50 NaN NaN NaN 5.0 4.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
595 NaN NaN NaN TCGA-A2-A25F-01 TCGA-A2-A25F-01 FEMALE 66.0 Negative Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 3.71 NaN NaN NaN NaN 1.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
596 TNBC TNBC TNBC TCGA-A7-A26F-01 TCGA-A7-A26F-01 FEMALE 55.0 Negative Negative Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I enrollment LIVING 8.44 NaN NaN NaN 5.0 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
597 TNBC TNBC TNBC TCGA-A7-A26G-01 TCGA-A7-A26G-01 FEMALE 50.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 6.87 NaN NaN NaN 4.0 5.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
598 HER2+ ER+ ER+/HER2+ TCGA-A7-A26H-01 TCGA-A7-A26H-01 FEMALE 72.0 Positive Negative Positive T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment LIVING 2.10 NaN NaN NaN NaN 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
599 TNBC TNBC TNBC TCGA-A7-A26I-01 TCGA-A7-A26I-01 FEMALE 65.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 4.01 NaN NaN NaN NaN 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
600 ER+ ER+ ER+ TCGA-A7-A26J-01 TCGA-A7-A26J-01 FEMALE 49.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 2.20 NaN NaN NaN 6.0 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
601 HER2+ ER+ ER+/HER2+ TCGA-A8-A08S-01 TCGA-A8-A08S-01 FEMALE 71.0 Positive Positive Positive T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment LIVING 19.06 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
602 ER+ ER+ ER+ TCGA-A8-A09E-01 TCGA-A8-A09E-01 FEMALE 73.0 Positive Positive Equivocal T4 T_Other N1 Positive M0 Negative Stage IIIB Stage IIIB enrollment LIVING 30.95 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
603 ER+ ER+ ER+ TCGA-A8-A09K-01 TCGA-A8-A09K-01 FEMALE 68.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment LIVING 29.93 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
604 HER2+ ER+ ER+/HER2+ TCGA-AC-A23C-01 TCGA-AC-A23C-01 FEMALE 62.0 Positive Positive Positive T2 T_Other N1 Positive M0 Negative NaN Stage IIB enrollment LIVING 0.95 NaN NaN NaN 7.0 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
605 ER+ ER+ ER+ TCGA-AC-A23E-01 TCGA-AC-A23E-01 FEMALE 50.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative NaN Stage IIB enrollment LIVING 2.37 NaN NaN NaN NaN 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
606 HER2+ ER+ ER+/HER2+ TCGA-AC-A23H-01 TCGA-AC-A23H-01 FEMALE 90.0 Positive Negative Positive T2 T_Other N0 Negative M0 Negative NaN Stage IIA enrollment LIVING 2.66 NaN NaN NaN NaN 3.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
607 NaN NaN NaN TCGA-AO-A1KR-01 TCGA-AO-A1KR-01 FEMALE 51.0 Negative Negative NaN NaN NaN NaN NaN NaN NaN NaN NaN enrollment LIVING 70.31 NaN NaN NaN 3.0 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
608 HER2+ ER+ ER+/HER2+ TCGA-AQ-A1H2-01 TCGA-AQ-A1H2-01 FEMALE 84.0 Positive Positive Positive T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 6.47 NaN NaN NaN 1.0 2.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
609 ER+ ER+ ER+ TCGA-AQ-A1H3-01 TCGA-AQ-A1H3-01 FEMALE 49.0 Positive Positive Negative T2 T_Other N3 Positive M0 Negative Stage IIIC Stage IIIC enrollment LIVING 4.53 NaN NaN NaN 6.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
610 ER+ ER+ ER+ TCGA-AR-A24H-01 TCGA-AR-A24H-01 FEMALE 65.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage II Stage IIA enrollment LIVING 109.51 NaN NaN NaN NaN 3.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
611 ER+ ER+ ER+ TCGA-AR-A24K-01 TCGA-AR-A24K-01 FEMALE 46.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage II Stage IIA enrollment LIVING 50.86 NaN NaN NaN NaN 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
612 ER+ ER+ ER+ TCGA-AR-A24L-01 TCGA-AR-A24L-01 FEMALE 26.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage II Stage IIB enrollment LIVING 72.97 NaN NaN NaN 4.0 2.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
613 ER+ ER+ ER+ TCGA-AR-A24M-01 TCGA-AR-A24M-01 FEMALE 38.0 Positive Positive Negative T2 T_Other N2 Positive M0 Negative Stage III Stage IIIA enrollment LIVING 65.38 NaN NaN NaN 7.0 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
614 ER+ ER+ ER+ TCGA-AR-A24N-01 TCGA-AR-A24N-01 FEMALE 54.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 68.14 NaN NaN NaN 3.0 3.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
615 ER+ ER+ ER+ TCGA-AR-A24O-01 TCGA-AR-A24O-01 FEMALE 43.0 Positive Positive Negative T3 T_Other N2 Positive M0 Negative Stage III Stage IIIA enrollment LIVING 65.61 NaN NaN NaN 7.0 1.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
616 ER+ ER+ ER+ TCGA-AR-A24P-01 TCGA-AR-A24P-01 FEMALE 47.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 0.85 NaN NaN NaN 2.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
617 ER+ ER+ ER+ TCGA-AR-A24Q-01 TCGA-AR-A24Q-01 FEMALE 49.0 Positive Negative Negative T3 T_Other N0 Negative M0 Negative Stage II Stage IIB enrollment LIVING 65.97 NaN NaN NaN 6.0 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
618 ER+ ER+ ER+ TCGA-AR-A24R-01 TCGA-AR-A24R-01 FEMALE 45.0 Positive Positive Negative T1 T1 N2 Positive M0 Negative Stage III Stage IIIA enrollment LIVING 57.33 NaN NaN NaN 5.0 3.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
619 ER+ ER+ ER+ TCGA-AR-A24S-01 TCGA-AR-A24S-01 FEMALE 61.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 62.03 NaN NaN NaN 4.0 2.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
620 ER+ ER+ ER+ TCGA-AR-A24T-01 TCGA-AR-A24T-01 FEMALE 46.0 Positive Positive Negative T3 T_Other N3 Positive M0 Negative Stage III Stage IIIC enrollment LIVING 53.23 NaN NaN NaN 2.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
621 HER2+ HER2+ ER-/HER2+ TCGA-AR-A24U-01 TCGA-AR-A24U-01 FEMALE 47.0 Negative Negative Positive T1 T1 N1 Positive M0 Negative Stage II Stage IIA enrollment LIVING 53.32 NaN NaN NaN 7.0 1.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
622 ER+ ER+ ER+ TCGA-AR-A24V-01 TCGA-AR-A24V-01 FEMALE 52.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage II Stage IIB enrollment LIVING 54.14 NaN NaN NaN 4.0 4.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
623 ER+ ER+ ER+ TCGA-AR-A24X-01 TCGA-AR-A24X-01 FEMALE 52.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage II Stage IIA enrollment LIVING 48.13 NaN NaN NaN 2.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
624 ER+ ER+ ER+ TCGA-AR-A24Z-01 TCGA-AR-A24Z-01 FEMALE 57.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage II Stage IIA enrollment LIVING 51.71 NaN NaN NaN NaN 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
625 HER2+ ER+ ER+/HER2+ TCGA-AR-A250-01 TCGA-AR-A250-01 FEMALE 58.0 Positive Negative Positive T2 T_Other N0 Negative M0 Negative Stage II Stage IIA enrollment LIVING 56.08 NaN NaN NaN 4.0 3.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
626 ER+ ER+ ER+ TCGA-AR-A251-01 TCGA-AR-A251-01 FEMALE 51.0 Positive Negative Negative T2 T_Other N2 Positive M0 Negative Stage III Stage IIIA enrollment LIVING 45.11 NaN NaN NaN NaN 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
627 ER+ ER+ ER+ TCGA-AR-A252-01 TCGA-AR-A252-01 FEMALE 50.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 40.61 NaN NaN NaN 1.0 1.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
628 HER2+ ER+ ER+/HER2+ TCGA-AR-A254-01 TCGA-AR-A254-01 FEMALE 50.0 Positive Positive Positive T2 T_Other N2 Positive M0 Negative Stage III Stage IIIA enrollment LIVING 39.82 NaN NaN NaN NaN 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
629 HER2+ ER+ ER+/HER2+ TCGA-AR-A255-01 TCGA-AR-A255-01 FEMALE 62.0 Positive Positive Positive T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 34.76 NaN NaN NaN NaN 3.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
630 ER+ ER+ ER+ TCGA-BH-A0B2-01 TCGA-BH-A0B2-01 FEMALE 43.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 40.81 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
631 ER+ ER+ ER+ TCGA-BH-A0DV-01 TCGA-BH-A0DV-01 FEMALE 54.0 Positive Positive Negative T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 45.14 NaN NaN NaN 6.0 1.0 ReacII 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
632 ER+ ER+ ER+ TCGA-BH-A201-01 TCGA-BH-A201-01 FEMALE 64.0 Positive Positive NaN NaN NaN NaN NaN NaN NaN NaN NaN enrollment LIVING 6.87 NaN NaN NaN 6.0 4.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
633 ER+ ER+ ER+ TCGA-BH-A202-01 TCGA-BH-A202-01 FEMALE 60.0 Positive Positive NaN NaN NaN NaN NaN NaN NaN NaN NaN enrollment LIVING 0.72 NaN NaN NaN 6.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
634 ER+ ER+ ER+ TCGA-BH-A28Q-01 TCGA-BH-A28Q-01 FEMALE 46.0 Positive Positive NaN NaN NaN NaN NaN NaN NaN NaN NaN enrollment LIVING 6.44 NaN NaN NaN NaN 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
635 ER+ ER+ ER+ TCGA-C8-A1HE-01 TCGA-C8-A1HE-01 FEMALE 59.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.00 NaN NaN NaN 2.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
636 TNBC TNBC TNBC TCGA-C8-A1HJ-01 TCGA-C8-A1HJ-01 FEMALE 53.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage II Stage IIA enrollment LIVING 0.16 NaN NaN NaN 5.0 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
637 HER2+ HER2+ ER-/HER2+ TCGA-C8-A1HK-01 TCGA-C8-A1HK-01 FEMALE 53.0 Negative Negative Positive T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 0.23 NaN NaN NaN 1.0 4.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
638 ER+ ER+ ER+ TCGA-C8-A1HO-01 TCGA-C8-A1HO-01 FEMALE 34.0 Positive Positive Negative T3 T_Other N3 Positive M0 Negative Stage III Stage IIIC enrollment LIVING 0.00 NaN NaN NaN 5.0 3.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
639 ER+ ER+ ER+ TCGA-C8-A26V-01 TCGA-C8-A26V-01 FEMALE 47.0 Positive Positive Negative T3 T_Other N2 Positive M0 Negative Stage III Stage IIIA enrollment LIVING 0.30 NaN NaN NaN NaN 4.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
640 HER2+ ER+ ER+/HER2+ TCGA-C8-A26W-01 TCGA-C8-A26W-01 FEMALE 58.0 Positive Positive Positive T2 T_Other N1 Positive M0 Negative Stage II Stage IIB enrollment LIVING 0.23 NaN NaN NaN NaN 1.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
641 TNBC TNBC TNBC TCGA-C8-A26X-01 TCGA-C8-A26X-01 FEMALE 58.0 Negative Negative Negative T1 T1 N1 Positive M0 Negative Stage II Stage IIA enrollment LIVING 0.36 NaN NaN NaN NaN 4.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
642 TNBC TNBC TNBC TCGA-C8-A26Y-01 TCGA-C8-A26Y-01 FEMALE 90.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage II Stage IIA enrollment LIVING 0.43 NaN NaN NaN NaN 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
643 ER+ ER+ ER+ TCGA-C8-A26Z-01 TCGA-C8-A26Z-01 FEMALE 59.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.13 NaN NaN NaN NaN 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
644 ER+ ER+ ER+ TCGA-C8-A273-01 TCGA-C8-A273-01 FEMALE 29.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 0.20 NaN NaN NaN NaN 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
645 ER+ ER+ ER+ TCGA-C8-A274-01 TCGA-C8-A274-01 FEMALE 63.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.03 NaN NaN NaN NaN 3.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
646 HER2+ HER2+ None TCGA-C8-A275-01 TCGA-C8-A275-01 FEMALE 56.0 Not Performed Not Performed Positive T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment LIVING 0.03 NaN NaN NaN NaN 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
647 HER2+ HER2+ ER-/HER2+ TCGA-C8-A278-01 TCGA-C8-A278-01 FEMALE 61.0 Negative Negative Positive T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 0.03 NaN NaN NaN NaN 4.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
648 ER+ ER+ ER+ TCGA-C8-A27A-01 TCGA-C8-A27A-01 FEMALE 48.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 12.19 NaN NaN NaN 5.0 3.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
649 TNBC TNBC TNBC TCGA-C8-A27B-01 TCGA-C8-A27B-01 FEMALE 48.0 Negative Negative Negative T3 T_Other N0 Negative M0 Negative Stage IIB Stage IIB enrollment LIVING 0.99 NaN NaN NaN 5.0 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
650 ER+ ER+ ER+ TCGA-D8-A146-01 TCGA-D8-A146-01 FEMALE 57.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 11.30 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
651 HER2+ ER+ ER+/HER2+ TCGA-D8-A1J9-01 TCGA-D8-A1J9-01 FEMALE 48.0 Positive Negative Positive T1 T1 N0 Negative M0 Negative Stage IA Stage I enrollment LIVING 8.15 NaN NaN NaN 1.0 3.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
652 HER2+ HER2+ ER-/HER2+ TCGA-D8-A1JA-01 TCGA-D8-A1JA-01 FEMALE 60.0 Negative Negative Positive T4 T_Other N0 Negative M0 Negative Stage X Stage IIIB enrollment LIVING 0.59 NaN NaN NaN 5.0 4.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
653 HER2+ ER+ ER+/HER2+ TCGA-D8-A1JB-01 TCGA-D8-A1JB-01 FEMALE 54.0 Positive Positive Positive T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 0.00 NaN NaN NaN 6.0 1.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
654 ER+ ER+ ER+ TCGA-D8-A1JC-01 TCGA-D8-A1JC-01 FEMALE 59.0 Positive Positive Negative T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 5.85 NaN NaN NaN 4.0 2.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
655 ER+ ER+ ER+ TCGA-D8-A1JD-01 TCGA-D8-A1JD-01 FEMALE 41.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 8.97 NaN NaN NaN 4.0 2.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
656 ER+ ER+ ER+ TCGA-D8-A1JE-01 TCGA-D8-A1JE-01 FEMALE 62.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment LIVING 1.87 NaN NaN NaN 4.0 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
657 ER+ ER+ ER+ TCGA-D8-A1JI-01 TCGA-D8-A1JI-01 FEMALE 54.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment LIVING 0.69 NaN NaN NaN 1.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
658 ER+ ER+ ER+ TCGA-D8-A1JJ-01 TCGA-D8-A1JJ-01 FEMALE 54.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 9.00 NaN NaN NaN 4.0 4.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
659 NaN NaN NaN TCGA-D8-A1JK-01 TCGA-D8-A1JK-01 FEMALE 90.0 Negative Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 3.58 NaN NaN NaN 4.0 1.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
660 TNBC TNBC TNBC TCGA-D8-A1JL-01 TCGA-D8-A1JL-01 FEMALE 72.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 8.71 NaN NaN NaN 2.0 5.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
661 ER+ ER+ ER+ TCGA-D8-A1JM-01 TCGA-D8-A1JM-01 FEMALE 59.0 Positive Negative Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 7.82 NaN NaN NaN NaN 4.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
662 ER+ ER+ ER+ TCGA-D8-A1JN-01 TCGA-D8-A1JN-01 FEMALE 80.0 Positive Positive Negative T3 T_Other N3 Positive M0 Negative Stage IIIC Stage IIIC enrollment LIVING 7.13 NaN NaN NaN 3.0 3.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
663 ER+ ER+ ER+ TCGA-D8-A1JP-01 TCGA-D8-A1JP-01 FEMALE 73.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I enrollment LIVING 5.49 NaN NaN NaN 6.0 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
664 HER2+ ER+ ER+/HER2+ TCGA-D8-A1X5-01 TCGA-D8-A1X5-01 FEMALE 81.0 Positive Positive Positive T2 T_Other N3 Positive M0 Negative Stage IIIC Stage IIIC enrollment LIVING 5.62 NaN NaN NaN 5.0 3.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
665 ER+ ER+ ER+ TCGA-D8-A1X6-01 TCGA-D8-A1X6-01 FEMALE 80.0 Positive Positive Negative T3 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 7.75 NaN NaN NaN 5.0 4.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
666 ER+ ER+ ER+ TCGA-D8-A1X7-01 TCGA-D8-A1X7-01 FEMALE 40.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 2.79 NaN NaN NaN 6.0 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
667 ER+ ER+ ER+ TCGA-D8-A1X8-01 TCGA-D8-A1X8-01 FEMALE 62.0 Positive Indeterminate Negative T1 T1 N2 Positive M0 Negative Stage IIA Stage IIIA enrollment LIVING 8.94 NaN NaN NaN 1.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
668 ER+ ER+ ER+ TCGA-D8-A1X9-01 TCGA-D8-A1X9-01 FEMALE 66.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIA Stage IIB enrollment LIVING 12.48 NaN NaN NaN NaN 3.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
669 ER+ ER+ ER+ TCGA-D8-A1XA-01 TCGA-D8-A1XA-01 FEMALE 64.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I enrollment LIVING 9.00 NaN NaN NaN 2.0 4.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
670 ER+ ER+ ER+ TCGA-D8-A1XB-01 TCGA-D8-A1XB-01 FEMALE 62.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 6.60 NaN NaN NaN 4.0 4.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
671 ER+ ER+ ER+ TCGA-D8-A1XC-01 TCGA-D8-A1XC-01 FEMALE 85.0 Positive Positive Negative T4 T_Other N1 Positive M0 Negative Stage IIIB Stage IIIB enrollment LIVING 2.66 NaN NaN NaN 7.0 2.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
672 ER+ ER+ ER+ TCGA-D8-A1XD-01 TCGA-D8-A1XD-01 FEMALE 36.0 Positive Positive Negative T1 T1 N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 5.09 NaN NaN NaN 5.0 4.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
673 ER+ ER+ ER+ TCGA-D8-A1XF-01 TCGA-D8-A1XF-01 FEMALE 45.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 6.47 NaN NaN NaN 5.0 3.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
674 ER+ ER+ ER+ TCGA-D8-A1XG-01 TCGA-D8-A1XG-01 FEMALE 86.0 Positive Negative Negative T4 T_Other N1 Positive M0 Negative Stage IIIB Stage IIIB enrollment LIVING 6.44 NaN NaN NaN 1.0 2.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
675 HER2+ ER+ ER+/HER2+ TCGA-D8-A1XJ-01 TCGA-D8-A1XJ-01 FEMALE 76.0 Positive Positive Positive T3 T_Other N1 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 11.56 NaN NaN NaN 7.0 3.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
676 TNBC TNBC TNBC TCGA-D8-A1XK-01 TCGA-D8-A1XK-01 FEMALE 55.0 Negative Negative Negative T2 T_Other N1 Positive M0 Negative Stage IB Stage IIB enrollment LIVING 10.71 NaN NaN NaN 5.0 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
677 ER+ ER+ ER+ TCGA-D8-A1XL-01 TCGA-D8-A1XL-01 FEMALE 34.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 10.48 NaN NaN NaN 7.0 1.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
678 ER+ ER+ ER+ TCGA-D8-A1XM-01 TCGA-D8-A1XM-01 FEMALE 57.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I enrollment LIVING 7.16 NaN NaN NaN 4.0 1.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
679 TNBC TNBC TNBC TCGA-D8-A1XQ-01 TCGA-D8-A1XQ-01 FEMALE 69.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 5.82 NaN NaN NaN 3.0 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
680 ER+ ER+ ER+ TCGA-D8-A1XR-01 TCGA-D8-A1XR-01 FEMALE 56.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 5.52 NaN NaN NaN 3.0 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
681 ER+ ER+ ER+ TCGA-D8-A1XU-01 TCGA-D8-A1XU-01 FEMALE 56.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I enrollment LIVING 4.90 NaN NaN NaN 6.0 3.0 NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
682 ER+ ER+ ER+ TCGA-D8-A1XV-01 TCGA-D8-A1XV-01 FEMALE 84.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 4.80 NaN NaN NaN 7.0 3.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
683 NaN NaN NaN TCGA-D8-A1XW-01 TCGA-D8-A1XW-01 FEMALE 53.0 Negative Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 3.84 NaN NaN NaN 3.0 5.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
684 HER2+ ER+ ER+/HER2+ TCGA-D8-A1XY-01 TCGA-D8-A1XY-01 FEMALE 74.0 Positive Positive Positive T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 2.66 NaN NaN NaN 4.0 2.0 NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
685 ER+ ER+ ER+ TCGA-D8-A1XZ-01 TCGA-D8-A1XZ-01 FEMALE 81.0 Positive Negative Negative T1 T1 N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 3.94 NaN NaN NaN 5.0 4.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
686 ER+ ER+ ER+ TCGA-D8-A1Y0-01 TCGA-D8-A1Y0-01 FEMALE 65.0 Positive Positive Negative T1 T1 N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 5.45 NaN NaN NaN 7.0 4.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
687 ER+ ER+ ER+ TCGA-D8-A1Y1-01 TCGA-D8-A1Y1-01 FEMALE 80.0 Positive Positive Negative T3 T_Other N1 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 3.78 NaN NaN NaN 7.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
688 ER+ ER+ ER+ TCGA-D8-A1Y2-01 TCGA-D8-A1Y2-01 FEMALE 71.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 2.37 NaN NaN NaN NaN 1.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
689 ER+ ER+ ER+ TCGA-D8-A1Y3-01 TCGA-D8-A1Y3-01 FEMALE 61.0 Positive Positive Negative T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 4.07 NaN NaN NaN NaN 3.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
690 ER+ ER+ ER+ TCGA-D8-A27E-01 TCGA-D8-A27E-01 FEMALE 66.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I enrollment LIVING 5.98 NaN NaN NaN NaN 5.0 NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
691 TNBC TNBC TNBC TCGA-D8-A27F-01 TCGA-D8-A27F-01 FEMALE 40.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 7.46 NaN NaN NaN NaN 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
692 ER+ ER+ ER+ TCGA-D8-A27G-01 TCGA-D8-A27G-01 FEMALE 75.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 6.87 NaN NaN NaN NaN 3.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
693 TNBC TNBC TNBC TCGA-D8-A27H-01 TCGA-D8-A27H-01 FEMALE 72.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 4.60 NaN NaN NaN NaN 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
694 ER+ ER+ ER+ TCGA-D8-A27I-01 TCGA-D8-A27I-01 FEMALE 58.0 Positive Positive Negative T1 T1 N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 6.08 NaN NaN NaN NaN 1.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
695 ER+ ER+ ER+ TCGA-D8-A27K-01 TCGA-D8-A27K-01 FEMALE 47.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 3.88 NaN NaN NaN NaN 1.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
696 ER+ ER+ ER+ TCGA-D8-A27L-01 TCGA-D8-A27L-01 FEMALE 49.0 Positive Positive Negative T1 T1 N2 Positive M0 Negative Stage IIB Stage IIIA enrollment LIVING 4.11 NaN NaN NaN NaN 1.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
697 TNBC TNBC TNBC TCGA-D8-A27M-01 TCGA-D8-A27M-01 FEMALE 59.0 Negative Negative Negative T1 T1 N0 Negative M0 Negative Stage IIA Stage I enrollment LIVING 4.73 NaN NaN NaN NaN 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
698 HER2+ ER+ ER+/HER2+ TCGA-D8-A27N-01 TCGA-D8-A27N-01 FEMALE 36.0 Positive Positive Positive T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 4.76 NaN NaN NaN NaN 4.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
699 ER+ ER+ ER+ TCGA-D8-A27P-01 TCGA-D8-A27P-01 FEMALE 64.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IIA Stage I enrollment LIVING 0.72 NaN NaN NaN NaN 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
700 ER+ ER+ ER+ TCGA-D8-A27R-01 TCGA-D8-A27R-01 FEMALE 41.0 Positive Positive Negative T2 T_Other N3 Positive M0 Negative Stage IIIC Stage IIIC enrollment LIVING 2.96 NaN NaN NaN NaN 1.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
701 ER+ ER+ ER+ TCGA-D8-A27T-01 TCGA-D8-A27T-01 FEMALE 53.0 Positive Positive Negative T2 T_Other N3 Positive M0 Negative Stage IIIC Stage IIIC enrollment LIVING 4.44 NaN NaN NaN NaN 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
702 ER+ ER+ ER+ TCGA-D8-A27V-01 TCGA-D8-A27V-01 FEMALE 62.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 2.40 NaN NaN NaN NaN 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
703 HER2+ ER+ ER+/HER2+ TCGA-D8-A27W-01 TCGA-D8-A27W-01 FEMALE 55.0 Positive Positive Positive T4 T_Other N0 Negative M0 Negative Stage IIIB Stage IIIB enrollment LIVING 0.49 NaN NaN NaN NaN 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
704 ER+ ER+ ER+ TCGA-E2-A1IE-01 TCGA-E2-A1IE-01 FEMALE 61.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 32.30 NaN NaN NaN 6.0 3.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
705 ER+ ER+ ER+ TCGA-E2-A1IF-01 TCGA-E2-A1IF-01 FEMALE 74.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 31.41 NaN NaN NaN 6.0 5.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
706 ER+ ER+ ER+ TCGA-E2-A1IG-01 TCGA-E2-A1IG-01 FEMALE 45.0 Positive Positive Not Available T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 24.81 NaN NaN NaN 4.0 4.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
707 ER+ ER+ ER+ TCGA-E2-A1IH-01 TCGA-E2-A1IH-01 FEMALE 80.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 21.62 NaN NaN NaN 6.0 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
708 NaN NaN NaN TCGA-E2-A1II-01 TCGA-E2-A1II-01 FEMALE 51.0 Negative Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 27.93 NaN NaN NaN 5.0 5.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
709 ER+ ER+ ER+ TCGA-E2-A1IJ-01 TCGA-E2-A1IJ-01 FEMALE 57.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 23.82 NaN NaN NaN 4.0 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
710 ER+ ER+ ER+ TCGA-E2-A1IK-01 TCGA-E2-A1IK-01 FEMALE 71.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment LIVING 17.02 NaN NaN NaN 7.0 1.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
711 ER+ ER+ ER+ TCGA-E2-A1IL-01 TCGA-E2-A1IL-01 FEMALE 78.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment LIVING 0.46 NaN NaN NaN 6.0 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
712 ER+ ER+ ER+ TCGA-E2-A1IN-01 TCGA-E2-A1IN-01 FEMALE 60.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 12.88 NaN NaN NaN 2.0 2.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
713 ER+ ER+ ER+ TCGA-E2-A1IO-01 TCGA-E2-A1IO-01 FEMALE 37.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 14.72 NaN NaN NaN 4.0 1.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
714 ER+ ER+ ER+ TCGA-E2-A1IP-01 TCGA-E2-A1IP-01 FEMALE 42.0 Positive Negative Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 14.03 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
715 ER+ ER+ ER+ TCGA-E2-A1IU-01 TCGA-E2-A1IU-01 FEMALE 60.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I enrollment LIVING 4.17 NaN NaN NaN 2.0 1.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
716 ER+ ER+ ER+ TCGA-E2-A1L6-01 TCGA-E2-A1L6-01 FEMALE 44.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment LIVING 43.11 NaN NaN NaN 7.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
717 TNBC TNBC TNBC TCGA-E2-A1L7-01 TCGA-E2-A1L7-01 FEMALE 40.0 Negative Negative Negative T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 20.80 NaN NaN NaN 5.0 2.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
718 ER+ ER+ ER+ TCGA-E2-A1L8-01 TCGA-E2-A1L8-01 FEMALE 52.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIA Stage IIB enrollment LIVING 33.35 NaN NaN NaN 6.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
719 ER+ ER+ ER+ TCGA-E2-A1L9-01 TCGA-E2-A1L9-01 FEMALE 40.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIB Stage IIA enrollment LIVING 12.75 NaN NaN NaN 6.0 1.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
720 ER+ ER+ ER+ TCGA-E2-A1LA-01 TCGA-E2-A1LA-01 FEMALE 59.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment LIVING 15.21 NaN NaN NaN 2.0 2.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
721 HER2+ HER2+ ER-/HER2+ TCGA-E2-A1LB-01 TCGA-E2-A1LB-01 FEMALE 41.0 Negative Negative Positive T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 31.94 NaN NaN NaN 3.0 4.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
722 TNBC TNBC TNBC TCGA-E2-A1LG-01 TCGA-E2-A1LG-01 FEMALE 50.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 11.50 NaN NaN NaN 5.0 5.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
723 TNBC TNBC TNBC TCGA-E2-A1LH-01 TCGA-E2-A1LH-01 FEMALE 59.0 Negative Negative Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 94.46 NaN NaN NaN NaN 5.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
724 TNBC TNBC TNBC TCGA-E2-A1LI-01 TCGA-E2-A1LI-01 FEMALE 57.0 Negative Negative Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 90.35 NaN NaN NaN NaN 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
725 TNBC TNBC TNBC TCGA-E2-A1LL-01 TCGA-E2-A1LL-01 FEMALE 73.0 Negative Negative Negative T3 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 33.31 NaN NaN NaN 4.0 1.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
726 TNBC TNBC TNBC TCGA-E2-A1LS-01 TCGA-E2-A1LS-01 FEMALE 46.0 Negative Negative Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I enrollment LIVING 7.85 NaN NaN NaN NaN 3.0 NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
727 NaN NaN NaN TCGA-E9-A1N3-01 TCGA-E9-A1N3-01 FEMALE 70.0 Not Performed Not Performed Negative T1 T1 N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 0.00 NaN NaN NaN NaN 4.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
728 ER+ ER+ ER+ TCGA-E9-A1N4-01 TCGA-E9-A1N4-01 FEMALE 41.0 Positive Positive Negative T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 0.00 NaN NaN NaN 7.0 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
729 ER+ ER+ ER+ TCGA-E9-A1N5-01 TCGA-E9-A1N5-01 FEMALE 45.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 0.00 NaN NaN NaN 2.0 4.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
730 HER2+ ER+ ER+/HER2+ TCGA-E9-A1N6-01 TCGA-E9-A1N6-01 FEMALE 52.0 Positive Positive Positive T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 0.00 NaN NaN NaN 4.0 4.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
731 NaN NaN NaN TCGA-E9-A1N8-01 TCGA-E9-A1N8-01 FEMALE 48.0 Negative Not Performed Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.00 NaN NaN NaN 5.0 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
732 NaN NaN NaN TCGA-E9-A1N9-01 TCGA-E9-A1N9-01 FEMALE 58.0 Negative Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.00 NaN NaN NaN 5.0 1.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
733 ER+ ER+ ER+ TCGA-E9-A1NA-01 TCGA-E9-A1NA-01 FEMALE 58.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.00 NaN NaN NaN 4.0 3.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
734 NaN NaN NaN TCGA-E9-A1NC-01 TCGA-E9-A1NC-01 FEMALE 61.0 Negative Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 0.00 NaN NaN NaN NaN 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
735 TNBC TNBC TNBC TCGA-E9-A1ND-01 TCGA-E9-A1ND-01 FEMALE 75.0 Negative Negative Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 0.00 NaN NaN NaN 5.0 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
736 ER+ ER+ ER+ TCGA-E9-A1NE-01 TCGA-E9-A1NE-01 FEMALE 28.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 0.00 NaN NaN NaN 6.0 4.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
737 ER+ ER+ ER+ TCGA-E9-A1NF-01 TCGA-E9-A1NF-01 FEMALE 60.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.00 NaN NaN NaN 4.0 4.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
738 ER+ ER+ ER+ TCGA-E9-A1NG-01 TCGA-E9-A1NG-01 FEMALE 62.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.00 NaN NaN NaN 4.0 2.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
739 ER+ ER+ ER+ TCGA-E9-A1NH-01 TCGA-E9-A1NH-01 FEMALE 71.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 0.00 NaN NaN NaN 4.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
740 ER+ ER+ ER+ TCGA-E9-A1NI-01 TCGA-E9-A1NI-01 FEMALE 51.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.00 NaN NaN NaN 4.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
741 NaN NaN NaN TCGA-E9-A1QZ-01 TCGA-E9-A1QZ-01 FEMALE 61.0 Not Performed Not Performed Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.00 NaN NaN NaN NaN 1.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
742 NaN NaN NaN TCGA-E9-A1R0-01 TCGA-E9-A1R0-01 FEMALE 58.0 Not Performed Not Performed Negative T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment LIVING 0.00 NaN NaN NaN NaN 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
743 ER+ ER+ ER+ TCGA-E9-A1R2-01 TCGA-E9-A1R2-01 FEMALE 51.0 Positive Negative Negative T2 T_Other N3 Positive M0 Negative Stage IIIC Stage IIIC enrollment LIVING 0.62 NaN NaN NaN 7.0 4.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
744 NaN NaN NaN TCGA-E9-A1R3-01 TCGA-E9-A1R3-01 FEMALE 70.0 Not Performed Not Performed Negative T2 T_Other N3 Positive M0 Negative Stage IIIC Stage IIIC enrollment LIVING 2.10 NaN NaN NaN 4.0 1.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
745 NaN NaN NaN TCGA-E9-A1R4-01 TCGA-E9-A1R4-01 FEMALE 66.0 Not Performed Not Performed Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I enrollment LIVING 0.95 NaN NaN NaN 4.0 1.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
746 NaN NaN NaN TCGA-E9-A1R5-01 TCGA-E9-A1R5-01 FEMALE 63.0 Not Performed Not Performed Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I enrollment LIVING 1.38 NaN NaN NaN 4.0 3.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
747 NaN NaN NaN TCGA-E9-A1R6-01 TCGA-E9-A1R6-01 FEMALE 63.0 Not Performed Not Performed Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 2.76 NaN NaN NaN 2.0 3.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
748 NaN NaN NaN TCGA-E9-A1R7-01 TCGA-E9-A1R7-01 FEMALE 64.0 Not Performed Not Performed Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 1.12 NaN NaN NaN 1.0 3.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
749 NaN NaN NaN TCGA-E9-A1RA-01 TCGA-E9-A1RA-01 FEMALE 48.0 Not Performed Not Performed Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I enrollment LIVING 0.95 NaN NaN NaN 6.0 1.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
750 NaN NaN NaN TCGA-E9-A1RB-01 TCGA-E9-A1RB-01 FEMALE 40.0 Not Performed Not Performed Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.69 NaN NaN NaN NaN 1.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
751 NaN NaN NaN TCGA-E9-A1RC-01 TCGA-E9-A1RC-01 FEMALE 56.0 Not Performed Not Performed Negative T4 T_Other N3 Positive M0 Negative Stage IIIC Stage IIIC enrollment LIVING 40.35 NaN NaN NaN NaN 3.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
752 NaN NaN NaN TCGA-E9-A1RD-01 TCGA-E9-A1RD-01 FEMALE 67.0 Not Performed Not Performed Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.66 NaN NaN NaN NaN 3.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
753 NaN NaN NaN TCGA-E9-A1RE-01 TCGA-E9-A1RE-01 FEMALE 74.0 Not Performed Not Performed Negative T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 1.54 NaN NaN NaN NaN 3.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
754 NaN NaN NaN TCGA-E9-A1RF-01 TCGA-E9-A1RF-01 FEMALE 68.0 Not Performed Not Performed Negative T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 1.25 NaN NaN NaN NaN 3.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
755 NaN NaN NaN TCGA-E9-A1RG-01 TCGA-E9-A1RG-01 FEMALE 62.0 Not Performed Not Performed Negative T1 T1 N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 1.15 NaN NaN NaN 5.0 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
756 NaN NaN NaN TCGA-E9-A1RH-01 TCGA-E9-A1RH-01 FEMALE 63.0 Not Performed Not Performed Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.46 NaN NaN NaN 4.0 4.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
757 NaN NaN NaN TCGA-E9-A1RI-01 TCGA-E9-A1RI-01 FEMALE 43.0 Not Performed Not Performed Not Available T1 T1 N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 1.58 NaN NaN NaN 4.0 1.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
758 NaN NaN NaN TCGA-E9-A226-01 TCGA-E9-A226-01 FEMALE 45.0 Not Performed Not Performed Negative T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 0.53 NaN NaN NaN NaN 3.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
759 ER+ ER+ ER+ TCGA-E9-A227-01 TCGA-E9-A227-01 FEMALE 42.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 0.79 NaN NaN NaN NaN 1.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
760 HER2+ HER2+ None TCGA-E9-A228-01 TCGA-E9-A228-01 FEMALE 58.0 Not Performed Not Performed Positive T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 0.00 NaN NaN NaN NaN 3.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
761 NaN NaN NaN TCGA-E9-A229-01 TCGA-E9-A229-01 FEMALE 37.0 Not Performed Not Performed Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I enrollment LIVING 0.00 NaN NaN NaN NaN 1.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
762 ER+ ER+ ER+ TCGA-E9-A22A-01 TCGA-E9-A22A-01 FEMALE 74.0 Positive Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.00 NaN NaN NaN NaN 3.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
763 ER+ ER+ ER+ TCGA-E9-A22B-01 TCGA-E9-A22B-01 FEMALE 71.0 Positive Negative Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I enrollment LIVING 0.00 NaN NaN NaN NaN 3.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
764 HER2+ ER+ ER+/HER2+ TCGA-E9-A22D-01 TCGA-E9-A22D-01 FEMALE 38.0 Positive Positive Positive T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.00 NaN NaN NaN NaN 3.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
765 ER+ ER+ ER+ TCGA-E9-A22E-01 TCGA-E9-A22E-01 FEMALE 56.0 Positive Positive Negative T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 0.00 NaN NaN NaN NaN 4.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
766 TNBC TNBC TNBC TCGA-E9-A22G-01 TCGA-E9-A22G-01 FEMALE 47.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIIA Stage IIA enrollment LIVING 0.00 NaN NaN NaN NaN 3.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
767 ER+ ER+ ER+ TCGA-E9-A22H-01 TCGA-E9-A22H-01 FEMALE 42.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 0.00 NaN NaN NaN NaN 1.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
768 NaN NaN NaN TCGA-E9-A243-01 TCGA-E9-A243-01 FEMALE 52.0 Not Performed Not Performed Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 1.41 NaN NaN NaN 3.0 5.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
769 NaN NaN NaN TCGA-E9-A244-01 TCGA-E9-A244-01 FEMALE 54.0 Not Performed Not Performed Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.66 NaN NaN NaN NaN 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
770 NaN NaN NaN TCGA-E9-A245-01 TCGA-E9-A245-01 FEMALE 47.0 Not Performed Not Performed Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 0.82 NaN NaN NaN NaN 2.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
771 NaN NaN NaN TCGA-E9-A247-01 TCGA-E9-A247-01 FEMALE 59.0 Not Performed Not Performed Negative T1 T1 N0 Negative M0 Negative Stage IB Stage I enrollment LIVING 0.39 NaN NaN NaN NaN 3.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
772 NaN NaN NaN TCGA-E9-A248-01 TCGA-E9-A248-01 FEMALE 51.0 Not Performed Not Performed Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.69 NaN NaN NaN 3.0 1.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
773 NaN NaN NaN TCGA-E9-A249-01 TCGA-E9-A249-01 FEMALE 45.0 Not Performed Not Performed Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 0.92 NaN NaN NaN 3.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
774 NaN NaN NaN TCGA-E9-A24A-01 TCGA-E9-A24A-01 FEMALE 69.0 Not Performed Not Performed Negative T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment LIVING 0.33 NaN NaN NaN 2.0 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
775 HER2+ ER+ ER+/HER2+ TCGA-EW-A1IW-01 TCGA-EW-A1IW-01 FEMALE 80.0 Positive Positive Positive T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 8.28 NaN NaN NaN 4.0 3.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
776 ER+ ER+ ER+ TCGA-EW-A1IX-01 TCGA-EW-A1IX-01 FEMALE 48.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment LIVING 35.55 NaN NaN NaN 4.0 1.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
777 ER+ ER+ ER+ TCGA-EW-A1IY-01 TCGA-EW-A1IY-01 FEMALE 38.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 8.48 NaN NaN NaN 7.0 1.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
778 ER+ ER+ ER+ TCGA-EW-A1IZ-01 TCGA-EW-A1IZ-01 FEMALE 53.0 Positive Positive Negative T2 T_Other N2 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 8.54 NaN NaN NaN 3.0 2.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
779 ER+ ER+ ER+ TCGA-EW-A1J1-01 TCGA-EW-A1J1-01 FEMALE 38.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 9.27 NaN NaN NaN 5.0 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
780 ER+ ER+ ER+ TCGA-EW-A1J2-01 TCGA-EW-A1J2-01 FEMALE 50.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIB Stage IIA enrollment LIVING 4.57 NaN NaN NaN 6.0 2.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
781 HER2+ ER+ ER+/HER2+ TCGA-EW-A1J3-01 TCGA-EW-A1J3-01 FEMALE 61.0 Positive Positive Positive T1 T1 N0 Negative M0 Negative Stage IA Stage I enrollment LIVING 8.28 NaN NaN NaN 2.0 4.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
782 ER+ ER+ ER+ TCGA-EW-A1J5-01 TCGA-EW-A1J5-01 FEMALE 59.0 Positive Positive Negative T3 T_Other N0 Negative M0 Negative Stage IIB Stage IIB enrollment LIVING 7.46 NaN NaN NaN 7.0 4.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
783 ER+ ER+ ER+ TCGA-EW-A1J6-01 TCGA-EW-A1J6-01 FEMALE 70.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage I Stage I enrollment LIVING 19.55 NaN NaN NaN 2.0 5.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
784 TNBC TNBC TNBC TCGA-EW-A1OV-01 TCGA-EW-A1OV-01 FEMALE 56.0 Negative Negative Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 17.15 NaN NaN NaN 5.0 4.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
785 TNBC TNBC TNBC TCGA-EW-A1OW-01 TCGA-EW-A1OW-01 FEMALE 58.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 15.21 NaN NaN NaN NaN 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
786 ER+ ER+ ER+ TCGA-EW-A1OX-01 TCGA-EW-A1OX-01 FEMALE 43.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 18.46 NaN NaN NaN 1.0 3.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
787 ER+ ER+ ER+ TCGA-EW-A1OY-01 TCGA-EW-A1OY-01 FEMALE 63.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 19.48 NaN NaN NaN 4.0 2.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
788 HER2+ ER+ ER+/HER2+ TCGA-EW-A1OZ-01 TCGA-EW-A1OZ-01 FEMALE 56.0 Positive Negative Positive T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 30.92 NaN NaN NaN 4.0 4.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
789 ER+ ER+ ER+ TCGA-EW-A1P0-01 TCGA-EW-A1P0-01 FEMALE 55.0 Positive Negative Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 36.83 NaN NaN NaN 7.0 5.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
790 TNBC TNBC TNBC TCGA-EW-A1P1-01 TCGA-EW-A1P1-01 FEMALE 68.0 Negative Negative Negative T2 T_Other N3 Positive M0 Negative Stage IIIC Stage IIIC enrollment LIVING 30.19 NaN NaN NaN 6.0 1.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
791 ER+ ER+ ER+ TCGA-EW-A1P3-01 TCGA-EW-A1P3-01 FEMALE 48.0 Positive Positive Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 32.43 NaN NaN NaN 4.0 1.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
792 TNBC TNBC TNBC TCGA-EW-A1P4-01 TCGA-EW-A1P4-01 FEMALE 43.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 16.46 NaN NaN NaN 5.0 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
793 ER+ ER+ ER+ TCGA-EW-A1P5-01 TCGA-EW-A1P5-01 FEMALE 77.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 11.99 NaN NaN NaN 3.0 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
794 ER+ ER+ ER+ TCGA-EW-A1P6-01 TCGA-EW-A1P6-01 FEMALE 64.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 10.25 NaN NaN NaN 2.0 2.0 NaN 4.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
795 TNBC TNBC TNBC TCGA-EW-A1P7-01 TCGA-EW-A1P7-01 FEMALE 59.0 Negative Negative Negative T2 T_Other N0 Negative M0 Negative Stage IIA Stage IIA enrollment LIVING 20.86 NaN NaN NaN 3.0 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
796 ER+ ER+ ER+ TCGA-EW-A1PA-01 TCGA-EW-A1PA-01 FEMALE 59.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 8.77 NaN NaN NaN NaN 4.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
797 TNBC TNBC TNBC TCGA-EW-A1PB-01 TCGA-EW-A1PB-01 FEMALE 70.0 Negative Negative Negative T3 T_Other N1 Positive M0 Negative Stage IIIA Stage IIIA enrollment LIVING 19.98 NaN NaN NaN 2.0 5.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
798 HER2+ ER+ ER+/HER2+ TCGA-EW-A1PD-01 TCGA-EW-A1PD-01 MALE 61.0 Positive Positive Positive T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment LIVING 5.72 NaN NaN NaN 4.0 2.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
799 ER+ ER+ ER+ TCGA-EW-A1PE-01 TCGA-EW-A1PE-01 FEMALE 56.0 Positive Positive Negative T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment LIVING 4.57 NaN NaN NaN 3.0 1.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
800 ER+ ER+ ER+ TCGA-EW-A1PF-01 TCGA-EW-A1PF-01 FEMALE 50.0 Positive Positive Negative T1 T1 N0 Negative M0 Negative Stage IA Stage I enrollment LIVING 4.57 NaN NaN NaN 4.0 1.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
801 ER+ ER+ ER+ TCGA-EW-A1PG-01 TCGA-EW-A1PG-01 FEMALE 53.0 Positive Positive Negative T2 T_Other N1 Positive M0 Negative Stage IIB Stage IIB enrollment LIVING 28.75 NaN NaN NaN 6.0 1.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
802 NaN NaN NaN TCGA-EW-A1PH-01 TCGA-EW-A1PH-01 FEMALE 52.0 Negative Negative Not Available T1 T1 N1 Positive M0 Negative Stage IIA Stage IIA enrollment LIVING 4.57 NaN NaN NaN 5.0 5.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
803 ER+ ER+ ER+ TCGA-EW-A2FS-01 TCGA-EW-A2FS-01 FEMALE 41.0 Positive Negative NaN NaN NaN NaN NaN NaN NaN NaN NaN enrollment LIVING 38.54 NaN NaN NaN NaN 4.0 NaN 5.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
804 ER+ ER+ ER+ TCGA-EW-A2FV-01 TCGA-EW-A2FV-01 FEMALE 39.0 Positive Positive NaN NaN NaN NaN NaN NaN NaN NaN NaN enrollment LIVING 7.82 NaN NaN NaN NaN 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
805 ER+ ER+ ER+ TCGA-EW-A2FW-01 TCGA-EW-A2FW-01 FEMALE 52.0 Positive Positive NaN NaN NaN NaN NaN NaN NaN NaN NaN enrollment LIVING 6.24 NaN NaN NaN NaN 2.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
806 ER+ ER+ ER+ TCGA-GM-A2DA-01 TCGA-GM-A2DA-01 FEMALE 46.0 Positive Positive NaN NaN NaN NaN NaN NaN NaN NaN NaN enrollment LIVING 194.14 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
807 NaN NaN NaN TCGA-GM-A2DB-01 TCGA-GM-A2DB-01 FEMALE 62.0 Negative Negative NaN NaN NaN NaN NaN NaN NaN NaN NaN enrollment LIVING 53.06 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
808 ER+ ER+ ER+ TCGA-GM-A2DC-01 TCGA-GM-A2DC-01 FEMALE 57.0 Positive Positive NaN NaN NaN NaN NaN NaN NaN NaN NaN enrollment LIVING 53.49 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
809 NaN NaN NaN TCGA-GM-A2DD-01 TCGA-GM-A2DD-01 FEMALE 53.0 Negative Negative NaN NaN NaN NaN NaN NaN NaN NaN NaN enrollment LIVING 43.01 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
810 NaN NaN NaN TCGA-GM-A2DF-01 TCGA-GM-A2DF-01 FEMALE 53.0 Negative Negative NaN NaN NaN NaN NaN NaN NaN NaN NaN enrollment LIVING 42.68 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
811 NaN NaN NaN TCGA-GM-A2DH-01 TCGA-GM-A2DH-01 FEMALE 58.0 Negative Negative NaN NaN NaN NaN NaN NaN NaN NaN NaN enrollment LIVING 42.25 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
812 NaN NaN NaN TCGA-GM-A2DI-01 TCGA-GM-A2DI-01 FEMALE 52.0 Negative Negative NaN NaN NaN NaN NaN NaN NaN NaN NaN enrollment LIVING 61.87 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
813 ER+ ER+ ER+ TCGA-GM-A2DK-01 TCGA-GM-A2DK-01 FEMALE 58.0 Positive Negative NaN NaN NaN NaN NaN NaN NaN NaN NaN enrollment LIVING 62.29 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
814 ER+ ER+ ER+ TCGA-GM-A2DL-01 TCGA-GM-A2DL-01 FEMALE 50.0 Positive Positive NaN NaN NaN NaN NaN NaN NaN NaN NaN enrollment LIVING 90.75 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
815 ER+ ER+ ER+ TCGA-GM-A2DM-01 TCGA-GM-A2DM-01 FEMALE 57.0 Positive Positive NaN NaN NaN NaN NaN NaN NaN NaN NaN enrollment LIVING 76.58 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
816 ER+ ER+ ER+ TCGA-GM-A2DN-01 TCGA-GM-A2DN-01 FEMALE 58.0 Positive Positive NaN NaN NaN NaN NaN NaN NaN NaN NaN enrollment LIVING 77.27 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
817 ER+ ER+ ER+ TCGA-GM-A2DO-01 TCGA-GM-A2DO-01 FEMALE 54.0 Positive Positive NaN NaN NaN NaN NaN NaN NaN NaN NaN enrollment LIVING 53.29 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
818 NaN NaN NaN TCGA-AR-A24W-01 TCGA-AR-A24W-01 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 6.0 1.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
819 NaN NaN NaN TCGA-AC-A2B8-01 TCGA-AC-A2B8-01 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 1.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
820 NaN NaN NaN TCGA-AC-A2FF-01 TCGA-AC-A2FF-01 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 1.0 NaN 1.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
821 NaN NaN NaN TCGA-AC-A2FB-01 TCGA-AC-A2FB-01 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 1.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
822 NaN NaN NaN TCGA-AC-A2FG-01 TCGA-AC-A2FG-01 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 1.0 NaN 2.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
823 NaN NaN NaN TCGA-GI-A2C8-01 TCGA-GI-A2C8-01 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 3.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma
824 NaN NaN NaN TCGA-E9-A295-01 TCGA-E9-A295-01 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 4.0 NaN 3.0 NaN NaN NaN Breast Cancer Invasive Breast Carcinoma